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THE PREDICTIVE PERFORMANCE OF THE POSSUM SCORING SYSTEM AND 
EARLY INDICATORS OF PERIPHERAL PERFUSION FOR COMPLICATIONS 
AFTER MAJOR ABDOMINAL SURGERY 
 
Abstract 
Postoperative complications are the major cause of postoperative morbidity and mortality and 
remain to be a serious burden for a healthcare system. The early identification of patients at risk 
may play a pivotal role in rational decisions regarding perioperative management. The aim of this 
study was to explore the characteristics of complications in high-risk patients after major abdominal 
surgery. We also assessed and compared the accuracy of the Clavien-Dindo classification (CDC) 
and the Comprehensive Complication Index (CCI) for evaluation of postoperative morbidity and the 
predictive performance of the POSSUM scoring system for complications and mortality. Finally, 
we wanted to explore the significance of early indicators of altered peripheral perfusion after major 
abdominal surgery for the occurrence of severe complications. 
A prospective, observational, cohort study included 206 high-risk surgical patients undergoing 
major abdominal surgery at the Clinic for Digestive Surgery, Clinical Center of Serbia, from 
November 2016 to October 2017.  
We found that the complication rate in our cohort was 60.7% and that the occurrence of 
complications was associated with the longer ICU stay (p<0.001), postoperative length of stay 
(p<0.001) and lower functional activity at hospital discharge (p<0.001). The CCI was shown to be 
of superior accuracy in high-risk patients with multiple complications compared to the CDC as it 
demonstrated a higher correlation to the resource utilization indicators (p<0.001). The POSSUM 
scoring system showed the sub-optimal performance for prediction of morbidity and mortality in 
this cohort of patients (AUCmorbidity= 0.708, O:E ratio=1.07; AUCmortality= 0.744, O:E ratio=0.38). 
We found that the alterations of peripheral perfusion early after the operation were more 
pronounced in patients who developed more severe complications. Capillary refill time, central-to-
peripheral temperature gradient, and venoarterial pCO2 difference to arteriovenous O2 content ratio 
on admission to the ICU after the operation, as well as serum lactate concentration and base excess 
12 hours after the admission to the ICU were the independent predictors of severe complications. 
Finally, based on the preoperative, intraoperative, and postoperative variables, with the application 
of the machine learning algorithms, we developed a new model for the prediction of postoperative 
complications. The model was validated  on the new set of patients and it demonstrated an excellent 
predictive performance (AUC=0.91; sensitivity 92%; specificity 78%; PPV 87%). 
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ZNAČAJ POSSUM SKORA I RANIH POKAZATELJA PERIFERNE PERFUZIJE 
ZA PREDVIĐANJE POSTOPERATIVNIH KOMPLIKACIJA U HIRURGIJI 
DIGESTIVNOG SISTEMA 
Sažetak 
Postoperativne komplikacije su vodeći uzrok postoperativnog morbiditeta i mortaliteta i 
predstavljaju značajno opterećenje za zdravstveni sistem u celini. Rana identifikacija 
bolesnika sa povećanim rizikom može imati ključnu ulogu u donošenju racionalnih odluka u 
vezi sa perioperativnim lečenjem. Cilj ove studije bio je da ispita karakteristike komplikacija 
kod visokorizičnih bolesnika nakon velike abdominalne hirurgije. Takođe smo procenili i 
uporedili preciznost Clavien-Dindo klasifikacije (CDC) i Comprehensive Complication 
Index-a (CCI) za evaluaciju postoperativnog morbiditeta i ispitali prediktivne karakteristike 
POSSUM skora za komplikacije i mortalitet. Konačno, analizirali smo značaj ranih 
pokazatelja periferne perfuzije za pojavu teških komplikacija nakon velike abdominalne 
hirurgije. 
Prospektivna, opservaciona, kohortna studija pratila je 206 visokorizičnih bolesnika 
podvrgnutih velikoj abdominalnoj operaciji na Klinici za digestivnu hirurgiju Kliničkog 
centra Srbije, od novembra 2016 do oktobra 2017.godine. 
Pokazali smo da je učestalost komplikacija u našoj kohorti bila 60.7% i da je pojava 
komplikacija bila udružena sa dužim boravkom u jedinici intenzivnog lečenja (JIL) (p< 
0.001), dužom postoperativnom hospitalizacijom (p<0.001) i nižim funkcionalnim 
kapacitetom na otpustu iz bolnice (p<0.001). Takođe je prikazano da je CCI prikladnija skala 
za visokorizične bolesnike sa udruženim komplikacijama u poređenju sa CDC jer je ispoljila 
jaču korelaciju sa parametrima hospitalizacije (p<0.001). POSSUM skor je pokazao 
suboptimalne karakteristike u predviđanju rizika za morbiditet i mortalitet u ovoj kohorti 
bolesnika (AUCmorbiditet = 0.708, O:E odnos = 1.07; AUCmortalitet = 0.744, O:E odnos =0.38). 
Poremećaj periferne perfizije rano nakon operacije bio je izraženiji kod onih bolesnika kod 
kojih su se razvile teže komplikacije. Kao nezavisni prediktori teških komplikacija su se 
izdvojili vreme kapilarnog punjenja, centralno-periferni gradijent temperature i odnos 
venoarterijske razlike pCO2 i arteriovenske razlike u sadržaju kiseonika na prijemu u JIL 
nakon operacije, kao i serumska koncentracija laktata i bazni eksces 12 sati nakon operacije. 
Konačno, na osnovu preoperativnih, intraoperativnih i postoperativnih varijabli, primenom 
algoritama mašinskog učenja, kreirali smo novi model za predviđanje postoperativnih 
komplikacija. Model je eksterno validiran i pokazao je odlične prediktivne karakteristike 
(AUC = 0.91; senzitivnost 92%; specifičnost 78%; pozitivna prediktivna vrednost 87%). 
 
 
Ključne reči: velika abdominalna hirurgija; postoperativne komplikacije; periferna perfuzija; 
POSSUM skor 
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1.1.1.Epidemiology and Significance  
 
Surgery is an effective treatment option for a variety of diseases and today one can 
hardly imagine it be replaced by conservative treatment even in the categories of very old 
patients, with numerous comorbidities and advanced malignant diseases. Estimates are that 
every year more than 312 million operations are performed worldwide, although 
epidemiological studies indicate that as many as 4.8 billion of the world population has no 
access to any surgical treatment. 1,2  Elective non-cardiac surgery can now be considered safe, 
even if associated with the global mortality rate of 1-4%.3–5 Abdominal surgery is amongst 
the most prevalent surgical fields and the associated mortality for hepatobiliary, colorectal 
and upper gastrointestinal surgery is 0.6%, 1.0% and 1.5%.4  However, within the population 
older than 65 years of age, the 90-day mortality up to 40% after surgery such as 
esophagectomy and gastrectomy is described.6 This information gains on importance bearing 
in mind that at this time one fifth of the population of Europe is over the age of 65, and that 
by 2050, this age group will constitute more than 30%.7 Advances in surgery and anaesthesia, 
as well as improving perioperative care, will inevitably reduce the overall surgery-related 
mortality, while the improvements of the health care systems will make surgical treatment 
accessible to more people. It is foreseeable that postoperative complications will then be 
appearing in a significant number of patients.2  
Postoperative complications are the leading cause of postoperative morbidity and mortality.8 
It has been shown that the occurrence of postoperative complications has a greater influence 
on long-term survival after surgery than preoperative patient condition and intraoperative 
events.9,10 The economic consequences of the complicated postoperative course are enormous 
both for the patients and the health system.11 Evidently, a large volume of surgical treatments 
will always be accompanied by complications, however their number and difficulty can be 
reduced by identifying patients with risk factors, early diagnosis, timely resolution, and by 
providing an adequate level of treatment such as placement in an intensive care unit (ICU).12  
2 
 
1.1.2.Definition and Classification of the Postoperative Complications 
 
Mortality as a surgical outcome has long been the only measure of work quality and risk, 
associated with a particular operation.13 Comparing the mortality rate after surgery between 
the states, hospitals and surgeons, provide information of importance to the patients, health 
system and institutions responsible for health policy. Death is an outcome incapable of 
subjective interpretation, dichotomous in its character and easily accessible in medical 
documentation, therefore being suitable as an indicator of the medical treatment outcome.3 
Drastic decline in mortality after elective surgery recognised in recent decades, in parallel 
with growing expectations of improved quality of surgical treatment and cost reductions, 
contributed to the shift of attention from mortality to other outcomes, such as morbidity, 
quality of life after surgery, length of hospitalisation and so forth.14,15 Morbidity resulting 
from postoperative complications is the usual way of measuring an adverse effect of surgery. 
However, the absence of standardisation in defining and quantifying the complications that 
exists in the professional literature makes it impossible to compare results and make valid 
conclusions about the overall morbidity that accompanies certain operations. The analysis of 
119 studies investigating short-term outcomes of esophagectomy, pancreatectomy and 
hepatectomy have shown that complications were defined in 34% of cases and their difficulty 
in only 20% of the studies.16  Many authors inconsistently quantify complications as minor 
and major, or show only those which they evaluate as being significant, all the while omitting 
others with lesser clinical significance.17,18 Undoubtedly, this leads to insufficient 
complications reporting, heterogeneity in reporting and more challenging interpretation of the 
surgical outcomes. 
 
1.1.3. The Clavien-Dindo Classification 
 
In 1992, with an aim to overcome these problems, a new proposal for classification of 
complications was presented.19 At first, three different types of negative outcomes were 
defined: complications, failure to cure, and sequelae.19,20  
The complication is defined as "any deviation from the ideal postoperative course that is not 
inherent in the procedure and does not comprise the failure to cure" .21 Pancreatic fistula and 
intra-abdominal abscess after pancreatic resection are examples of the complications in 
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accordance with this definition. 
Failure to cure is a failure of surgical therapy to meet the basic goal of the surgery.19 The 
surgery may be unsuccessful, even though it is well performed and the postoperative course 
is complications free. An example of this would be R2 resection of pancreatic tumour, which 
has failed to reach an oncological aim of the surgery. 
Sequelae is an outcome whose main feature is that it is inherent to the procedure.19 As such, it 
is in a certain way anticipated, as well as being characterised by durability. Diabetes after 
total pancreatectomy or “short bowel syndrome” after extensive resection of the intestines are 
typical sequelae in the abdominal surgery. 
The Clavien-Dindo Classification of Surgical Complications is a system that ranks 
complications based on the therapeutic interventions applied to their treatment.19,20 In this 
way, it avoids subjectivity in the qualification of the severity of complications and allows for 
the recording of all relevant complications, especially in retrospective analyses, since 
therapeutic intervention data is usually well documented. The system consists of five levels 
of complications severity (I-V).20 Grade I complications are all deviations from the ideal 
postoperative course without the need for a specific pharmacological or surgical and 
endoscopic treatment.  Grade II represents complications requiring pharmacotherapy. 
Complications of Grade III are those that are treated by surgical, endoscopic or radiological 
intervention, either in the local (Grade IIIa) or general anaesthesia (Grade IIIb). Patients with 
Grade IV complications have a life-threatening condition due to mono-organ (Grade IVa) or 
multiorgan (Grade IVb) dysfunction and require treatment in an Intensive Care Unit (ICU). 
Grade V signifies the death of a patient. To each of the grades the suffix "d" can be added, 
indicating invalidity (disability) and defined as a temporary or permanent disorder of function 
that usually lags upon completion of the surgical treatment. (Table 1.1) 
Since its publication and after the revision in 2004, The Clavien-Dindo Classification of 
Surgical Complications has gained great popularity as a way of assessing the quality of 
perioperative treatment and has been used as a basis for reporting complications in over 1000 
papers in specialised literature for various areas of surgery.17,22–25 In addition, it is used as a 
measure of quality of work in everyday practice and is supported by several professional 
associations.26 
For a classification to be widely accepted, it is necessary for it to be precise, simple and 
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reproducible. Validation of The Clavien-Dindo Classification of Surgical Complications was 
first performed retrospectively in the cohort of patients undergoing general surgery when a 
positive correlation of the grade of complications with the length of hospitalisation and the 
complexity of the surgery was shown.20,27 
 
Table 1. The Clavien-Dindo Classification of Surgical Complications20 
Grade Definition 
Grade I Any deviation from the normal postoperative course without the need for 
pharmacological treatment or surgical, endoscopic and radiological 
interventions 
Allowed therapeutic regimens are drugs as antiemetics, antipyretics, 
analgesics, diuretics, electrolytes and physiotherapy. This grade also includes 
wound infection, which are being treated only locally.  
Grade II Requiring pharmacological treatment with drugs other than such allowed for 
grade I complications. 
Blood transfusions and total parenteral nutrition are also included. 
Grade III 
   Grade IIIa 
   Grade IIIb 
Requiring surgical, endoscopic or radiological intervention 
Intervention not under general anaesthesia 
Intervention under general anaesthesia 
Grade IV 
  Grade IVa 
Life-threatening complication requiring ICU treatment 
Mono-organ dysfunction  
  Grade IVb Multiorgan dysfunction 
Grade V Death of a patient 
Suffix „d“ If the patient suffers from a complication at the time of discharge, the suffix 
„d“is added to the respective grade of complication. This label indicates the 
need for a follow-up with the aim to evaluate the disability.  
 
Also, the reproducibility of the classification was demonstrated by the correct identification 
and classification of complications in the identical clinical scenario by surgeons with various 
experiences on all 5 continents.20 Finally, the subjective severity-of-complication experience 
of the patients measured by the visual analogue scale has shown a high correlation with the 
grade of the Clavien-Dindo classification.20 This provides for a possibility to use the 
classification while informing the patient on the surgical risk and postoperative morbidity 
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during joint decision- making about the surgery. 
The important limitation regarding The Clavien-Dindo Classification is that with the aim of 
simplicity, the entire postoperative course is described with one and the most severe 
complication, while ignoring the significance of other, less severe ones.  
As an example, in this way, the postoperative course of a patient who, after the total 
colectomy developed acute renal insufficiency (Grade IVa) as the only complication, is 
assessed as more severe, than the postoperative course of the patient who developed 
pneumonia (Grade II), deep venous thrombosis (Grade II), bleeding ulceration managed with 
the endoscopic haemostasis (Grade IIIa) and anastomotic breakdown that required surgical 
treatment (Grade IIIb). 
The Clavien-Dindo classification is, in addition, an ordinal scale rather than a continuous one, 
so the difference between grades III and IV do not have to be the same as between grades II 
and I. This makes it difficult to apply it to the analysis and interpretation of the actual severity 
of the postoperative course. 
 
1.1.4. The Comprehensive Complication Index 
 
Recognising the significance of the appearance of multiple complications on the precise view 
of the postoperative outcome, as well as the fact that the patients and doctors have a different 
perception of the severity of complications, Ksenija Slankamenac and associates proposed, in 
2013, a new comprehensive system for measuring the morbidity in surgery.28,29 
The Comprehensive Complication Index (CCI) is created using a methodology widely used 
in economic sciences, which takes into account the perspective of the different stakeholders. 
In the first phase, doctors and patients, applying a numerical analogue scale, separately 
evaluated the severity of 30 postoperative complications suggested in the identical 
questionnaire. For each complication, a median-severity as assessed by patients and 
physicians was multiplied and for the patients with multiple complications these products 
were summed.29 Finally, with the aim of easier clinical application, mathematical 
transformation has provided a linear scale at which "0" corresponds to the absence of 
complications and "100" to the death of a patient. The CCI takes into account all the 
complications occurring in the postoperative period, graded according to the Clavien-Dindo 
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classification. In a complex clinical scenario, in patients with multiple complications, the CCI 
value accurately describes postoperative morbidity as a relative contribution of less severe 
complications decreases with the increasing values of the score.29 In a patient who has died as 
the consequence of numerous complications, morbidity can not be observed in this way only, 
because CCI resulting in a death of a patient is always 100, regardless of the severity and the 
number of complications that preceded it. (Table 1.2) Calculation of CCI for an individual or 
a group of patients is easy and can be done using a public online program 
(www.assessurgery.com).29  
Table 2. Clinical examples of the CCI in cases with one or more complications after the total 
gastrectomy procedure 
Outcome Complication Clavien-Dindo 
Complication Grade 
CCI 



























Arrhythmia due to hyperkalaemia 











Scenario 2 Wound infection 
Pneumonia 






Scenario 3 Transient increase in creatinine 
Tachyarrhythmia 
C. dificille colitis 
Bleeding 







Scenario 4 Pain 


















After the creation of the score, validation of the CCI for complications after the abdominal 
surgery was performed.29 It has been shown that the score is suitable for use in randomised 
clinical trials as it reduces the required sample size when the overall postoperative morbidity 
is viewed as an outcome.30  In patients undergoing esophagectomy, there was a stronger 
correlation of CCI with the length of hospitalisation, the frequency of reoperation and 
reintubation compared to the Clavien-Dindo classification.31 The scale was used to 
demonstrate morbidity after hyperthermic intraperitoneal chemotherapy (HIPEC), for 
comparison of outcomes of open and minimal invasive esophagectomy, and risk factors for 
high CCI after hepatectomy were also examined.32–34 A prospective study involving all 
operated patients at the Department of Surgery of the University Hospital in Zurich, has 
shown that concomitant complications occur in 44% of patients with complicated 
postoperative course and that CCI significantly improves the Clavien-Dindo classification 
while showing the outcomes of the surgery.35 In this centre, both complication classification 
systems are used in daily work and in weekly analyses of hospital morbidity and mortality.35 
 
1.2. COMPLICATIONS AFTER THE ABDOMINAL SURGERY 
 
1.2.1. Introduction 
Abdominal surgery is burdened with a significant morbidity because after the routine, major 
elective surgical procedures complications occur with an incidence of over 50%.36,37 Etiology 
of the postoperative complications, both medical and surgical, is complex and multifactorial. 
The risk factors for complications include factors related to the patient, such as life 
expectancy, comorbidity, and functional capacity at the time of surgery. Then, there are the 
surgery related factors, complexity of surgery, localisation, and the degree of urgency. 
Finally, the occurrence of complications is affected by the organisation of the perioperative 
care and availability of an adequate level of care.8,38  It is very likely that not all of the factors 
that contribute to the complications can be fully comprehend, nor all the mechanisms that 
explain their occurrence can be identified. 
There are numerous studies that point to the link between the global oxygen delivery to the 
tissues (DO2) and unfavourable surgical outcome.
39,40 Changes that occur in the splanchnic 
circulation during major surgery can at least partially explain significant morbidity after 
abdominal surgery, and very frequent gastrointestinal complications after non-abdominal 
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operations as well.41  
1.2.2. Splanchnic Circulation and the Significance of Changes in Gastrointestinal 
Perfusion 
 
Splanchnic circulation is a complex system that plays a major role in maintaining basic 
functions of the digestive tract, such as digestion and absorption, preservation of the mucosal 
membrane, secretion and motility, as well as numerous liver functions. It comprises blood 
flow to the abdominal gastrointestinal organs including liver, spleen, pancreas, and stomach, 
small and large intestines. The splanchnic system receives about 25% of the cardiac output 
across the first three major branches of the abdominal aorta: truncus coeliacus, superior and 
inferior mesenteric arteries. About a fourth of the arterial flow through the splanchnic region 
is immediately directed to the liver via the hepatic artery, the branch of the celiac artery.42 
The other three quarters arrive to the liver after the perfusion of the digestive organs, via the 
portal vein system. 
Digestive organs make up about 10% body weight, but contain about 25% of the total blood 
volume. In the condition of the sympathetic stimulation, nearly two thirds of the splanchnic 
blood volume can be autotransfused into systemic circulation within just a few seconds, 
which is more than 800 ml of blood in a normally nourished adult.43 Therefore, the 
splanchnic circulation is an important reservoir of blood for the entire circulatory system and 
is highly adaptive thanks to the physiological functions performed by the digestive system. 
Flow regulation through splanchnic circulation is performed by acting of the  internal (local 
metabolites with myogenic activity), external (autonomic nervous system) and humoral 
factors (locally produced or circulating vasoactive substances).42 The ability of 
catecholamines to increase the cardiac output largely depends on the compliance, capacity 
and volume of blood in the splanchnic circulatory system. Depending on the type of 
catecholamines and the density of adrenoreceptors in the blood vessels, the effect on the 
arteries may be constriction or relaxation. The dominant effect catecholamines produce on 
the large veins in the form of venocostrition, by increasing pressure in these blood vessels, 
efficiently displacing splanchnic blood into the systemic circulation. With this mechanism, 
during the physical activity, the volume of blood in the splanchnic circulation is decreased by 
35%.44 Hypovolemia causes activation of the sympathetic nervous system and increased 
concentration of the circulating catecholamines. The suppression of blood from the body 
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reservoirs (predominantly splanchnic veins) into systemic circulation is a form of 
compensation for the reduction of circulating volume. A study analysing the effects of 
controlled hemorrhage in dogs has shown that bleeding of such a size to cause the reduction 
in mean arterial pressure by 50% produces a reduction in the cardiac output by 50% and 
almost 90% reduction in the splanchnic volume of the blood.45 It has also been shown that 
moderate hypervolemia and hypovolemia that have no significant effect on cardiac output, 
significantly decrease the intestinal blood volume. 
The effects of catecholamines applied in the state of hypovolemia depend on the available 
amount of blood in the splanchnic resevoir. Under conditions of very severe hypovolaemia, 
when homeostatic mechanisms for maintaining blood pressure and cardiac output have 
already led to its significant discharge, the ability of exogenous catecholamines to improve 
systemic hemodynamics by modulating splanchnic flow rapidly decreases.43 Maintaining 
perfusion of the heart and brain can then partially be provided with large doses of 
catecholamines through further increase of systemic vascular resistance in the splanchnic 
region and other vascular beds. However, such an intensive vasoconstriction may have a 
detrimental effect on digestive organs due to severe ischemic injury. 
Hypoperfusion often occurs during major surgeries in general anesthesia as well as in the 
course of critical illness and the resulting non-occlusive mesenteric ischemia has different 
consequences for the digestive organs. Under the conditions of splanchnic hypoperfusion, the 
integrity of the intestinal villi and mucous barrier is disturbed and the conditions for the 
formation of bacterial translocation and the release of proinflammatory cytokines are created. 
The current theory is that the proinflammatory mediators and bacteria from ischemic intestine 
are not transmitted by portal blood flow, but by the mesenteric lymphatic system.46 As these 
directly enter into ductus thoracicus and then into v.subclavia, the first changes as a 
consequence of mucosal barrier damage usually occur in the lungs in the form of acute 
respiratory distress rather than on the liver as it could be expected.46 Reperfusion of the 
splanchnic region is causing the emergence of events that begin by creating free radicals, 
which cause tissue damage and neutrophil activation.42 The release of the inflammatory 
mediators, increased endothelial adhesion and increased vascular permeability are steps that 
can lead to the development of systemic inflammatory response syndrome (SIRS) and 
multiple organ dysfunction. 
It is clear that surgical manipulation has a direct mechanical effect on the splanchnic 
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circulation. Hemodynamic effects of the laparoscopic surgery depend primarily on the 
pressure of the insufflation that usually ranges from 12-15mmHg and the type of the gas 
used. Interestingly, although muscle relaxants do not have any direct effect on 
hemodynamics, the use of a deep neuromuscular block provides better surgical conditions 
with lower insufflation pressure and better splanchnic perfusion than moderate muscular 
block.47  
The technique of anesthesia and the choice of the anesthetic influence as well. It is expected 
that epidural blockage through the sympathetic and reduction of peripheral vascular 
resistance can cause an increase in splanchnic flow. However, systemic effects in the form of 
moderate mean arterial pressure reduction and cardiac output decrease potentially oppose this 
effect. One of the few studies directly measuring the flow in the inferior mesenteric artery 
(AMI – Acute Mesentric Ischemia) and the erythrocyte flux in colon serosa has shown that 
thoracic epidural anesthesia induces a flow decrease in AMI accompanied by the lowering of 
the mean arterial pressure.48 Re-establishing the normal flow was impossible to achieve by 
infusion of fluids nor by increasing the cardiac output, but exclusively by the use of 
vasopressors.48 
Vasoactive drugs, which have a broad application both  in anesthesia and in critically ill 
patients, have their own effect on the splanchnic perfusion. It has been shown that 
noradrenaline, the first-line vasopressor in septic shock, has minimal effect on mesenteric 
flow, but in combination with dobutamine it improves the splanchnic perfusion.49 Dopamine 
is traditionally attributed to be acting protectively on the splanchnic bed via D1- and D2-
receptors-mediated vasodilation. It has been shown, however, that although dobutamine and 
dopamine inotropic effect increase cardiac index and improve global hemodynamics, they do 
not have an effect on the increase of the flow in gastrointestinal mucosa, pancreas and kidney 
in septic patients.50 Adrenaline and phenylephrine reduce splanchnic perfusion.51  
Mechanical ventilation of the lungs during anesthesia and in the intensive care unit, by 
increasing intrathoracic pressure, has an effect on systemic circulation and flow through the 
gastrointestinal tract. The application of large tidal volumes and high inspiratory and end-
expiratory pressures reduces splanchnic perfusion. Repeated recruitment maneuvers reduce 
oxygen delivery to the splanchnic region, even though leading to the over-all improvement in 
oxygenation, while spontaneous breathing tests favorably affect the gastrointestinal flow.52 
Data on events in splanchnic circulation during abdominal operations can mostly be found in 
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the studies on experimental animal models. Thus, it has been shown that the maintenance of 
normovolemia is not enough to prevent intestinal hypoperfusion during and after the 
digestive tract operation.53 Because of the changed vasoregulation, the redirection of the flow 
from the superior and inferior mesenteric arteries to the organs supplied by the blood through 
the celiac artery occurs. Such redistribution of the flow causes signs of borderline perfusion 
of the intestinal mucosa despite normovolemia.53 Brügger et al demonstrated that changes in 
the regional gastrointestinal flow after fluid-challenge occur independently of changes in 
stroke volume (SV).54 This leads to an important conclusion that if intraoperative fluid 
resuscitation is guided by changes in SV exclusively, as required by the "goal-directed fluid 
management" protocols, an opportunity may be missed for optimising splanchnic perfusion 
during abdominal operations. 
The awareness of the importance of perfusion of the digestive tract for successful abdominal 
surgeries and events in critical illness has contributed to the creation of numerous measuring 
techniques of the flow through the splanchnic circulation.55 Unfortunately, these methods are 
only tested on animal models. The only technique that has been introduced in clinical practice 
is gastrointestinal tonometry for measuring intraluminal CO2 based on the observation that 
under the conditions of compromised local perfusion, CO2 production increases and pH 
decreases due to conversion to anaerobic metabolism.56 However, the widespread use of 
gastric tonometers has not survived to this day, in part due to certain technical limitations and 
partly due to the problems with the interpretation of the results and the fact that this method 
does not provide additional information in relation to some routine analyses, such as arterial 
blood gas testing.  
Because of the inability to perceive directly and reliably the flow through splanchnic 
circulation, the microvascular flow analysis is performed in other vascular beds. Especially 
attractive, for the ease of its accessibility, is sublingual capillary bed, therefore, various 
methods of evaluating microvascular flow are applied in clinical practice through information 
obtained from this vascular network.57 However, it must be taken into account that the 
sublingual bed significantly differs from the anatomically distant, distal parts of the digestive 
tract, as well as its likelihood to exhibit a different sensitivity to hypoperfusion under stress 
conditions. 
Given the critical importance of adequate local perfusion for the healing of gastrointestinal 
anastomosis, it can be concluded that there is still a large gap in understanding of all of the 
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mechanisms, which contribute to maintaining the optimal splanchnic flow and the great need 
for a reliable and simple method that can be used for monitoring. 
1.3. RISK ASSESSMENT IN ABDOMINAL SURGERY 
 
1.3.1.“High-risk “ Surgical Patient  
 
In literature, we can often come across the term "high-risk patient" concerning a particular 
surgery. Despite the widespread use of the term, there is still no clear definition of what this 
risk exactly implies.58 Different participants in the process of treatment may have a different 
perception of the risk.59 When the operation is in question, the patient considers the risk of 
failure of the surgery, long-term disability or absence from work. An anaesthesiologist is 
thinking about the risk of unfavourable events during surgery and the immediate 
postoperative course, while for the surgeon the concept of risk is often associated with the 
inability to carry out the planned surgery and surgical complications that will require long-
term engagement and unforeseeable consequences. For an intensivist, the risk is associated 
with a potentially long-term stay in the intensive care unit, while for the hospital management 
the risk of an intervention is an outcome, which will be worse than that of the competitive 
hospitals and will infer unplanned costs. However, the common denominator of all these 
qualms is the chance of occurrence of the postoperative complications, including those most 
severe, with a deadly outcome. The qualification of the perceived risk for complications as 
"high" is also subject to individual interpretations. When individual patient risk is being 
assessed, it is usually considered high if it is higher than expected for the population. More 
precisely, if the risk is above the two standard deviations compared to the risk expected for 
the entire population undergoing that particular type of surgery.59 This mathematical 
approach is not an ideal way to treat the problem of quantifying risks because population risk 
is most commonly unknown and is expected to vary in different environments. 
Assessment of the risk for postoperative morbidity and mortality is a mandatory part of the 
preoperative evaluation according to the latest guidelines.60 This procedure is of an outmost 
importance for precisely identifying those patients who will benefit from additional specialist 
check-ups and preoperative examinations, as well as the application of various interventions 
aiming to optimise the condition in order to reduce the risk to available evidence from the 
literature. Risk assessment is also important in terms of resource planning and determination 
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of the required postoperative care level. Finally, there is the highest level of recommendation 
that the perioperative risk information is to be presented to each patient during the 
preoperative interview.60 In most countries, it is legally binding to provide adequate 
information and obtain consent for each medical intervention. As means to ensure better 
information immersion on perioperative risk, additional information resources, such as 
multimedia content on the Internet, is also provided.61  
If the assessed risk for a particular operation is very high for a patient or unacceptable for the 
institution, consideration may be given to postponing surgery or choosing an alternative, less 
invasive treatment. 
1.3.2.Risk Assessment in the Preoperative Period 
 
1.3.2.1.Determining Functional Capacity 
The highest extent of information based on which a high-risk surgical patient is identified is 
obtained in the preoperative period. Risk assessment at this stage is of the outmost 
importance because risk-based decisions can be made to modify the treatment plan and take 
measures to improve the patient's condition with an intent of reducing the risk. 
Evaluation of preoperative functional capacity is, according to the recommendations of the 
European Society of Cardiologists and the European Society of Anaesthesiology (ESC / 
ESA), the first step in preoperative risk assessment.62 Functional capacity is measured by 
metabolic equivalents (METs) and one MET matches the basal metabolism level. Although 
its objective measurement is achieved by cardiac stress tests, it can be quite well estimated 
based on the patient's ability to perform various activities from everyday life.63  The Duke 
Activity Status Index is a validated and simple questionnaire that provides quick insight into 
the state of functional capacity. (Table 2.1) As one MET coresponds to the requirement for 
the resting state (3.5ml / kg / min), different degrees of stress correspond to multiplies of the 
basal metabolic levels.64 Thus, self-maintenance of the hygiene corresponds to 2 METs, a 
100m long walk at a speed of 3-5km / h requires 4 METs, while an intense physical activity 
during sports performance requires more than 10 METs.62 Metabolic demands during the 
postoperative response to stress have been increased, so the ability to climb two sets of stairs 
is commonly used as a discriminator, thus corresponding to the consumption of more than 4 
METs.65 Several prospective studies have shown the correlation of stair-climbing capacity to 
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unfavourable outcome after the non-cardiac surgery.66,67 This simple test, in which the 
symptoms appear to limit stairs climbing, has shown a positive predictive value of 82% for 
the occurrence of pulmonary and cardiac complications after major non-cardiac surgery.65 
The inability to climb up the stairs has shown an impact on overall mortality after thoracic 
surgery, probably because it leads to a linear increase in minute ventilation, which is of 
critical importance for this category of patients.67 Such an effect, however, is not recorded in 
other types of non-cardiac surgery.65 It should be borne in mind that the functional capacity is 
not only about the performance of the cardiovascular system, since it also depends on the 
function of the respiratory system, nutritional status, certain medications, and may be limited 
due to neurological disorders, orthopaedic immobilisation and other reasons.  
Table 3. The Duke Activity Status Index63,68 
The Duke Activity Status Index 
METs Activity 
Less than 4 
METs 
Can You… 
1. Take care of yourself (eat, dress, bath, use toilet)? 
2. Walk indoors around the house? 
3. Walk a block or two on ground level at 4-5 km/h? 
4. Do the light work around the house like dusting or washing dishes? 
4 METs 5. Climb a flight of stairs or walk up the hill? 
6. Do moderate work around the house like vacuuming, sweeping floors, or 
carrying groceries? 
6 METs 7. Do heavy work around the house like scrubbing floors, or lifting or moving 
heavy furniture? 
8. Do moderate yard work like raking leaves or weeding? 
9. Have sexual relations? 
8 METs 10. Participate in moderate recreational activities like golf, bowling, dancing, or 
throwing a baseball or football? 
10 METs 11. Participate in strenuous sports like swimming, singles tennis, football, 
basketball or skiing? 
12. Run a short distance? 
 
Wiklund and associates, in their analysis of 5939 patients, 633 of whom had a major 
abdominal surgery, found a low predictive value of the functional capacity of the METs for 
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postoperative complications.68 The same author has shown significant differences in the 
estimation of METs in the range of 4-8 by the different doctors.68 
According to the valid recommendations, it can be said that if the estimated functional 
capacity is more than 10 METs, the prognosis is good, regardless of the existence of coronary 
disease, cardiomyopathy or additional risk factors.62 Conversely, if it is lower than 4-6 METs, 
the existence of other risk factors and the type of the planned surgery will determine the 
definitive risk, but such a patient requires additional evaluation.62,64 
 
1.3.2.2. ASA Classification 
American Society of Anaesthesiologists Physical Status Classification – ASA classification is 
the oldest and probably the most widely used risk classification applied on patients 
undergoing surgery and anaesthesia. It was created in 1941 when the American Association 
of Anaesthesiologists instructed a committee of three doctors (Meyer Saklad, Emery 
Rovenstine and Ivan Taylor) to study and propose a system that would enable 
anaesthesiologists to determine the risk for the upcoming operation based on data on the 
overall health status of the patient..69 Although the original intention of the author was to 
come up with an estimate of the "operational risk", they quickly gave up on this intention 
facing difficulties in regards to classifying the operation and due to awareness of the large 
variation of practice in various hospitals. For these reasons, a classification system with 
gradations, which are not in correlation with the type of surgical intervention, the competence 
of the anaesthesiologist and the surgeon, or the type of anaesthesia the patient will receive, 
was devised. The original ASA classification had 6 classes (Classes 5 and 6 referred to the 
emergency surgery for patients who would otherwise be classified as Class 1 or 2, or Class 3 
or 4, respectively).69 The first revision was done in 1963, and with minor changes, remains in 
use to this day.70 (Table 2.2) 
Affiliation to a particular ASA class is a piece of data that is probably contained in any 
anaesthesia chart in the world. In a retrospective study by Hackett and associates, analysing 
more than two million patient histories, a strong predictive ability of the ASA classification 
for complications and mortality in all types of surgery has been demonstrated.71 The risk for 
medical complications for classes 2,3,4 and 5 was 2, 5, 17, and 63 times higher than in class 
1.71 It has also been proven that the ASA class correlates well with the functional capacity 




There is also an interesting analysis of Hopkins and associates who were investigating the 
impact of the ASA class on 48-hour mortality by comparing their findings with a large 
historical cohort from almost 50 years ago.73 The increase in mortality with the rising of the 
ASA class was shown, without a difference in the two cohorts, except for that it was 
significantly higher for the class 5 in the contemporary cohort compared to the historical 
one.73 However, there are studies that have failed to demonstrate good predictive 
characteristics of the ASA classification for postoperative morbidity and mortality after major 
abdominal surgery.74 The fact is that in published studies there was a very large variation in 
mortality rates for different ASA classes (7.8-25.9% for ASA 4, 9.4-57.8% for ASA 5).75 
 




1 A normal healthy patient 
2 A patient with mild systemic disease without substantive functional limitations 
3 A patient with severe systemic disease with substantive functional limitations 
4 A patient with severe systemic disease that is a constant threat to life 
5 A moribund patient who is not expected to survive without the operation 
6 A declared brain-dead patient whose organs are being removed for donor 
purposes 
The addition of suffix “E” denotes emergency surgery (when delay in treatment of the patient would 
lead to a significant increase in the threat to life or body part) 
 
Subjectivity is the characteristic of the ASA classification. There is also a potential for 
significant variation in determining the affiliation of a patient to an ASA class. The research 
conducted among the members of the Finnish Association of Anaesthesiologists has shown a 
significant variation in the ASA classification between the employees of the university 
hospital and smaller regional hospitals.76 In contrast, a very good alignment in the 
classification of patients undergoing urgent gastrointestinal surgery in 19 hospitals in Japan 
has been presented.77 The highest degree of disagreement with the ASA class assignment was 
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noticed among the various specialists, anaesthesiologists and internists during the 
preoperative consultation, while the significant difference was not observed between the 
anaesthesiologists with different work experience.78 It is likely that these differences are 
partly encouraged by the fact that the classification itself does not take into account many 
factors, such as gender, age, type and extent of surgery, specificities related to perioperative 
care, and the term "systemic disease" contained in class 2 description and 3 are not precisely 
defined. 
It should be mentioned that the ASA classification is a classification system, and not a score, 
and since its first publication it is clear that in terms of its predictive characteristics 
(sensitivity, specificity, positive and negative predictive value) it does not provide reliable 
prediction of outcomes for individual patients. However, it has been used to create models 
that more reliably predict postoperative morbidity and mortality.79 
1.3.2.3. Risk scores for Cardiac Events in Non-Cardiac Surgery 
 
The estimates are that approximately 10 million people who are undergoing a major non-
cardiac surgery each year worldwide experience a serious undesirable cardiac event within 
the first 30 postoperative days.60 For this reason, risk assessment for undesirable cardiac 
events is an important part of the preoperative assessment. In the previous decades, several 
scales for assessing the said were proposed, based on multivariate analysis of data from 
observational studies. "Multifactorial Index of Cardiac Risk in Noncardiac Surgical 
Procedures", known as Goldman score, classifies patients into one of four classes of 
significantly different risk for severe and potentially fatal postoperative cardiac events 
centred around the presence of 9 identified predictors.80  (Table 2.3). As 28 out of a total of 
53 points available for assignment could potentially be controlled, it allows the elective 
surgery to be postponed until the cardiopulmonary status stabilisation. Although proved to be 
superior to the ASA class in prediction of undesirable cardiac event, ASA classification was 
better in predicting the overall postoperative mortality.81 About then years later, Detsky and 
associates, after validating Goldman score in their patient population, suggested their own 
modification as Detsky score, which has also found the wide application among cardiologists 
in preoperative evaluation.82 In order to simulate the risk of cardiac complications after non-
cardiac surgery, Lee analysed a small number of predictors, creating a risk scale known as 
The Revised Cardiac Risk Index (RCRI).83 This scale has gone through numerous external 
validations, as well as the further attempts at simplification or elaboration in the sense of 
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more precise risk definition of the surgery itself and by adding age, increasing its predictive 
characteristics for cardiac complications.84,85 Goldman Scale, Detsky Scale, and Lee RCRI 
are supported by the European Society of Cardiologists as identification tools for patients 
requiring additional preoperative cardiac evaluation, pharmacotherapy or some other risk 
reduction strategy for cardiac complications.62 
Table 5. Goldman Cardiac Risk Index 80 and The Revised Cardiac Risk Index 83 
Goldman Cardiac Risk Index (1977) 
 
The Revised Cardiac Risk Index (1999) 
Risk factor 
 
Points Risk factor Points 
Third heart sound (S3) 11 High-risk type of surgery 1 
Elevated jugular venous pressure 11 Ischaemic heart disease 1 
Myocardial infarction in past 6 months 10 History of congestive heart failure 1 
ECG: premature atrial contractions or any 
rhythm other than sinus 
7 History of cerebrovascular disease 1 
ECG shows > 5 premature ventricular 
contractions per minute 
7 Insulin therapy for diabetes 1 
Age > 70 years 
 
5 Preoperative serum creatinine > 
177μmol/l 
1 
Emergency procedure 4   
Intra-thoracic, intra-abdominal or aortic 
surgery 
3   
Poor general status, metabolic or bedridden 3   
Risk of major complications or cardiac death 
 
Class I= 0-5 points (1% complications) 
Class II= 6-12 points (7% complications) 
Class III=13-25 points (14% complications) 
Class IV ≥ 26 (78% complications) 
Risk of major cardiac event 
 
Class I= 0 points     (0.4%) 
Class II=1 point      (0.9%) 
Class III= 3 points (6.6%) 
Class IV= 4 points (>11%) 
 
Unfortunately, there are very few studies that have tried and succeeded in showing that the 
outcome can be corrected if this risk is known.86,87 The fact is that the mentioned risk 
stratification scales were developed several decades ago, and since then the significant 
advances in cardiological diagnosis and therapy, operational techniques and perioperative 
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care have been achieved. The usage of biomarkers (troponin and NT-pro-BNP) in the 
stratification of perioperative cardiac risk, although widely used, still has not achieved the 
highest recommendation.60  This points out to the need for a new predictive model that would 
allow more precise risk stratification, above all in terms of creating opportunities to improve 
outcomes. 
 
1.3.2.4. Charlson Comorbidity Index  
Charlson score (The Charlson Comorbidity Index) was created in 1987 with the aim of 
classifying the comorbidities affecting the mortality risk for longitudinal epidemiological 
studies.88 The original index was created in the cohort of hospitalised internal medical 
patients and validated in surgical patients with various comorbidities after their discharge 
from the hospital during a long period of follow-up.89 This index encompasses 17 
comorbidities with the appropriate severity (1-6) assigned. The final score value is generated 
by summing of the assigned points and may have a value of 0 (without the accompanying 
diseases) to 29 (maximum severity of comorbidity). (Table 6) 
More than 5,000 publications cited the Charlson index with the aim of showing the 
comorbidity of the patients covered by the examination. This score proved to be an 
independent predictor of pulmonary complications after abdominal surgery and the most 
important prognostic factor in older patients after colorectal cancer resection.90,91 The 
influence of Charlson index on a complicated postoperative course has been verified after 
radical gastrectomy due to cancer and liver resection.92 However, as well as the ASA 
classification, the Charlson index also did not show having an impact on the costs of 
hospitalisation and length of hospitalisation after elective surgery, such as laparoscopic 








                                           Table 6. Charlson Comorbidity Index88 
Score Comorbidity 
1 Myocardial infarction 
 Congestive heart failure 
 Peripheral vascular disease 
 Cerebrovascular disease 
 Dementia 
 Chronic pulmonary disease 
 Connective tissue disease 
 Ulcer disease 
 Mild liver disease 
 Diabetes 
2 Hemiplegia 
 Moderate or severe renal disease 
 Diabetes with end organ damage 
 Any malignancy 
3 Moderate or severe liver disease (cirrhosis with ascites) 
4 AIDS 
 Metastatic solid tumour 
               Note: For each decade > 40 years of age one point is added to the score 
 
1.3.2.5.Score for Prediction of Postoperative Respiratory Complications 
Pulmonary complications after abdominal surgery occur with a frequency of up to 10-16%. 
60,94 However, in some types of gastrointestinal surgery, especially those in the upper 
abdomen and in esophagectomy, the incidence of even over 50% is recorded.95 As the 
pulmonary complications may have a high severity, such as pneumonia or ARDS, and may 
require mechanical ventilation and extended hospitalization, the need for preoperative 
identification of patients with increased risk has been imposed. The ARISCAT score for 
pulmonary complications was developed in a prospective multicentre study, which included 
59 randomly selected hospitals.96 This score, in addition to preoperative characteristics (age, 
preoperative pulmonary function and anaemia), also takes into account the parameters related 
to the planned surgical approach, its duration and urgency. ARISCAT is an externally 
validated score and has demonstrated good predictive features in various types of surgery.97,98 
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ARISCAT was the basis for the identification of patients for whom the team of experts 
proposed a set of measures to reduce the incidence of postoperative pulmonary 
complications.99 
1.3.3. Risk Assessment of Complications Based on Information from the Intraoperative 
Period  
 
Preoperative patient evaluation is just one part of a large puzzle and we can intuitively 
conclude that it only partially affects the overall outcome of the surgical treatment. Although 
it is clear that the surgery and anaesthesia cause a strong physiological stress response, 
relatively few studies have examined how the information from an intraoperative period can 
help identify patients with elevated risk of postoperative complications. The factors that have 
been shown to have an impact on the outcome are the complexity and urgency of the surgery, 
its duration, tissue injury extent, undesirable intraoperative events, minimally invasive 
approaches, anaesthetic techniques and so on.3,100 On the other hand, it is almost certain that 
all of the factors, which can influence the outcome, could never be taken into account in 
entirety nor objectively measured. A surgery is performed by people, professionals whose 
competence, interest, attention to detail, skill, mood, current fatigue level, and motivation 
have not been examined in a study in the context of risk for complications. In addition, there 
are some patient characteristics such as "tissue quality" and healing capacity that can not be 
characterised only by standard analysis. Consideration of the relevant information from the 
intraoperative period can help except in quantifying the overall risk, and in decision making 
on further treatment and providing an adequate postoperative care level. 
1.3.3.1.Surgery Complexity 
The risk that the patient bears is evaluated to the greatest extent in relation to the complexity 
of the surgery. In the literature, there is no final agreement about what represents a "major" 
surgery. 
In 1917, in his letter to the editor of the journal Annals of Surgery, Dr Robert Earl addresses a 
request for explanation to be given to him of what constitutes a minor and what a major 
surgery, as according to the applicable law of the Minnesota State,by which the osteopaths 
are allowed to perform only a minor surgery.101 Mr Lewis Pilcher, the editor, gave the 
following answer: “...I would say that major surgery includes all work requiring a general 
anaesthetic; all operations which involve openings into the great cavities of the body; all 
operations in the course of which hazards of severe haemorrhage are possible; all conditions 
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in which the life of the patient is at stake; all conditions which require for their relief 
manipulations, for the proper performance of which special anatomic knowledge and 
manipulative skill are essential.“101 To this over a 100 years old definition, not much could be 
added even today. However, due to the great development that surgery has achieved in the 
meantime, there was a need for a more precise definition of the complexity of the surgical 
treatment. Large hospitals and professional associations provided different classification of 
surgeries, resulting in a significant confusion in literature.102 The fact that the complex 
surgery is associated with the greater risk for death, long-term hospitalisation and higher 
costs of treatment, have also been recognised by health insurance funds thus creating a 
practical classifications of surgical procedures  according to complexity.23 The British United 
Provident Association (BUPA) has divided surgical interventions into 5 classes according to 
complexity (minor, intermediate, major, major plus, and complex major) and this division has 
become an integral part of the operational risk assessment.79 The mortality after some of the 
undelayable surgeries is much higher than the elective, and for this reason there are 
subdivisions of surgeries according to the degree of urgency.79,103 
1.3.3.2.Hospital Volume and Surgeon Volume  
A number of operations of a particular type performed in a hospital, as well as the number of 
interventions made by a certain surgeon, are among the most important factors affecting the 
hospital mortality rate. An analysis of over 2.5 million Medicare insured patients operated in 
hospitals across the United States has unambiguously pointed to the inverse relationship 
between the hospital volume and mortality rate.104 When hospital volumes are divided into 
quintiles, the biggest difference in mortality was observed in esophagectomy (23.1% at very 
low volume vs 8.1% at very high volume) and pancreatectomy (17.6% vs. 3.8%).104 The need 
for centralisation of the certain types of surgery derives from the evidence that mortality after 
major oncological surgeries can be reduced by up to 50% if a certain number of surgeries per 
centre each year is guaranteed.105 Significantly lower mortality after radical gastrectomy in 
the high-volume hospitals in Germany is primarily attributed to the ability to adequately treat 
the postoperative complications.106 Schmidt and associates study, which analysed the results 
of 1003 duodenopancreatectomies in two long observation periods in the same center, took 
into account the hospital volume, surgeon's experience, and surgeon's volume.107 These 
authors have clearly shown that the number of duodenopancreatectomies performed annually 
in the centre is the only factor influencing mortality, but that even in the "high-volume" 
centre the surgical experience is of undeniable significance because this variable has 
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determined total morbidity rate.107 The significance of surgical volume was also confirmed in 
a large systematic analysis for almost all types of surgeries, as well as in a study that has 
shown that switching of the high-volume surgeons for pancreatic surgery in a low-volume 
centre did not result in a change in results.108,109 
The surgeon's experience also depends on the learning curve while adopting a new surgical 
technique. Usually, the parameters used to measure reaching a plateau on the learning curve 
are the duration of surgery, length of hospitalization, or the percentage of conversion for 
laparoscopic procedures. It is considered that 30-35 operations are required to master the 
laparoscopic rectal surgery.110 Perhaps during the analysis of the learning curve, the 
postoperative complications should be considered. They certainly speak more of the quality 
of work than the speed at which the surgery is completed. 
 
1.3.3.3. Unfavourable Intraoperative Events 
Many intraoperative events that deviate from the standard course of the surgery may have an 
effect on the occurrence of the postoperative complications. It has been shown that even 
short-term intraoperative hypotension significantly increases the chance of myocardial 
ischemia and acute renal insufficiency.111 
Surgical Apgar score has emerged relying on the neonatal Apgar score with the aim of 
enabling the surgical team to evaluate in a simple and reliable way the patient’s condition at 
the end of the surgery, his risk of postoperative complications, and propose accordingly a 
further treatment plan.112 This simple score obtained as a result of multivariate logistic 
regression analysis takes into account only three factors: intraoperative blood loss, heart rate 
and blood pressure. (Table 7) The authors have shown that the score has excellent predictive 
characteristics for postoperative morbidity because the incidence of severe complications was 
58.6% in patients with a 0-4 score and 3.6% in those with a score of 9-10. Also, the score was 
predictive for mortality in cohorts of patients undergoing general and vascular surgery 
(p<0.0001).112 
The score has been validated in several studies, and one of them suggests that for each patient 
with the score lower than 4 an intensivist consultation is needed in order to arrange the 





Table 7. Surgical Apgar Score (Gawande et al)112 
 0 points 1 point 2 points 3 points 4 points 
Estimated blood loss (ml) >1000 601-1000 101-600 ≤ 100 - 
Lowest mean arterial pressure (mmHg) < 40 40-54 55-69 ≥70 - 
Lowest heart rate (beats/min) >85 76-85 66-75 56-65 ≤ 55 
Surgical score= sum of the points for each category  
Occurrence of pathologic bradyarrhythmia, atrioventricular block, and asystole also receive 0 points 
 
Retrospective analysis from the Columbia University Medical Centre, which covered the 
seven-year period, has shown that the surgical Apgar was closely associated with a ICU 
triage decision immediately after a high-risk abdominal surgery.114  
 
1.3.4. Risk Stratification Systems for Complications that Combine Preoperative and 
Intraoperative Factors 
 
1.3.4.1. Shoemaker Criteria 
Shoemaker and associates have proposed a list of criteria for "high-risk" patients who 
undergo elective or emergency surgery based on mortality rate analysis from the previous 
years.39 He had observed that the mortality in patients who fitted one or more criteria from 
the list was around 30%. Approximately 7% of patients in general surgery could fall into 
high-risk criteria, but they accounted for 82% of total mortality. The purpose of this list was 
to define inclusive criteria for the needs of randomised studies, which tested the strategies for 
supranormal oxygen delivery to tissues that were shown to be effective in the previous 
studies. (Table 8) Other authors have also used similar the criteria for defining the high-risk 
patients in randomised trials, but this list was rarely used in routine stratification of risk. 115 It 
does not allow for the risk grading, but only states its presence or absence, and is, besides, 






Table 8. „High-risk“ patient criteria (Shoemaker et al)39 
“High-risk” criteria 
 Previous severe cardiorespiratory illness (acute MI, COPD, stroke, etc.) 
 Extensive ablative surgery planned for carcinoma; e.g. esophagectomy and total 
gastrectomy, prolonged surgery (>8h) 
 Severe multiple trauma; e.g. > 3 organs or > 2 systems, or opening 2 body cavities 
 Massive acute blood loss (>8 units), Blood volume <1.5L/m2, Hct <20% 
 Age over 70 years and evidence of limited physiologic reserve of one or more 
vital organs 
 Shock: Mean arterial pressure <60mmHg; CVP < 15 cmH2O and urinary 
output<20ml/h 
 Septicaemia, positive blood culture or septic focus, WBC>13000, spiking fever to 
38.3˚C for 48 hour, and hemodynamic instability  
 Respiratory failure: e.g. PaO2 <60 mmHg on FiO2 > 0.4, Qs/Qt>30%, mechanical 
ventilation needed>48h 
 Acute abdominal catastrophe with hemodynamic instability: e.g. pancreatitis, 
gangrenous bowel, peritonitis, perforated viscus, GI bleeding 
 Acute renal failure (Blood urea nitrogen > 17.8 mmol/l; creatinine 265.2 μmol/l) 
 Late stage vascular disease involving aortic disease 
MI-myocardial infarction; COPD-Chronic obstructive pulmonary disease; CVP-central venous 
pressure; Hct-Haematocrit; PaO2 – arterial partial pressure of oxygen; FiO2-Inspired fraction of 
oxygen; Qs/Qt –shunt fraction; GI-Gastrointestinal 
 
 
1.3.4.2. The Surgical Risk Scale 
Based on the clinical experience that the physical status and comorbidity, together with the 
surgery volume and degree of urgency, determine the final outcome, Sutton and associates 
with their methodology of logistic regression analysis created a sketch for predicting 
postoperative mortality. 79 This score uses only three readily available parameters: ASA class, 
urgency category according to the National Confidential Enquiry into Perioperative Deaths 
(NCEPOD) and the surgery volume in accordance with the British United Provident 
Association (BUPA) classification. (Table 9) In the validation set, the authors showed a good 
score calibration and good predictive performance in low-risk categories. The score is 
obtained by a simple addition of the points, and the mortality risk is less than 1% if the score 
is < 9.79 It is unclear why, according to the BUPA classification, laparoscopic 
cholecystectomy is classified as major plus surgery, in the range of gastrectomy, and greater 




Table 9. The Surgical Risk Score (Sutton et al)79 







Routine booked non-urgent case, e.g. varicose veins or hernia 
Booked admission, e.g. cancer of the colon or AAA 
Cases requiring treatment within 24±48h of admission, e.g. obstructed 
colon 














Removal of sebaceous cyst, skin lesions, oesophagogastric duodenoscopy 
Unilateral varicose veins, unilateral hernia repair, colonoscopy 
Appendectomy, open cholecystectomy 
Gastrectomy, any colectomy, laparoscopic cholecystectomy 















No systemic disease 
Mild systemic disease 
Systemic disease affecting activity 
Serious disease but not moribund 







CEPOD- Confidential Enquiry into Perioperative Deaths; AAA-Abdominal Aortic Aneurysm; 
BUPA– British United Provident Association operative severity score; ASA-PS- American Society of 
Anaesthesiologists Physical Status 
1.3.4.3. Physiological and Operative Severity Score for the Enumeration of Mortality and 
Morbidity (POSSUM score) 
In 1991, Graham Copeland, a urologist from Liverpool, described a scoring system for 
tracking outcomes in surgery.116 He named it the Physiological and Operative Severity Score 
for the Enumeration of Mortality and Morbidity and used the acronym POSSUM under 
which the score is known. A cohort of surgical patients from the general hospital served for a 
retrospective analysis of 62 individual factors (48 preoperative and 14 intraoperative). In a 
prospective analysis, in the next 6-month monitoring period, by multivariate discriminatory 
analysis, the number of factors was reduced and only independent predictors were included in 
the final model.116 Each independent variable was given a value on the exponential scale (1, 
2, 4, 8), and physiological score was created with 12 variables each having 4 gradations. It 
was immediately noted that this preoperative physiological score, although having good 
predictive characteristics for the general population of the patients, shows significant group 
differences in relation to the characteristics of the surgery. By further analysis, an "operative 
score" was created with 6 variables and was added to physiological. (Table 10 and 11) 
Physiological and operative POSSUM scores are obtained by adding points in each group and 
then these values are entered to the following formula for calculating the probability of 








; where p represents the probability of outcome (mortality or morbidity);  
y (morbidity) = -5.91+(0.16 x Physiological score) + (0.19 x Operative score);  
y (mortality) = -7.04 + (0.13 x Physiological score) + (0.16 x Operative score) 
POSSUM score is currently validated in colorectal surgery, liver resection, pancreas, 
oesophagus, vascular surgery, orthopaedics, in urgent surgeries due to peritonitis, in geriatric 
population.117–122 It was also used to compare the efficiency of various hospitals, surgeons, 
and various levels of postoperative care (intensive care vs. ward).123–125 As a method for 
comparing the different populations of patients, POSSUM has found a very wide application 
in professional literature. However, when assessing an individual risk there are certain 
limitations in the interpretation of results. 























































Pulse (bpm) 50-80 81-100 
40-49 




15 12-14 9-11 ≤ 8 
Urea (mmol/l) ≤ 7.5 7.6-10 10.1-15 ≥ 15.1 
Na
+
 (mEq/l) ≥ 136 131-135 126-130 ≤ 125 
K
+



















ECG Normal - Atrial fibrillation (60-90) Any other 
change 
JVP-jugular venous pressure, SOB-shortness of breath, BP-blood pressure, bpm-beats per minute, 
WCC-white cell count, ECG-electrocardiogram 
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Table 11. POSSUM Operative Severity Score (Copeland)116 
Variable 
 






Minor Intermediate Major Major + 
Operations 
within 30 days 
1 - 2 >2 
Blood loss per 
operation (mls) 
≤ 100 101-500 501-999 ≥ 1000 
Presence of 
malignancy 
No Primary cancer 
only 
Node metastases Distant metastases 
Timing of 
operation 
Elective - Emergency, resuscitation 
possible, operation<24h 
Emergency, 
immediate operation < 
2 hours 
* Moderate severity: appendectomy, cholecystectomy, mastectomy, transurethral resection of prostate; 
Major surgery: any laparotomy, bowel resection, choledochotomy, peripheral vascular procedure; 
Major + surgery: any aortic procedure, abdominoperineal resection, pancreatic or liver resection, 
oesophagectomy  
A part of these constraints stems from the equation derived from the logistic regression. 
Specifically, the lowest possible risk for the death outcome that can be predicted (when all 
physiological score parameters are normal and when the surgical severity is minimal) is 
1.05%. This is an unacceptably high risk for a healthy patient undergoing a minor 
intervention. Many studies have shown that POSSUM predicts significantly higher mortality 
and morbidity than observed (over predicts) in low-risk categories.126 This was also noticed 
by Prytherch and his associates, so they carried out a prospective analysis of the POSSUM 
score in a large cohort of surgical patients, which resulted in the remodelling of the mortality 
score equation.127 The score was given a name P-POSSUM, applying the same predictors as 
POSSUM but with greater precision in predicting mortality in low-risk patients than the 
original POSSUM score.117,127 The P-POSSUM score is derived only for mortality prediction, 
not postoperative complications. 
As a score, which resulted from a patient cohort analysis from a general hospital, POSSUM 
contains variables that are not relevant to prediction of outcome in specific patient 
populations. Glasgow Coma Score (GCS) is an integral part of the physiological score, but 
the patients who undergo elective major surgery in which it is below 8 are extremely rare. In 
addition, for orthopaedic procedures the variable "peritoneal contamination" is insignificant. 
Therefore POSSUM variants are proposed for use in esophagogastric (O-POSSUM) or 
colorectal (CR-POSSUM) surgery.128,129 
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The lack of POSSUM is also due to the fact that some variables are not available immediately 
after the end of surgery (lymphadenopathy and distant metastases), which sometimes makes 
it difficult to apply it in the early identification of the patients at risk. Also, computing the 
predicted risk for mortality and morbidity requires a lot of time. 
Although the official anaesthesia chart of the Clinical Centre of Serbia contains a section for 
the record of the POSSUM, it is unlikely that it has ever been filled. Possible reason is that 
the score has never been validated in our population. 
 
1.3.4.4. The American College of Surgeons National Surgical Quality Improvement Program 
(ACS NSQIP) Surgical Risk Calculator 
In 1996, the American Congress passed a law requiring all Veterans Affairs (VA) hospitals to 
submit reports on surgical treatment results for comparison with the national average. Based 
on the results of a major study (National Surgical Risk Study), from which various models for 
outcome prediction were derived, taking into account the severity of the patients’ condition, 
in 1994 the National Surgical Quality Improvement Program (NSQIP) was organised.130 This 
programme entails collecting relevant data pertaining to each operation performed in the 
Veterans Affairs hospital system. The data are forwarded to the co-ordination centres and 
from them the hospitals receive periodic reports in the form of observations relating to the 
expected morbidity and mortality (O: E ratio). With regards to this and other parameters, the 
quality of work of an institution is assessed. It has been noted that in the first ten years since 
the start of NSQIP, 30-day mortality rate after major surgery dropped by one third and 
morbidity by 45%.131 One of the greatest achievements of NSQIP is generation of the 
databases of undeniable significance, with high quality information on millions of operations 
performed at VA hospitals.131 Based on this information, the ACS NSQIP surgical risk 
calculator was created.100 This calculator is based on a series of demographic, clinical and 
laboratory indicators and calculates the risk of death and numerous individual complications 
for almost all types of surgeries except for trauma and transplantation.100 The risk is 
expressed in percentages, and the chance of a certain outcomes qualifies as average, below or 
above the average. The calculator provides a prediction of the length of hospitalisation. The 
prediction of outcome is made by including 21 preoperative risk factors in different formulas 
obtained by statistical modelling. The calculator allows the surgeon to increase or decrease 
the calculated risk within a given confidence interval for a certain outcome if he considers 
that some significant parameters for a particular patient are not taken into account.100 ACS 
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NSQIP Surgical Risk Calculator is available on the website 
http://www.riskcalculator.facs.org. The great advantage of the calculator is that it is 
comprehensible, thanks to the technical solution and its visual acceptability for the patient, 
thus enabling discussion of the foreseen risks by providing the complete information. 
The analysis of the ACS NSQIP score in South Korea has shown that it has good predictive 
characteristics, not only for the complications but also for remote oncological outcomes after 
cephalic duodenopancreatectomy due to pancreatic cancer.132 On the other hand, this risk 
calculator did not demonstrate predictive ability for any specific type of complications, and it 
has demonstrated only moderate estimate for mortality in old patients who underwent the 
spine surgery in China.133 
It is unlikely that any country in the world has a database as comprehensive as NSQIP. 
Therefore, it remains for the ACS NSQIP Surgical Risk Calculator yet to be validated 
through large prospective studies for the evaluation of its application possibilities in patients 
from other health systems. 
1.3.5. Risk Assessment of Complications based on Information from the Early 
Postoperative Period 
1.3.5.1.Risk Factors Related to the Postoperative Process of Care 
A large observational study by Pearse et al showed that one relatively small group of patients 
who account for about 12% of all hospital admissions is responsible for over 80% of deaths 
after surgery.8 This group was identified as high-risk surgical patients by the authors. Further 
analysis showed that the highest mortality was observed in those patients who were urgently 
accepted in the Intensive Care Unit (ICU) due to postoperative complications and after the 
initial treatment at the ward.8,38 This study, as well as the later EUSOS study, attracted the 
attention of the public due to the fact that about 75% of the patients who died did not have 
any access to the ICU.3 Such data on mortality and triage after general surgery were 
compared to cardiac surgery practice. Mortality after the aortocoronary by-pass is maintained 
at around 2% worldwide, despite the fact that the patients usually have many associated 
comorbidities.134 Unlike general surgery, cardiac surgery is determined by the available 
resources in ICU, because every patient is routinely admitted in ICU after surgery. Such 
findings have posed the question of whether treatment in ICU for high-risk patients after 
general surgery could improve the outcome. Unfortunately, the answer to this question can 




Staying in ICU also has a number of well-known adverse effects, such as risk for nosocomial 
infections, long-lasting immobilisation, excessive sedation, and psychological sequelae.135 It 
has been shown that hospitals in which the rate of admission to ICU is the highest have 
poorer results in the treatment of pneumonia.136 A study investigating the relationship 
between ICU and mortality after five types of surgery (open aortic aneurysm surgery, 
endovascular aortic aneurysm, duodenopancreatectomy, cystectomy and esophagectomy) 
showed a large variation between hospital use of ICU resources for these operations ranging 
from 5-100%.137 No correlation was found between the rate of use of ICU and mortality for 
any of these surgeries. However, this study only included insured persons over the age of 65, 
and lacked the data on the time of their stay in ICU (immediately after surgery or during a 
postoperative course). An observational study involving 45,000 patients in 27 countries 
showed a greater incidence of the fatal outcome in patients with planned admission to ICU 
immediately after surgery.138 The hospital level analysis did not establish a correlation 
between the death outcome and the planned ICU stay, or for treatment of complications, and 
concluded that scheduled admission to ICU did not improve the outcome after the surgery.138 
What the critique of this study might be is that it did not take into account equipment and 
personnel standards in the ICU and in the surgical wards, which likely show huge variations 
between hospitals in the countries covered. 
To what extent the elements of the postoperative care influence the outcome also point out 
the findings of the studies that show that the greatest mortality after elective surgery is 
recorded in patients treated at the end of the working week and on the weekends, as well as 
during the month of August.139,140 
1.3.6. Peripheral perfusion disorders 
 
Based on the evidence that the peripheral perfusion disturbance, accompanied by decreased 
oxygen delivery, has a significant influence on the development of organ dysfunction and 
mortality in critically ill patients, a hypothesis has been made that the early detection of the 
deteriorated tissue perfusion may help identify surgical patients at risk for 
complications.141,142  The tissue hypoxia after the surgical trauma is due to the inability to 
increase the oxygen supply to the tissues or its extraction in conditions of increased oxygen 
demand.39 Today there are many techniques for assessing the adequacy of tissue perfusion 
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and oxygenation.143,144 The fact is that orthogonal polarization spectroscopy, laser Doppler 
flowmetry, near-infrared spectroscopy, and peripheral perfusion index cannot yet be 
considered as the standard monitoring tools in surgical intensive care units. Therefore, the 
significance of other, clinically easily available signs of disturbed tissue perfusion for the 
identification of patients with a risk of postoperative complications has been studied. This 
allows further study of strategies for correction of the observed disorders with the aim of 
improving the postoperative outcome. 
The subjective assessment of peripheral perfusion is one of the basic elements of a physical 
examination that must be adopted by each and every medical student. There are numerous 
examples in the literature in which the state of shock is depicted in very detailed descriptions 
of its appearance, colour and heat of the skin and mucosa. One of the pioneers of US military 
surgery,dr Nicholas Senn, describes the condition of the soldiers injured in the American-
Spanish War in 1898:„... The patient lies on the ground, motionless. He has lost little blood, 
but his lips are pale...the hands are cold, and the pulse at the wrist cannot be felt. The 
respirations are irregular...it takes repeated questions to elicit the simplest answer.“145 More 
than a century later, Lima with associates, in a prospective observational study, proves the 
importance of physical examination in the discrimination of hemodynamically stable critical 
patients and those who develop severe organ dysfunction.146 In this study, the subjective 
assessment of the adequacy of perfusion is correlated with objective parameters such as the 
capillary refill time, body temperature gradients, and the noninvasively measured peripheral 
perfusion index.146 
1.3.6.1. Capillary refill time 
Henry Beecher introduced the capillary refill time in clinical practice on the basis of his 
research of only 100 seriously injured patients.147 He qualitatively labeled the time needed to 
return the colour of the nail capillary bed after the compression, as "normal", "clearly slow" 
and "very sluggish" and this correlated with the shock of "mild", "moderate", and "severe 
degree".147 The physiological explanation of this phenomenon is based on the existence of 
different degrees of vasoconstriction that accompany shock states and dehydration. Although 
the author did not numerically quantify the capillary refill delay, in most subsequent studies, 
the threshold value is 2 seconds.148 However, it has been shown that normally the time of 
capillary filling varies significantly depending on the gender, the temperature and the age of 
the patient.149 The increase in ambient temperature with each degree in the average increases 
the capillary refill time by 1.2%, regardless of the body temperature.150 On the other hand, the 
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increase in body temperature by 1 degree shortens the capillary refill time by an average of 
5%, non-co-dependent of the ambient temperature.150 Meta-analysis by Fleming et al 
characterized the capillary refill time as a "vital sign" for children of all ages because if 
prolonged, it was coupled with a fourfold greater chance of death.151 It has also been shown 
that delayed capillary refill time has a positive predictive value of 93-96% to point to the 
central venous blood saturation less than 70%.151 With regard to high specificity, this 
indicator has low sensitivity so that the normal values do not exclude the existence of 
perfusion disorders.151 Problems linked to the capillary refill are also related to the relative 
subjectivity in the assessment, as well as the lack of conformity with the length of 
compression and the site at which the tests are being conducted. In any case, this is a simple 
and quick test but we cannot yet be sure if within a matter of seconds, while we are actually 
doing it, we get clinically relevant data on peripheral perfusion or just a moment of time to 
peacefully consider what will our next step in the care of a critical patient be. It is possible 
that the objectivities of this method, the quantitative capillary refill time (Q-CRT), which was 
shown to correlate well with lactate values and circulatory status, would help to eliminate 
some of the aforementioned shortcomings associated with this parameter.152 
1.3.6.2. Temperature gradients 
Body temperature is one of the most accessible vital parameters. However, the research 
carried out by the Thermoregulation in Europe Monitoring and Managing Patient 
Temperature Study Group has shown that the intraoperative temperature monitoring was one 
of the least monitored parameters.153 This study, conducted in over 800 hospitals across 
Europe, showed that intraoperative temperature monitoring was conducted in 19.4% of 
patients and that some form of active heating was used in less than 40% of the patients.153  
The normal core temperature is 36.5-37.3 °C, while the temperature of the periphery is 2-4 
°C lower thanks to the thermoregulatory vasoconstriction mechanism with the aim of 
maintaining the core temperature.154 There are many reasons to lose heat during operations 
under general or regional anaesthesia, and it typically occurs in 3 phases: at first quickly due 
to the thermal redistribution to the periphery,  then slower due to the redistribution from the 
periphery to the environment, and ultimately very slowly because of the activation of 
peripheral vasoconstriction when the core temperature drops to 33-35˚C.155 Heat loss, 
especially after prolonged surgery may result in the appearance of unintended perioperative 
hypothermia. Numerous studies have shown a negative influence of hypothermia on 
postoperative outcomes. The increased predisposition to bleeding and the need for 
34 
 
transfusions occurring in both non-intentional and intentional hypothermia are the result of 
temperature-dependent and enzymatically mediated coagulation disorders: modified platelet 
function, coagulation factor, and fibrinolytic activity.156 In a randomized study, Frank et al 
showed that even mild hypothermia, with a 1.4 ° C core temperature reduction, contributes to 
a threefold increase in the chance of developing perioperative myocardial infarction.157 This 
result can be attributed to the hemodynamic effect of hypothermia in the form of 
hypertension and tachycardia, as well as postoperative shivering which increases the 
accentuated postoperative oxygen consumption. Surgical site infection after colorectal 
surgery occurs with a frequency of about 10%, which, in the hypothermic conditions with a 
temperature drop of 1.9 ° C, increases by triple.158 This can be explained by direct 
disturbance of the immune function, but also by the influence of hypothermia-induced 
vasoconstriction on the wound perfusion and reduction of tissue oxygen partial pressure. 
There is even a hypothesis that unintended hypothermia could be responsible for the 
appearance of tumor relapse and the appearance of metastases after oncological surgery, 
probably through suppression of T-cell immunity.159 Postoperative shivering and feeling cold 
are not severe postoperative complications, but they are often described by the patient as the 
more unpleasant experience than pain. Long-term shivering as a compensatory mechanism 
increases oxygen consumption by 2-3 times.160 
One very old study has shown that the temperature of the toe is very well correlated with the 
heart rate and that this correlation is even stronger when placed in the context of ambient 
temperature.161 It has also been shown that early skin temperature measurement at the toe has 
good predictive characteristics for the outcome of a critically ill patient.161 These findings 
were the basis for the introduction of temperature gradients for estimating peripheral 
perfusion because under constant ambient temperature, changes in skin temperature are the 
result of changes in the skin blood flow.162 Usually, as temperature gradients we use the 
difference between the forearm-to-finger-tip (Tskin-diff) skin-temperature, the difference 
between central and peripheral temperature (dTc-p), and the difference between peripheral 
and ambient temperature (dTp-a). It is considered that dTc-p in patients with stable 
hemodynamic is 3-7 ° C, and that the gradient is increased when vasoconstriction occurs in 
order to perfuse vital organs and maintain a central temperature stable.143 It was shown that 
the mean value of dTc-p during 24 hours after admission to ICU together with lactate 
concentrations and mean arterial pressure (MAP) is an ICU and hospital mortality predictor 
in septic patients.141 Also, the dTc-p value greater than 5 ° C significantly correlates with 
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central venous oxygen saturation (ScvO2) and lactate concentrations in patients with septic 
shock.163 Studies which were investigating the importance of temperature gradients in 
surgical patients mainly refer to cardiac surgery. However, Genderen with associates showed 
that peripheral perfusion disorders after major abdominal surgery, including temperature 
gradients, were associated with severe complications, independent of systemic 
hemodynamics.142 New studies are needed to investigate the effectiveness of strategies which 
by influencing peripheral perfusion may contribute to improving postoperative outcomes. 
Several studies related to the use of vasodilators after initial resuscitation of septic patients 
showed that along with the decrease of dTc-p, there was also an improvement in flow through 
microcirculation.51,164,165 
1.3.6.3. Serum lactate 
Elevated lactate levels are frequently found in critically ill patients and often correlate with 
disease severity. Because of its prognostic role, lactate has been widely used as a biomarker 
for screening, diagnosis, risk stratification, and monitoring in critically ill patients. Moreover, 
lactate levels can be used for outcome prediction and as a surrogate endpoint to guide 
treatment.166 The rationale for lactate monitoring in critically ill patients is based on the fact 
that hyperlactatemia is most often caused by tissue hypoperfusion and increased anaerobic 
glycolysis. Elevated lactate might also be due to increased aerobic glycolysis, i.e. pyruvate 
production is higher than the capacity of pyruvate dehydrogenases, which occurs as a 
response to cytokine release, increased circulated catecholamines, or the accumulation of 
leukocytes at the site of inflammation.166 Whatever the underlying cause, early detection of 
hyperlactatemia has shown to be beneficial since lactate levels were strongly related to the 
Sequential Organ Failure Assessment (SOFA) score and outcomes in critically ill 
patients.167,168 Multiple studies have evaluated the prognostic value of lactate in 
heterogeneous groups of critically ill patients, in the intensive care unit (ICU) and emergency 
departments.169,170 Most of these studies involved patients with sepsis, trauma, shock, or 
severe respiratory failure. On the other hand, data on the significance of lactate monitoring in 
patients undergoing elective major non-cardiac surgery is scarce. It has been shown that 
hyperlactatemia occurs in more than a third of patients admitted to the ICU following the 
elective surgery.171 Creagh-Brown et al. evaluated the effect of the peak serum lactate, in the 
first 24 hours of ICU admission after major gastrointestinal surgery, in a very large cohort of 
more than a hundred thousand patients from 249 hospitals in the United Kingdom.172 They 
found that increased in-hospital mortality was associated with elevated lactate levels, with no 
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differences between elective and emergency surgery. Moreover, the positive linear 
relationship between the lactate levels and risk of mortality continued down into the normal 
range of lactate (<2 mmol/l). It has been demonstrated by that lactate levels measured 12 
hours after ICU admission could discriminate between survivors and nonsurvivors in a group 
of high-risk, hemodynamically stable surgical patients.173 Furthermore, persistent 
hyperlactatemia in the nonsurvivors at 48 hours correlated with a poor clinical outcome. 
These findings are attributed to a continuous and inadequate resuscitation that resulted in 
occult hypoperfusion. The assumption that hyperlactatemia results from oxygen debt is the 
ground for „lactate-guided“ resuscitation protocols. However, not all studies showed good 
results with these protocols.174 Postoperative hyperlactatemia may be due to different 
etiologies and measures that only target tissue hypoxia to resolve hyperlactatemia may yield 
unsatisfactory results. Increased serum lactate concentration after the elective surgery may be 
due to a local ischemia inherent in the surgical procedure, such as the pringle maneuver 
during hepatic resection. Early postoperative causes of hyperlactatemia may be the 
awakening from anesthesia, pain, and hypothermia with a resultant increase in the 
endogenous catecholamines. Intraoperative and postoperative catecholamine administration 
may also lead to hyperlactatemia.175 It is therefore unlikely that the interventions aimed at 
increasing oxygen delivery can resolve the hyperlactatemia that arises in response to marked 
surgical stress, postoperative pain, or hypothermia. Whatever the underlying cause, elevated 
serum lactate levels on ICU admission following surgery should prompt clinicians to analyze 
all the possible etiologies and undertake various measures to control hyperlactatemia early. 
 
1.3.6.4. Central venous oxygen saturation (ScvO2) 
Mixed venous oxygen saturation (SvO2)  represents the fraction of oxygenated hemoglobin in 
the pulmonary artery and it serves as an indicator of the global oxygen supply (DO2) to 
oxygen consumption (VO2) relationship. Since its measurement requires pulmonary artery 
catheter in situ which is rarely used nowadays during abdominal surgery, a central venous 
oxygen saturation (ScvO2) as its surrogate measured in the superior vena cava is a frequently 
used parameter to estimate global VO2/DO2 ratio. Normally, ScvO2 is about 2-3% lower than 
SvO2 , but it has been shown that they are highly correlated and change simultaneously across 
a wide range of DO2/VO2 ratios.
176,177 The normal value of ScvO2 is around 70-75% and it 
reflects the relationship of oxygen delivery and consumption of the upper part of the body.178 
This value is under normal conditions lower than SvO2 mainly due to the high oxygen 
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extraction in the brain compared to that in the splanchnic region. Factors that influence ScvO2 
are cardiac output (CO), hemoglobin level, arterial oxygen saturation (SaO2) and oxygen 
consumption.179 Oxygen extraction ratio (O2ER) which is a quotient of tissue oxygen 
consumption and supply (VO2/DO2) directly influences ScvO2 .
180  
Since   O2ER= 
VO2
DO2
 , where: 
       DO2 = CO x (Hb x 1.34 x SaO2 + 0.003 x PaO2),  
and VO2 = CO x ((Hb x 1.34 x SaO2 + 0.003 x PaO2) – (Hb x 1.34 x ScvO2 + 0.003 x PcvO2) 
(CO-cardiac output; Hb-hemoglobin concentration; SaO2 –arterial oxygen saturation; PaO2 – arterial partial pressure of 
oxygen; ScvO2- central venous oxygen saturation; PcvO2-central venous partial pressure of oxygen) 




If we approximate that in a healthy individual SaO2 is 1, the relation of ScvO2 to VO2/DO2 
ratio becomes clear:   O2ER = 1 – ScvO2.
180 
Clinical situations where ScvO2 is higher than SvO2 are general anesthesia and traumatic brain 
injury, because of depressed cerebral metabolism and reduced oxygen extraction.179 Different 
types of shock, characterized by a diversion of blood from splanchnic circulation and 
increased oxygen extraction cause a decreased inferior vena cava saturation, thereby lowering 
SvO2.
176 
It has been shown by many observational studies that low perioperative ScvO2 was 
independently associated with complications in high-risk patients after major non-cardiac 
surgery.181,182  Several randomized trials aiming to improve oxygen delivery/consumption 
balance in high-risk surgical patients, with a goal-directed strategy using ScvO2 as an endpoint 
were able to demonstrate that this approach was associated with more interventions, more 
fluid boluses and a higher need for transfusion.183,184 However, it resulted in less organ 
dysfunction, fewer complications, and better survival. Significant fluctuations in ScvO2 occur 
after major abdominal surgery, and a sudden drop can be observed particularly during the 
first postoperative hour.184 This phenomenon can be attributed to an increased brain oxygen 
consumption during awakening from anesthesia, but also to hemodilution caused by 
aggressive fluid resuscitation leading to hemoglobin drop.179 A recent animal study has 
shown that ScvO2 as a reflection of VO2/DO2 ratio during isovolemic anemia can be used as a 
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transfusion threshold better than hemoglobin level.185 
However, it should be kept in mind that a normal ScvO2 does not rule out ongoing tissue 
hypoperfusion, particularly in conditions characterized with a heterogeneity of 
microcirculation and mitochondrial dysfunction.177 Perioperative hemodynamic optimization 
requires cautious interpretation of ScvO2 taking into account all possible mechanisms 
interfering with oxygen delivery and consumption balance. 
 
1.3.6.5. Venous-to-arterial carbon dioxide tension difference  
Venous-to-arterial carbon dioxide tension difference (ΔPCO2, CO2 gap) is the difference 
between partial pressure of CO2 (PvCO2) in mixed venous blood and the partial pressure of 
CO2 (PaCO2) in arterial blood. Since central venous PCO2 has shown strong accordance with 
mixed venous PCO2, central venous-to-arterial carbon dioxide difference, calculated after 
simultaneous sampling of central venous and arterial blood, is equally reliable and much 
easier.186 It should be noted that PCO2 represents partial pressure of dissolved CO2 which is 
only a fraction of total CO2 , transported in blood also as bicarbonate and bound to plasma 
proteins (carbamino compounds). 
ΔPCO2 = PcvCO2 – PaCO2 
Normally, ΔPCO2 values are between 2 mmHg and 6 mmHg.
187 According to the Fick 
equation, carbon dioxide production is a product of cardiac output and the difference between 
venous (central venous) and arterial CO2 content: 
VCO2 = CO x (CcvCO2 – CaCO2) 
(CO – cardiac output; CcvCO2 – carbon dioxide content in central venous blood; CaCO2 – carbon dioxide content in arterial 
blood) 
Since the calculation of whole blood CO2 content requires the use of complicated Douglas 
formula, it is more convenient to represent it with a surrogate measure, PCO2.
188 The 
association of PCO2 and total CO2 content is curvilinear and influenced by oxygen saturation, 
hematocrit, pH and temperature.189 Thus, it can be assumed that: 
ΔPCO2 = k x ( CcvCO2 – CaCO2 ), where k is a constant in physiological circumstances 
After substitution of venous- to-arterial CO2 content difference with PCO2 into a modified 
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Fick equation, CO2 gap can be calculated as follows: 
ΔPCO2 = VCO2 x k / CO 
As shown by the equation, ΔPCO2 is linearly influenced by carbon dioxide production 
(elimination) and inversely related to cardiac output. However, changes in constant k 
dependent on oxygen saturation, and varying CO2 production cause different effects of 
cardiac output on ΔPCO2 in normoxic and hypoxic conditions.
189 
Under normal (normoxic) circumstances, the CO2 production during oxidative metabolism is 
directly related to oxygen consumption (VO2). The relationship (ratio) of VCO2 and VO2 can 
be represented with the respiratory quotient (R) which ranges from 0.7 to 1 depending of the 
main energy source (lipids or carbohydrates). Decrease of cardiac output leads to a rise of 
venous CO2 content and the resultant increase in ΔPCO2  due to a stagnation phenomenon.
190  
However, this relationship is curvilinear, meaning that the  sharp increase in ΔPCO2 occurs in 
the lowest ranges of cardiac output.189  
The relationship between ΔPCO2 and the cardiac output becomes more complex in hypoxic 
conditions when VCO2 is not constant. Decrease in VO2 during hypoxia is associated with 
reduced aerobic VCO2 production.
191 Anaerobic generation of carbon dioxide may take place 
in such circumstances, but it is debatable to what extent it contributes to changes in ΔPCO2. 
During tissue hypoxia with reduced blood flow, widening of CO2 gap can be attributed 
mainly to the inadequacy of venous blood flow to wash tissue CO2, and to a much lesser 
extent to a rise in venous CO2 content from the increased production. On the other hand, 
tissue hypoxia with preserved or increased blood flow results in normal or decreased CO2 
gap.192 Therefore, ΔPCO2 shouldn’t be regarded as a reliable indicator of tissue hypoxia.
193 
It should be kept in mind that during tissue hypoxia, a decrease in VO2 is greater than that of 
VCO2 due to some anaerobic production of carbon dioxide. The resultant change in the 
respiratory quotient, may, therefore, indicate the existence of tissue hypoxia.194 The 
respiratory quotient (VCO2/VO2 ratio) is not routinely measured in everyday practice, but it 
can be substituted as follows: 
(1)      VO2 = CO x (CaO2 – CvO2) 
(2)      VCO2 ∝ CO x ΔPCO2 
It is obvious from these equations that ΔPCO2/ Ca-vO2 ratio may be employed as an indicator 
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of the global tissue hypoxia. It has been shown that ΔPCO2/Ca-vO2 ratio was able to detect 
ongoing tissue hypoxia in critically ill patients with normalized cardiac output, and to predict 
the development of hyperlactatemia better than CO2 gap alone, and Ca-vO2 alone.
195 The 
other studies demonstrated that this ratio detected the VO2/DO2 dependency far better than 
ScvO2 and serum lactate.
177,196 The interpretation of CO2 gap and ΔPCO2/Ca-vO2 ratio should 
consider the other hemodynamic and metabolic parameters. A resuscitation algorithm for 
septic shock patients was proposed, based on ΔPCO2 and oxygen-derived parameters.
193 
(Figure 1)  
 
Figure 1. Protocol for hemodynamic optimisation guided by venoarterial CO2 tension difference  
(Mallat, 2016)177 
 
Data on the usefulness of CO2 gap monitoring during resuscitation originate mostly from 
trials involving patients with septic shock or critically ill patients. There isn’t much data on 
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the value of this parameter in high-risk surgical patients. However, there are studies that 
showed that an increased CO2 gap during an early postoperative period was associated with 
the occurrence of postoperative complications.197 These studies were also able to demonstrate 
that the CO2 gap may serve as a complementary tool to ScvO2 during goal-directed 
hemodynamic optimization in high-risk patients following major surgery.198 Further studies 
are needed to elucidate the role of this easily obtainable parameter in guiding  resuscitation 

























1. To evaluate the incidence and type of postoperative complications after high-risk major 
abdominal surgery and to analyze their association with the intensive care unit and hospital 
length of stay, mortality, and functional activity on discharge. 
2. To assess the accuracy of The Clavien-Dindo Classification (CDC) and The 
Comprehensive Complication Index (CCI) in evaluation of postoperative morbidity in high-
risk patients undergoing major abdominal surgery and to compare the impact of the two 
scales on resource utilization indices. 
3. To validate the use of the POSSUM scoring system in predicting postoperative morbidity 
and mortality after major abdominal surgery. 
4. To determine the clinical relevance of markers of tissue perfusion (capillary refill, central-
to-toe body temperature gradient, serum lactate, and CO2 gap) and their repeated assessment 
during the first postoperative day for the occurrence of severe complications. 
5. To identify preoperative, intraoperative, and early postoperative risk factors for 
complications after high-risk major abdominal surgery and to develop a new model for 
prediction of complications. 











This was a prospective, observational study conducted at the Clinic for Digestive Surgery, 
Clinical Center of Serbia, which is a tertiary care university hospital, over a two-year period 
(November 2016-October 2018). The study was performed in collaboration with the Georgia 
Tech University, M. Stewart School of Industrial & Systems Engineering, Atlanta, GA, USA. 
The Ethics Committee of the School of Medicine, University of Belgrade (reference number 
29/XI-13) approved the study, and the informed consent was obtained from all included 
patients. 
3.1.Patient selection  
The study enrolled all consecutive adult patients (older than 18 years) if they fulfilled the 
following inclusion criteria: 
1. Elective major or major +  abdominal surgery  
2. Surgery duration > 120 minutes 
3. Evidence of limited physiologic reserve of one or more organs as reflected by ASA≥2 or 
the age >70 years 
4. POSSUM predicted mortality > 3% 
5. A planned postoperative ICU stay of at least 24 hours 
Major and major + surgery were defined according to the criteria of Copeland et al.116 The 
examples of major surgery in our cohort were: bowel resection, splenectomy, 
hepaticojejunostomy. Oesophagectomy, gastrectomy, hepatic and pancreatic resection, 
abdominoperineal resection, pelvic exenteration, and multiorgan resections were classified as 
major + surgery. If a patient underwent major surgery, the criterion of ASA > 2 or the age 
over 70 had to be met. If major + surgery was done, the ASA could be  ≥ 2. All other criteria 
were obligatory. 
The following exclusion criteria were used: 
1. Emergency surgery 
2. ICU admission after an operation performed in another hospital 
3. Known peripheral arterial occlusive disease 
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4. The absence of central venous line (if it has not been inserted during the operation) 
A final decision to enroll a patient was made at the end of the operation, after computation of 
the POSSUM predicted mortality. Along with other inclusion criteria present and 
nonexistence of exclusion criteria, the patient was considered a suitable candidate for further 
follow-up. 
 
3.2. Data collection 
Clinical and demographic data were recorded in several time points: before surgery, during 
the operation, on admission to the ICU (H0), twelve hours after the admission (H12), and on 
the first postoperative day (H24). 
A questionnaire containing basic demographic and clinical data was completed before the 
operation. For each patient, the following preoperative data were obtained: gender, age, 
length of preoperative hospitalization, body mass index (BMI), ASA score, and functional 
status (graded as independent, partially dependent, and totally dependent).  Comorbidities 
were recorded as present or absent. The presence of respiratory, cardiovascular (hypertension, 
coronary artery disease, congestive heart failure, valvular disease, other), diabetes (with or 
without end-organ damage), chronic renal disease, liver disease, neurologic, psychiatric, 
endocrine, and a systemic connective tissue disease was further noted. Obesity was defined as 
a BMI >30 and recorded if present, as well as malnutrition, defined as a BMI<18.5. Besides, 
weight loss before admission, smoking status, and alcohol consumption were also 
documented. A section related to chronic therapy contained the information about the number 
of drugs that the patient regularly takes, as well as previous corticosteroid and antibiotic 
therapy. Chemotherapy or radiotherapy that preceded hospital admission were also 
documented. 
The following laboratory data were recorded:hemoglobin (g/l), white blood cell count 
(WBC), platelet count, albumin (g/l), urea (mmol/l), creatinin (μmol/l), INR, AST, ALT ,and 
CRP. 
Finally, the physiologic part of the POSSUM score was calculated before the operation.   
During  the operation, following variables were recorded: type of surgical disease (benign or 
malignant), site of surgery (oesophagogastric, hepatic, pancreaticobiliary, colorectal, 
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multiorgan resection, and other), surgical approach (midline laparotomy, subcostal 
laparotomy, thoraco-abdominal, minimally invasive), duration of operation in minutes (from 
anesthesia induction until the skin closure), type of anesthesia (general or combined with 
epidural), the use of intraoperative warming, and the amount and type of administered fluids. 
The occurrence of intraoperative adverse events was noted too.  Hypotension was defined as  
systolic blood pressure (SP) < 90mmHg or 20% lower than basal SP for more than 15 
minutes. Hypertension as SP > 160mmHg for more than 15 minutes. Hypoxia as SpO2 < 
90% measured by pulse oximetry. Hypercapnia as etCO2 > 6.0 kPa for more than 15 
minutes. Bleeding and hypotension requiring vasopressor use were also considered as adverse 
events.  
At the end of the surgery, the operative part of the POSSUM score was calculated, and 
finally, the POSSUM predicted morbidity and mortality for each patient. 
Anesthetic drugs and techniques, intraoperative monitoring, and fluid management were 
selected on the discretion of the attending anesthesiologist. Different surgical teams 
performed the operations. Most of them are high-volume surgeons for the type of surgery 
they execute. 
The patients were transferred to the ICU immediately after the end of surgery. 
Standard hemodynamic monitoring, upon admission to the ICU, included continuous 
monitoring of the electrocardiogram, invasive monitoring of blood pressure, pulse oximetry, 
and central venous pressure (CVP). Concurrently, an arterial and venous blood sample was 
taken for blood gas analysis, including blood glucose and lactate concentration. (Radiometer 
ABL700, Radiometer Medical, Copenhagen, Denmark). The CO2 gap was calculated as the 
difference between central venous partial pressure of carbon dioxide and arterial partial 
pressure of carbon dioxide.  A skin temperature probe (Mon-A-Therm skin temperature 
probe, Covidien, UK) was attached to the patient’s toe to measure the peripheral temperature 
and remained for the next 24 hours. The central temperature was obtained with an electronic 
epitympanic thermometer (GeniusTM 2 Tympanic Thermometer, Covidien,UK). A 
temperature gradient (deltaT) was calculated as the difference between the central and 
peripheral temperature (˚C). A capillary refill time (CRT) was measured simultaneously, and 
it was defined as the time (in seconds) needed for a nail capillary bed to regain its color after 
the pressure was applied to a fingertip to cause blenching. All of these recordings were done 
within the first 10 minutes after the admission to the ICU. 
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Twelve hours later (H12) all measurements were repeated to obtain data on: heart rate (HR), 
systolic pressure (SP), mean arterial pressure (MAP), CVP, pH, base excess (BE), arterial 
partial pressure of oxygen (paO2), CO2 gap, anion gap (AG), lactate concentration, CRT, and 
deltaT. 
On the first postoperative day (H24) we collected data on vasopressor use, transfusion, a total 
amount of intravenous fluids for the 24-hour period, urine output, and output via abdominal 
or thoracic drains. Fluid balance was calculated as a difference between the amount of 
infused fluids and output by urine and drains for the 24 hours, starting from the onset of 
surgery. Laboratory analyses included the same measurements as preoperatively. We used 
data from the last 24 hours to calculate the Simplified Acute Physiologic Score (SAPS II) for 
each patient. 
Since this was not an interventional study, patients were treated according to the local 
practice during their ICU stay. They were monitored and resuscitated to achieve usual 
hemodynamic goals and the target values were as follows: mean arterial pressure (MAP) of 
65mmHg, central venous oxygen saturation (ScvO2) of 70%, urine output of 0.5-1.0 ml/kg/h, 
and hematocrit (Hct) of 25%. No specific algorithm was used to achieve these hemodynamic 
goals and laboratory values, and the use of intravenous fluids, vasopressors, inotropes, 
diuretics, antihypertensives, and packed red blood cells (PRBC) was guided by the 
assessment of the attending intensivist. Results of the assessment of peripheral perfusion 
(CRT, deltaT, CO2 gap, and lactates) were not directly used to guide patient management at 
the ICU. 
3.3.Follow-up 
Patients were followed during their ICU stay and after transfer to the surgical ward for the 
occurrence of postoperative complications. All complications (medical and surgical) were 
recorded as well as their treatment. 
A complication was defined as „any deviation from the normal postoperative course“ 
including asymptomatic complications.20  A clear distinction was made from sequela that is 
inherent to the procedure or „failure to cure“ situation. These were not classified as 
complications. 
More specifically, we used the European Perioperative Clinical outcome (EPCO) definitions 
of perioperative outcome measures, issued by the European Society of Anaesthesiology –
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European Society of Intensive Care Medicine (ESA-ESICM) joint task force, to define each 
medical postoperative complication.199  To define anastomotic leak we used the proposed 
definitions of the relevant International Study Groups for different fields of digestive 
surgery.200,201 
According to the treatment applied, each complication’s severity was classified with 
appropriate Clavien-Dindo (CD) grade. The highest CD grade was finally retained and 
assigned to the patient. 
Patients were followed during the entire hospitalization, until discharge from the hospital or 
death, or if the readmission occurred within the 30 days after the index surgery. 
To assess the impact of complications on a patient-centered outcome, we estimated the 
functional capacity on discharge with one of three grades: independent, partially dependent 
(walks with assistance), or totally dependent (bedridden). We also recorded the discharge 
location (home or other institution).  
Hospitalization indices that were documented on discharge were: ICU length of stay (LOS), 
postoperative LOS, and a total hospital LOS. 
Following discharge, we entered CD grade of every single complication that an individual 
patient developed into an online database created on the website www.assessurgery.com, to 
calculate the Comprehensive Complication Index (CCI) per patient. The CCI®-calculator is a 
registered trademark and is owned by the University of Zurich. 
 
3.4.Validation of the POSSUM and the P-POSSUM score 
For each patient Physiologic and Operative Score were derived using data collected 
preoperatively and at the end of the operation. Predicted mortality and morbidity were 




   
where p is predicted mortality or morbidity and y is the linear combination of predictors. 
For POSSUM morbidity: y= -5.91+(0.16 x Physiologic Score) + (0.19 x Operative Score); 
For POSSUM mortality: y= -7.04 + (0.13 x Physiologic Score) + (0.16 x Operative Score) 
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For P-POSSUM mortality: y= -9.37 + (0.19 x Physiologic Score) + (0.15 x Operative Score) 
The ability of the scores to predict morbidity and mortality were tested through three 
characteristics: discrimination, the observed to expected mortality (morbidity) ratio (O:E 
ratio), and calibration. 
Discrimination of the models was assessed by the area under a receiver operating 
characteristic (ROC) curve. A traditional academic scale was used to classify the area under 
the curve (AUC) and assess the performance of the test (< 0.6 – F (failed); 0.6-0.7 – D (poor); 
0.7-0.8 – C (fair); 0.8-0.9 – B (good); 0.9-1.0 – A (excellent)). 
We split patients into 4 groups according to the predicted risk of the outcome (death, 
complication). Expected number of deaths (or patients with complications for POSSUM 
morbidity) for each risk group was calculated by multiplying the number of patients in a 
group with the predicted average risk in that group. The ratio of observed to expected (O:E) 
outcome (death or complication) was then calculated for each risk band and for the entire 
cohort.  
Calibration of the model was assessed by the Hosmer-Lemeshow (HL) test, to calculate HL 













where Q is the total number of probability intervals. We compared the computed Hosmer-
Lemeshow statistic to a chi-square distribution with Q-2 degrees of freedom (DF) to calculate 
the p-value. Poor calibration was considered when p ≤ 0.05. 
3.5. Development of a model for prediction of complications 
Model development procedure consisted of first selecting predictors from 107 candidate 
covariates, then fitting the logistic regression model on the training data, and last rounding 
the model coefficients to the closest integers or other simpler numbers. The finalized model 
was both validated on the training set and a testing data set.  
3.5.1.Variable selection 
Variable selection was challenging in this study. The challenges included: 1) The covariates 
could be intuitively divided into three groups according to the time when they were measured 
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or collected: preoperative, intraoperative, and postoperative. Ideally, we wanted to select 
predictors from all of the three groups to take into account patients’ conditions at all times;  
2) Forty-nine out of 206 patients didn’t have all of the 107 covariates, and therefore we could 
not simply delete those with missing data. To solve these challenges, we conducted variable 
selection within each group of covariates and then combined them together. Besides, median 
imputation was used in dealing with missing data.  
The procedure of variable selection within each covariate group (Preoperative, Intraoperative, 
and Postoperative) was in order of the following three steps: 
 Step 1: We compared candidate covariates across patients with and without 
complications, and selected the ones that were significantly different across those two 
groups. The numeric variables were compared using Mann Whitney Wilcoxon test and 
the Student’s t-test, and categorical variables were compared based on chi-square test. P 
value less than 0.05 was considered as being significant.  
 Step 2: After filling in the missing data with column median, we checked the correlations 
of the covariates selected from step 1. Selection among the highly correlated ones 
(correlation coefficient >=0.6) was based on clinical interpretations and domain 
knowledge. 
 Step 3: Among the covariates from step 2, further conducted variable selection was based 
on statistical algorithms, LASSO or stepwise regression. 
 
After within-group selection, we combined the selected covariates from each group, and then 
applied statistical algorithms (LASSO or stepwise regression) to determine the final 
predictors.  
Specifically, a Lasso logistic regression model aims to minimize the sum of the negative log-
likelihood function and the 𝐿1 norm scaled by a tuning parameter 𝜆: 
 
− ∑ (𝑦𝑖 log(?̂?𝑖)
𝑁
𝑖=1 + (1 − 𝑦𝑖)log (1 − ?̂?𝑖)) + 𝜆 ∑ |𝛽𝑗|
𝑝
𝑗=0 , 




, 𝑦𝑖  is the binary outcome (either 0 or 1), 𝑝 is 
the total number of covariates, 𝛽0 is the intercept, and 𝛽𝑗 ′𝑠 (j > 0) are the coefficients of the 
covariates. The parameter 𝜆 is a tuning parameter controlling the extent of the shrinkage. The 
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result is an estimate of the 𝛽 coefficients, with several coefficients potentially shrunk to zero. 
This coefficient shrinkage is the mechanism by which covariates selection occurs, with those 
covariates with zero coefficients being removed from the model. Larger tuning parameter 𝜆 
will lead to less selected variables, and the value of 𝜆 will be determined by the following 
cross-validation procedure: 
1. Set up a lambda candidate sequence;  
2. For each lambda in the sequence, conduct a 10-fold cross validation, and calculate the 
mean cross-validated area under curve (AUC);  
3. Repeat step 2 for 100 times and calculate the averaged “mean cross-validated AUC” 
for each lambda; 
4. Select the best lambda to be the one corresponding to the largest averaged “mean 
cross-validated AUC”. 
 
These procedures in Lasso have been applied to select the covariates within each group 
(preoperative, intraoperative, …etc). The lambda candidate sequence was set to be from 
0.001 to 0.1, with a step size 0.001. After within-group selection, the selected covariates from 
each group were combined, and the above Lasso procedures repeated to select the final 
predictors. 
Lasso selected variables were finally used to build logistic regression model to predict 
complication occurrence.  
Logistic regression model was fitted on the training data to predict the probability of 




= ?̂?0 + ?̂?1𝑋𝑖1 + ⋯ + ?̂?𝑞𝑋𝑖𝑞 ,                                                                                              
(1) 
where 𝑋𝑖𝑗 is the 𝑗th predictor of patient 𝑖, with 𝑗 = 1, … , 𝑞 and 𝑞 is the total number of 
predictors, and ?̂?𝑖 is the predicted probability of developing complication (𝑦𝑖 = 1). The 
model was fitted on training data to obtain the estimated ?̂? coefficients. 
3.5.2.Rounding the model coefficients 
In order to simplify the model and make it easier to be implemented in real life, we rounded 
the coefficients in the fitted logistic regression model to some simpler numbers, without 




The predictive model has been validated on both the training set and a testing set. The testing 
set consisted of 60 consecutive high-risk patients included with the same inclusion criteria as 
for the training set. Data on these patients were prospectively collected from September 2018 
to December 2018. Only variables selected in the final model were recorded. These patients 
were followed for complications until hospital discharge. Given each subject 𝑖, we calculated 
the patient’s predicted probability of developing complications, i.e. ?̂?𝑖 , using equation (1). 
The predicted complication was then obtained by comparing that probability with cutoff 0.5. 
In other words, if the predicted probability was over 0.5, then the patient was predicted as 
having complications. The model predictive performance was measured by prediction error 
rate, sensitivity, specificity, positive predictive value (ppv), and AUC.  
 
3.6.Statistical analysis 
Continuous data were presented as means ± standard deviations or medians (interquartile 
range) and analyzed using the Student’s t-test or Mann-Whitney U-test depending on the 
normality of data distribution. Kolmogorov-Smirnov test was used to test the normality. 
Categorical data were analyzed with Chi-square or Fisher’s exact test as appropriate. The 
differences between the grades of functional activity were tested with the Kruskal-Wallis test. 
A Spearman’s rank test was used to asses the correlations between the CCI and the CDC, and 
to calculate the correlation coefficients of the two scales with the number of complications, 
ICU length of stay (LOS), postoperative LOS, hospital LOS, and the prolonged LOS. 
Correlation coefficients (rs) of 0.10-0.29 ;0.30-0.49; and 0.5-1.0 were considered weak, 
moderate, and strong correlation, respectively. William’s modification of Hotelling’s test of 
equality of dependent correlation coefficients was used to test the difference between 
correlation coefficients of the CCI and the CDC with the above-listed variables. 
To evaluate the validity of the POSSUM and the P-POSSUM for prediction of complications, 
ROC curve analysis was used to test the discrimination of the models. To test the difference 
between observed and expected morbidity and mortality, the Hosmer-Lemeshow test was 
applied as previously described. We considered that significant difference was present 
suggesting poor calibration if the p value was < 0.05. 
To test the change of perfusion parameters over time Wilcoxon signed rank test was used. 
Univariate logistic regression was used to determine the significant predictors of the CCI>50. 
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Predictors with p values < 0.1 were entered in a multivariate analysis to determine predictors 
independently associated with the CCI>50. Odds ratios and 95% confidence intervals were 
calculated. 
Lasso and stepwise algorithms were used to select variables and then fit the logistic 
regression model for the prediction of complications. The tunning parameter lambda and the 
final model were selected to have a large area under curve (AUC) but at the meantime keep 
the reasonable clinical explanations. 10-fold cross-validation was used for within sample 
validation of the model. Mean error rate, sensitivity, specificity, AUC were calculated for 
each testing set and then averaged across the testing data set. The error statistics from each 
cross-validation fold were further averaged. The model was validated in the new sample of 
patients. The area under curve and error statistics were calculated. 
Statistical analysis was performed with IBM SPSS Statistics for Windows, Version 22.0 






























































































































































































































































































4. RESULTS       
4.1.Demographic and clinical characteristics of the study cohort    
During the study period, 4458 patients were operated in our hospital. Out of 856 patients 
admitted to the ICU following surgery and were screened for eligibility, a total of 206 
patients met the inclusion criteria and were thus eligible for further analysis (Figure 3) 
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Baseline clinical and demographic characteristics of the study patients are summarized in 
table 12. One hundred thirty-three (64.6%) patients were male. Mean age of the patients in 
the cohort was 63.9 ± 11.8 years. Majority of patients were operated for cancer (188; 91.3%) 
and 33 (16.0%) of them had metastatic cancer. Comorbidity was present in 154 (74.7%) of 
patients, of whom 103 (50.0%) had ASA score 3 (89; 43.2%) or 4 (14; 6.8%). The overall 
POSSUM predicted morbidity was 57.9 % [38.0-76.3], while the POSSUM predicted 
mortality for the cohort was 13.2% [7.2-24.0]. Patients spent on average 8.0 [4.0-15.0] days 
in hospital prior to the scheduled operation. 












No (N=81) Yes (N=125) 
Age (years) 63.9±11.8 62.8 ± 12.8 64.6 ± 11.2 0.292 
Male gender 133 (64.6) 50 (61.7) 83 (66.4) 0.552 
BMI 24.4 [22.1-27.3] 24.3 [21.3-26.8] 24.5 [22.1-27.7] 0.179 
Functional status (< 4 METs) 31 (11.7) 11 (13.6) 20 (16.0) 0.694 
Commorbidity 154 (74.7) 60 (74.1) 94 (75.2) 0.871 
ASA 
       2 
       3 














Cancer 188 (91.3) 76 (93.8) 112 (89.6) 0.334 
Metastatic cancer 33 (16.0) 9 (11.1) 24 (19.2) 0.122 
Cigarette smoker 57 (27.7) 22 (27.2) 35 (28.5) 0.874 
Alcohol consumption 79 (38.3) 29 (35.8) 50 (40.6) 0.557 
Obesity 19 (9.2) 4 (4.9) 15 (12.0) 0.137 
Malnutrition 21 (10.2) 11 (13.6) 10 (8.0) 0.240 
Unintentional weight loss 69 (33.5) 25 (30.9) 44 (35.8) 0.546 
Haemoglobin (g/l) 123.6±20.8 130.2±17.8 119.2±21.5 <0.001 
WBC (109/l) 6.6 [5.0-7.5] 6.2 [5.0-7.7] 6.1 [4.8-7.1] 0.359 
Platelets (109/l) 229.0 [177.0- 299.0] 244.0 [187.0-289.0] 222.0 [175.0-305.0] 0.375 
Creatinine (μmol/l) 77.0 [60.0-89.0] 78.0 [64.0-88.0] 74.0 [58.2-92.5] 0.892 
Urea (mmol/l) 6.3 [4.2-6.9] 5.7 [4.0-7.3] 5.3 [4.4-6.8] 0.625 
Bilirubine (μmol/l) 12.6 [8.3-20.1] 13.1 [7.7-17.6] 12.6 [8.5-20.1] 0.520 
Albumin (g/l) 36.8 ± 6.0 39.4 ± 4.3 35.1 ± 6.4 <0.001 
CRP (mg/l) 9.9 [3.0-33.0] 5.9 [2.7-5.9] 11.2 [3.1-43.7] 0.025 
AST (IU/l) 20.0 [16.0-32.0] 20.0 [15.0-32.0] 20.0 [17.0-29.2] 0.526 
ALT (IU/l) 17.0 [12.0-32.0] 16.0 [11.0-25.0] 19.0 [13.7-33.2] 0.419 
POSSUM predicted morbidity 
(%) 
57.9 [38.0-76.3] 41.6 [30.6-61.5] 65.7 [50.0-80.9] <0.001 
POSSUM predicted  
mortality (%) 
13.2 [7.2-24.0] 8.1 [5.6-14.7] 16.5 [10.7-27.9] <0.001 
Preoperative LOS(days) 8.0 [4.0-15.0] 5.0 [4.0-14.0] 9.0 [6.0-16.0] 0.002 
Data are presented as mean ± standard deviation, number (%), or median [IQR]; BMI- Body mass index 
(kg/m2);  ASA- American Society of Anesthesiologists;WBC-white blood cell count; CRP-C-reactive protein; 
AST – aspartate aminotransferase; ALT- alanin aminotransferase; POSSUM-Physiological and operative 




One hundred and twenty five (60.7%) patients developed at least one complication, including 
death in 14 (6.8%) patients. The remaining 81(39.3%) patients had no complications. 
Compared to patients without complications, patients with complications had significantly 
lower preoperative haemoglobin (130.2±17.8 g/l  vs 119.2±21.5 g/l, p<0.001) and albumin 
levels (39.4 ± 4.3 g/l vs 35.1 ± 6.4 g/l, p<0.001), but a higher baseline CRP value (11.2 mg/l 
[3.1-43.7] vs 5.9 mg/l [2.7-5.9], p=0.025). The group of patients who developed 
complications had a higher POSSUM predicted morbidity (65.7 % [50.0-80.9] vs 41.6 % 
[30.6-61.5], p<0.001) and mortality (16.5 % [10.7-27.9] vs 8.1%  [5.6-14.7], p<0.001), and a 
longer preoperative LOS (9.0 days [6.0-16.0] vs 5.0 days [4.0-14.0], p=0.002) 
 
4.1.1 Comorbidities in patients with and without complications 
Chronic health characteristics of study patients are presented in table 13. The most frequently 
encountered comorbidities were cardiovascular diseases (other than hypertension,i.e. 
coronary artery disease, valvular disease, cardiomyopathy, arrhythmias – 73 patients 
(35.4%)) and hypertension (64 patients (31.1%)). Patients with complications were more 
frequently diabetic (28 (22.4%) vs 5 (6.2%), p=0.002) and received more frequently a chronic 
corticosteroid treatment (7 (5.6%) vs 0 (0.0%), p=0.044).  


































































Chronic therapy 138 (76.0) 58 (71.6) 80 (64.0) 0.290 
Number of drugs 2.0 [0.0-4.0] 2.0 [0.0-3.0] 2.0 [0.0-4.0] 0.984 
Corticosteroids 7 (5.6) 0 (0) 7 (5.6) 0.044 
Chemotherapy 18 (8.7) 4 (4.9) 14 (11.2) 0.137 
Antibiotic within 7 days 38 (18.4) 19 (23.5) 19 (15.2) 0.145 
Physiological POSSUM 18.0 [15.0-22.0] 16.0 [14.0-20.0] 19.0 [16.0-23.0] 0.001 
Data are presented as number (%) and median (IQR); POSSUM-Physiological and operative 
severity score for enumeration of mortality and morbidity 
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There were no other differences among patients with and without complications regarding 
preoperative health status. However, the physiological POSSUM score was significantly 
higher in patients who developed complications (19 [16-23] vs 16 [14-20], p<0.001). 
 
4.1.2.Surgical and intraoperative characteristics of the study patients 
Most operations were oesophagogastric (60 (29.1%); 28 esophagectomies and 32 
gastrectomies) and colorectal (47 (22.8%)). There were no differences in the incidence of 
complications regarding the type of surgery, except the group of multiorgan resections where 
complications were recorded more frequently (13.6% vs 1.2%, p=0.002). Intraoperative 
warming was used in 104 (50.5%) patients, less frequently in patients who developed 
complications (44% vs 60.5%, p=0.023). Patients who developed complications, when 
compared to patients without complications had a longer operation (260 min [187-360] vs 
210 min [137-300], p=0.002) and were more likely to receive more intraoperative fluids (4.0 l  
[2.5-5.7] vs 3.0 l [2.0-3.7], p<0.001). However, the amount of fluids adjusted to body weight 
and duration of operation (ml/kgxh) didn’t differ between two groups. (10.7 ml/kgxh [8.1-
16.7] vs 10.5 ml/kgxh [8.5-12.9], p=0.512). (Table 14) 









No (N= 81) Yes (N=125) 





























































Regional anesthesia 16 (7.8) 10 (12.3) 6 (4.8) 0.063 
Advanced monitoring 13 (6.3) 4 (4.9) 9 (7.2) 0.573 
Intraoperative warming 104 (50.5) 49 (60.5) 55 (44.0) 0.023 
Duration of surgery (minutes) 240 [180-320] 210 [137-300] 260 [187-360] 0.002 
Intraoperative fluid volume (l) 3.2 [2.2-4.8] 3.0 [2.0-3.7] 4.0 [2.5-5.7] <0.001 
Fluid volume (ml/kg/h) 10.5 [8.4-14.4] 10.5 [8.5-12.9] 10.7 [8.1-16.7] 0.512 




Intraoperative adverse events occurred in around half of the operations (51%). Hypertension 
(12.6%), bleeding (7.8%), and hypotension (6.3%) were the leading causes of intraoperative 
instability. (Figure 4). In 13 (6.3%) patients more than one adverse event was recorded during 
the operation. Although they were more likely to occur in patients with complications, the 
significance was not reached (56.0% vs 43.2%, p=0.087). 
                                              Figure 4. Intraoperative adverse events 
 
4.1.3.Postoperative characteristics of patients on ICU admission 
 
Postoperative characteristics of patients with and without complications on admission to the 
ICU are summarized in table 15. 
On average, a mild inadvertent hypothermia was present, with no significant difference in 
patients with and without complications (35.6 ± 0.9˚C vs 35.8 ± 0.7˚C, p = 0.197). However, 
a peripheral (toe) temperature was significantly different in the two groups, resulting in a 
different central-to-toe temperature gradient (delta T) which was higher in patients with 
complications (9.0 ± 2.3˚C vs 7.7 ± 2.4˚C, p<0.001).  In general, patients were normotensive 
on admission to the ICU with a mean MAP of 93.6 ± 18.5mmHg. Patients who developed 
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complications were likely to have a lower blood pressure (91.1 ± 19.2 vs 97.3 ± 16.9, 
p=0.016) and a higher heart rate (86 ± 7 vs 72 ± 12, p<0.001).  










No (N=81) Yes (N=125) 
Peripheral temperature (˚C) 27.2 ± 2.6 28.0± 2.6 26.6±2.4 <0.001 
Central temperature (˚C) 35.7±  0.8 35.8 ± 0.7 35.6± 0.9 0.197 
Delta T (˚C) 8.5 ± 2.4 7.7 ± 2.4 9.0 ± 2.3 <0.001 
Systolic pressure (mmHg) 135.9 ± 26.3 141.2 ± 22.7 132.5 ± 27.9 0.016 
MAP (mmHg) 93.6 ± 18.5 97.3 ±16.9 91.1 ± 19.2 0.016 
Heart rate (bpm) 80.2 ± 17.5 71.8 ± 12.2 85.7 ± 7 < 0.001 
SpO2 (%) 99 [97-100] 99 [97-100] 99 [97-100] 0.546 
ScvO2 (%) 72.3 ± 9.7 72.3 ± 7.1 72.3 ± 11.1 0.999 
pH 7.32 ± 0.07 7.34 ± 0.06 7.31 ± 0.08 <0.001 
Base excess (mmol/l) -6.2 ± 4.2 -4.2 ± 3.3 -7.5 ± 4.2 <0.001 
PaCO2 (kPa) 5.1 ± 0.7 5.2 ± 0.7 5.0 ±0.7 0.015 
PvCO2 (kPa) 6.1 [5.7 – 6.5] 6.2 [6.0 - 6.7] 6.1 [5.6 - 6.4] 0.004 
CO2 gap (mmHg) 8.1 ± 3.7 8.1 ± 4.1 8.1 ± 3.4 0.925 
Anion gap (mmol/l) 11.7 [9.0-14.2] 11.2 [9.0-12.8] 11.8 [9.0-14.2] 0.224 
Capillary refill time (s) 3.0 [2.5-4.0] 3.0 [2.5-4.0] 3.0 [2.5-4.0] 0.435 
Lactate (mmol/l) 1.9 [1.2-2.5] 1.3 [1.0-2.1] 2.1 [1.4-3.2] <0.001 
Glycemia (mmol/l) 9.7 [8.1-11.2] 9.4 [8.0-11.0] 10.0 [8.1-11.5] 0.393 
Intubated 140 (68.0) 93 (74.4) 49 (60.5) 0.045 
Mechanical ventilation 77 (37.4) 25 (30.1) 52 (41.6) 0.141 
Delta T – central-to-toe temperature gradient; MAP-mean arterial pressure; SpO2-oxygen saturation 
by pulse oxymetry; ScvO2- central venous oxygen saturation; PaCO2 – arterial partial pressure of 
carbon dioxide; PvCO2- venous partial pressure of carbon dioxide; Data are presented as means ± 
standard deviation; medians [IQR] or number (%). P values were calculated with the Student’s t-test, 
Mann-Whitney-Wilcoxon test or Chi-square  
On admission to the ICU patients presented with a mild acidosis (pH 7.32 ± 0.07; BE - 6.2 ± 
4.2 mmol/l). The acid-base disorder was more pronounced in patients with complications (pH 
7.31±0.08; BE -7.5 ± 4.2 mmol/l vs 7.34 ± 0.06; -4.2 ± 3.3mmol/l, p<0.001). Compared to 
patients without complications, patients with complications had significantly lower both 
PaCO2 (5.0 ± 0.7kPa vs 5.2 ± 0.7 kPa, p=0.015) and PvCO2 (6.1 [5.6-6.4] kPa vs 6.2 [6.0-6.7] 
kPa, p=0.004). As a result, the CO2 gap was not significantly different between them 
(p=0.925), though the average CO2 gap (8.1 ± 3.7mmHg) was above the normal range. The 
median lactate on admission was 1.9 [1.2-2.5] mmol/l. Lactate concentration was 
significantly higher in patients with complications compared to patients without 
complications (2.1 [1.4-3.2]mmol/l vs 1.3 [1.0-2.1]mmol/l, p<0.001). Patients on admission 
didn’t differ with regards to capillary refill time (p=0.435), glycemia (0.393), nor the rate of 
mechanical ventilation (p= 0.141). 
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4.1.4.Characteristics of patients 12 hours after the ICU admission 
 
Twelve hours after the admission to ICU both patients’ central (36.4 ± 0.6˚C) and peripheral 
(29.7 ± 3.9˚C) temperature increased showing no difference between patients with and 
without complications. Similarly, delta T decreased (6.6 ± 3.8˚C) in both groups. Though the 
temperature gradient was higher in patients with complications, the difference was non-
significant (6.9 ± 3.9˚C vs 6.3 ± 3.7˚C, p=0.249).  Compared to patients without 
complications, patients with complications tended to have a higher heart rate (84.0 ± 18.4 vs 
76.2 ± 12.5, p<0.001) and a lower central venous oxygen saturation (71.8 ± 8.2 vs 74.4 ± 5.0, 
p=0.006). Patients with complications had lower pH (7.37±0.09 vs 7.40±0.06, p=0.003), 
more negative base excess (-4.6±6.1mmol/l vs -0.8±3.22 mmol7l, p<0.001), lower PaCO2 
(4.8±0.8 kPa vs 5.2±0.5 kPa , p<0.001) , lower PvCO2 (5.8±0.7 vs 6.2±0.6 kPa, p=0.004) and 
a higher CO2 gap (7.7 [5.7-9.2]mmHg vs 6.6 [4.1-8.7]mmHg, p=0.026).  










No (N=81) Yes (N=125) 
Peripheral temperature (˚C) 29.7 ± 3.9 30.2 ± 3.68 29.4 ± 4.1 0.185 
Central temperature (˚C) 36.4 ± 0.6 36.4 ± 0.5 36.3 ± 0.6 0.171 
Delta T (˚C) 6.6 ± 3.8 6.3 ± 3.7 6.9 ± 3.9 0.249 
Systolic pressure (mmHg) 124.6 ± 21.8 126.9 ± 17.7 123.1 ± 24.1 0.197 
Heart rate (bpm) 80.8 ± 16.7 76.2 ± 12.5 84.0 ± 18.4 <0.001 
SpO2 (%) 99 [97-100] 99 [98-100] 99 [97-100] 0.768 
ScvO2 ( %) 72.8 ± 7.3 74.4 ± 5.0 71.8 ± 8.2 0.006 
pH 7.38 ± 0.08 7.40 ± 0.06 7.37 ± 0.09 0.003 
Base excess (mmol/l) -3.1 ± 5.5 -0.8 ± 3.22 -4.6 ± 6.1 <0.001 
PaCO2 (kPa) 4.9 ± 0.7 5.2 ± 0.5 4.8 ± 0.8 <0.001 
PvCO2 (kPa) 5.9 ± 0.7 6.2 ± 0.6 5.8 ± 0.7 0.004 
CO2 gap (mmHg) 7.4 [5.1-9.1] 6.6 [4.1-8.7] 7.7 [5.7-9.2] 0.026 
Anion gap (mmol/l) 9.7[8.3-11.1] 9.1 [7.5-10.8] 10.3 [8.7-11.5] 0.004 
Capilary refill time (s) 2.5 [2.0-3.0] 2.0 [1.5-3.0] 3.0 [2.0-3.0] 0.002 
Lactate (mmol/l) 1.2 [0.8-2.0] 0.9 [0.7-1.2] 1.7 [1.1-2.8] <0.001 
Glycemia (mmol/l) 8.1 [6.7-10.8] 7.5 [6.5-9.5] 8.2 [7.0-11.0] 0.009 
Intubated 25 (12.6) 2 (2.5) 23 (18.5) <0.001 
Ventilation 18 (8.7) 2 (2.5) 16 (12.9) 0.010 
Delta T – central-to-toe temperature gradient; MAP-mean arterial pressure; SpO2-oxygen saturation 
by pulse oxymetry; ScvO2- central venous oxygen saturation; PaCO2 – arterial partial pressure of 
carbon dioxide; PvCO2- venous partial pressure of carbon dioxide; Data are presented as means ± 
standard deviation; medians [IQR] or number (%). P values were calculated with the Student’s t-test, 




There were statistically significant differences 12 hours after ICU admission in anion gap 
(p=0.004), capillary refill time (3.0[2.0-3.0] s vs 2.0[1.5-3.0]s, p=0.002), lactate 
concentration (1.7 [1.1-2.8] mmol/l vs 0.9 [0.7-1.2] mmol/l, p<0.001), and glycemia (8.2 
[7.0-11.0] mmol/l vs 7.5 [6.5-9.5]mmol/l, p=0.009) between patients who did and did not 
develop postoperative complications. Only two (2.5%) patients without complications 
required mechanical ventilation compared to 16 (12.9%) with complications (p=0.010). 
(Table 16) 
4.1.5.Characteristics of patients on the first postoperative day 
Characteristics of patients on the first postoperative day (24 hours after the operation) are 
shown in table 17.  
Patients who developed complications were likely to receive more intravenous fluids (7.2 ± 
2.6 l vs 5.7 ± 1.8 l, p<0.001) for the 24-hour period (including the operation), to have a higher 
drainage output (400[250-635] ml vs 250[150-350] ml, p<0.001), and a higher positive fluid 
balance (4.6 ± 2.4 l vs 3.2 ± 1.5 l, p<0.001).  










No (N=81) Yes (N=125) 
Intravenous fluids (l) 6.6 ± 2.5 5.7 ± 1.8 7.2 ± 2.6 < 0.001 
Diuresis (l) 1.9 [1.5-2.6] 1.8 [1.5-2.7] 2.0 [1.6-2.6] 0.654 
Drainage output (ml) 300 [200-500] 250 [150-350] 400 [250-635] <0.001 
Fluid balance (l) 4.1 ± 2.2 3.2 ± 1.5 4.6 ± 2.4 <0.001 
Vasopressor  21 (16.8) 0 0 <0.001 
Transfusion 60 (29.1) 6 (7.4) 54 (43.2) <0.001 
Units of PRBC 0 [0-1] 0 [0-0] 0 [0-2] <0.001 
Hemostatic 11 (5.3) 3 (3.7) 8 (6.4) 0.533 
Haemoglobin (g/l) 111.6 ± 17.1 117.6 ± 15.6 107.9 ± 17.0 <0.001 
WBC  (109/l) 11.3 [9.1-13.5] 11.1 [8.9-13.1] 11.4 [9.1-14.1] 0.276 
Platelets (109/l) 209 [174-255] 221 [177-270] 209 [164-254] 0.384 
Bilirubin (μmol/l) 14.9 [9.7-20.7] 11.2 [9.0-16.8] 15.3 [11.6-25.9] <0.001 
Urea (mmol/l) 4.7 [3.8-6.6] 4.5 [3.3-5.7] 5.3 [3.9-7.0] 0.013 
Creatinine (μmol/l) 80.0 [64.0-97.7] 73.0 [64.0-82.0] 87.0 [64.0-104.0] <0.001 
AST (IU/l) 51.0 [23.2-140.0] 34.0 [23.0-132.5] 65.0 [23.5-166.5] 0.322 
ALT (IU/l) 49.5 [15.0-159.7] 29.0 [14.0-129.7] 71.0 [18.5-171.0] 0.206 
CRP (mg/l) 102.5 ± 34.2 95.7 ± 30.6 106 ± 35.7 0.054 
Albumin (g/l) 31.1 ± 4.0 34.1 ± 2.5 29.2 ± 3.6 <0.001 
SAPS II 19.0 [13.0-25.0] 16 [11.5-21.0] 22.5 [16.0-27.0] <0.001 
Data are presented as mean ± standard deviation, number (%), or median [IQR]; PRBC-packed red 
blood cells; WBC-white blood cells; AST – aspartate aminotransferase; ALT- alanin 
aminotransferase; CRP-C-reactive protein; SAPS II – Simplified Acute Physiology Score 
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Vasopressor use was recorded only in patients with complications (21 (16.8%) vs 0, p < 
0.001).                                                                                                                                       
Patients with complications had lower haemoglobin level (107.9 ± 17.0 g/l vs 117.6 ± 15.6 
g/l, p<0.001) and were more likely to receive a transfusion (54 (43.2%) vs 6 (7.4%), p< 
0.001). The number of blood units received by patients with subsequently complicated 
postoperative course was significantly higher. (Figure 5) 
Figure 5. Number of units of PRBC received by patients with and without complications; p-value 
indicates the significance of difference between the patients with and without complications (Fisher’s 
exact test) 
 
Postoperative laboratory data revealed that bilirubin level was higher (15.3 [11.6-25.9] μmol/l 
vs 11.2 [9.0-16.8] μmol/l, p<0.001), as well as the creatinine level (87.0 [64.0-104.0] μmol/l 
vs 73.0 [64.0-82.0] μmol/l, p<0.001), whereas the serum albumin concentration was 
significantly lower (29.2 ± 3.57 g/l vs 34.1 ± 2.53 g/l, p<0.001) in patients with 
complications. The median SAPS II score was 19 [13-25], and, as expected, higher in patients 
in whom complications occurred (22.5 [16.0-27.0] vs 16 [11.5-21.0], p<0.001).  
 
4.1.6. Type of postoperative complications 
One hundred twenty-five patients (60.7%) developed a total of 424 postoperative 
complications. The most common complications encountered during the postoperative period 
were infections (72/424; 16.9%), followed by hematologic (69; 16.3%), cardiovascular (69; 
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16.0%), and pulmonary (65; 15.2%) complications. (Table 4) Anastomotic leak, a surgical 
complication in narrow context, occurred in 22 (5.2%) patients.  
                               Table 18. Type of postoperative complications 
 





SSI – superficial 
SSI – organ/space 
CVC associated blood stream infection 
Urinary tract infection 









Anastomotic leak 22 (5.2) 

























































Metabolic 25 (5.9) 






SSI-surgical site infection; CVC-central venous catheter; ARDS-acute respiratory distress syndrome; 
Data are presented as number of complications (percentage) 
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4.1.7. Length of ICU and hospital stay 
The median ICU-LOS for the entire cohort was 2.0 days [1.0-5.0]. Ninety-four (45.6%) 
patients spent only one day in the ICU. (Figure 6) Postoperative LOS and total hospital LOS 
were 14.0 days [9.0-20.0] and 25.0 days [16.0-35.5].(Figures 7 and 8)    







                                           
                                          
Figure 6. Histogram of ICU length of stay 

















                                  Figure 8. Histogram of hospital length of stay 
A prolonged LOS was considered if it was longer than the median of the specific parameter. 
Therefore, a prolonged ICU-LOS, prolonged postoperative LOS, and prolonged hospital LOS 
were considered if they were longer than 2, 14, and 25 days, respectively. As expected all 
indicators of hospitalization were significantly greater in patients with complications. (Table 
19, Figure 9-11) A prolonged ICU LOS was recorded in 75 (60%) patients with 
complications and in 11 (13.6%) patients without complications (p < 0.001). Higher 
proportion of patients with complications also had the prolonged postoperative LOS (61.6% 
vs 11.6%, p<0.001) and the prolonged hospital LOS (62.4% vs 25.9%, p<0.001) compared to 
patients with uneventful postoperative course. 










No (N=81) Yes (N=125) 
ICU LOS (days) 2.0 [1.0-5.0] 1.0 [1.0-1.0] 4.0 [2.0-7.0] < 0.001 
Postoperative LOS (days) 14.0 [9.0-20.0] 9.0 [8.0-12.0] 17.5 [13.2-27.0] < 0.001 
Hospital LOS (days) 25.0 [16.0-35.5] 16.0 [12.0-27.0] 29.0 [21.0-47.7] < 0.001 
Prolonged ICU LOS 86 (41.7) 11 (13.6) 75 (60.0) < 0.001 
Prolonged postoperative LOS 86 (41.7) 9 (11.1) 77 (61.6) < 0.001 
Prolonged hospital LOS 99 (48.1) 21 (25.9) 78 (62.4) < 0.001 














Figure 9. ICU LOS in patients with and without complications. Boxplots and T-bars represent the 











Figure 10. Postoperative LOS in patients with and without complications. Boxplots and T-bars 











Figure 11. Hospital LOS in patients with and without complications. Boxplots and T-bars represent 
the median hospital LOS, interquartile range and the extreme values (minimum and maximum) 
 
Kaplan-Meyer curve analysis showed that the patients with complications were more likely to stay 
hospitalized (log-rank test:p<0.001). The probability to stay hospitalized after 20 days reached 0 in 
patients without complications while it was around 50% in those who developed complications. 
(Figure 12)  
 




4.1.8. Functional activity on hospital discharge 
The assessment of functional activity on hospital discharge in 192 patients who survived, 
demonstrated that 164 (85.4%) patients were independent, 18 (9.4%) patients were partially 
dependent (walk with assistance), and 10 (5.2%) patients were totally dependent (bedridden). 
The levels of functional activity were not equally distributed among patients with and without 
complications, as significantly more patients with complications were bedridden (9.0% vs 








        Figure 13. Functional activity on discharge in patients with and without complications 
 
4.2. The assessment of the Clavien-Dindo classification (CDC) and the 
Comprehensive Complication Index (CCI) in evaluation of postoperative 
morbidity 
4.2.1. Complication grading with CDC and CCI 
The median CCI for the entire cohort was 20.9 [0-44.9]. The CD grade 0 was the most 
frequent (81/206; 39.3%). The highest CD grade among patients with complications was CD 
II (62/125; 49.6%). However, their median CCI was 29.6, ranging from 20.9 to 47.4. Table 
20 shows the median CCI value and number of complications for the CD grade captured as 
the highest graded complication. The range of CCI values overlaps in all adjacent CD grades, 
except in the grade I and grade II. The median CCI for a CD grade IIIb is 52.0 and its range 
(39.7-65.4) extensively overlaps with those of the grade IIIa (26.2-54.2) and the grade IVa (47.3-
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79.2). The table also shows the increasing number of complications with the higher Clavien-Dindo 
grade, with a median of 9 (2-12) complications in patients who died (grade V). 
Table 20. The median CCI value and number of complications corresponding to the CDC grade of 
206 analyzed patients 
Clavien-Dindo grade n (%) Median CCI (range
*




0 81(39.3) 0 (0-0) 0 
I 4 (1.9) 10.4 (8.7-12.2) 1.5 (1-2) 
II 62 (30.1) 29.6 (20.9-47.4) 2 (1-5) 
IIIa 12 (5.8) 33.5 (26.2-54.2) 2 (1-5) 
IIIb 16 (7.8) 52.0 (39.7-65.4) 3 (2-6) 
IVa 13 (6.3) 65.2 (47.3-79.2) 5 (2-9) 
IVb 4 (1.9) 65.2 (54.9-75.4) 4.5 (3-6) 
V 14 (6.8) 100.0 (100.0-100.0) 9 (2-12) 
*Range represents the extremes (minimum-maximum) 
 
The comparison of the CCI values between the CD grades revealed a significant difference 
among all grades except grades IVa and IVb (the Mann-Whitney U-test; p=0.703). (Figure 
14) Furthermore, a strong correlation of the CCI and the CDC was determined on Spearman’s 
rank test with a correlation coefficient of 0.969 (p<0.01). 
Figure 14. Comparison of the CCI values between the CDC grades. Boxplots and T-bars represent the 
median CCI, interquartile range, and the extreme values (min-max) for the CCI of each CD group. P 
values were calculated with the Mann-Whitney U-test 
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4.2.2.Number of complications and multiple complications 
The median number of complications in the entire cohort was 1.0 [0-3.00], while it was 2.0 
[2.0-4.0] in patients with complications. The rate of multiple complications was high as 100 
(48.5%) patients developed more than one complication. (Figure 15)  
 
                                     Figure 15. Number of complications in the study patients 
The proportion of patients who suffered more than 3 complications rose significantly with the 
increasing CD grade (p<0.001) (Table 21) 













1 2 (50) 20 (32.3) 3 (10.7) 0 (0) 0 (0) 
2 2 (50) 27 (43.5) 6 (21.4) 3 (17.6) 1 (7.1) 
3 0 (0) 7 (11.3) 11 (39.3) 5 (29.4) 0 (0) 
              >3 0 (0) 8 (12.1) 8 (28.5) 9 (52.9) 13 (92.9) 
n- number of patients (%) 
 
Both classification systems correlated significantly with the number of complications (rs for 





4.2.3. Correlation of number of complications, the CCI and the CDC with 
hospitalization indices 
The pair-wise correlations between the number of complications and ICU LOS, number of 
complications and postoperative LOS, and number of complications and hospital LOS were 
significant and strong (p<0.001). The correlation coefficients were 0.55, 0.55, and 0.49, 
respectively. These were stronger than the correlations between the occurrence of any 
complication with the ICU LOS, postoperative LOS, and hospital LOS (r1=0,25; r2=0.43; 







Table 22. Correlations of complication occurrence and number of complications with ICU LOS, 
postoperative LOS, and hospital LOS   
A significant moderate and strong correlations of the CCI and the CDC were found with a Spearman’s 
rank test with all hospitalization indices (p<0.01). A moderate correlation was found between the CCI 
and prolonged total LOS (r = 0.450) and the CD grade with the same parameter (r = 0.432). All other 
correlations were strong. The significantly stronger correlation of the CCI with the ICU LOS (0.670 
vs 0.628, p<0.001), postoperative LOS (0.652 vs 0.630, p=0.041), prolonged ICU LOS (0.604 vs 
0.555, p<0.001), and prolonged postoperative LOS (0.577 vs 0.555, p=0.021) was found. The rest of 
the correlations differences were not significant. (Table 23) 
Table 23. Correlations of the CCI and the CDC with the parameters of hospitalization 
Hospitalization parameter CCI (rs1) CD (rs2) p value
* 
ICU LOS 0.670 0.628 < 0.001 
Postoperative LOS 0.652 0.630    0.041 
Hospital LOS 0.519 0.508    0.218 
Prolonged ICU LOS 0.604 0.555 < 0.001 
Prolonged postoperative LOS 0.577 0.550    0.021 
Prolonged hospital LOS 0.450 0.432    0.105 
All correlation coefficients were significant at the 0.01 level (2-tailed); *-p value was calculated with the 




4.2.4. The association of the CCI and the CDC with patients’ functional activity on 
discharge 
The analysis of the CCI values and the CD grade according to the functional activity was 
performed for 192 patients who were alive on the day of hospital discharge. Ten patients 
(5.2%) were totally dependent (bedridden), 18 (9.4%) were partially dependent, while 164 
(85.4%) were independent.The median CCI for the “independent“, “partially dependent“and 
“totally dependent” patients was 20.9 [0.0-29.6], 47.3[20.9-54.4], and 59.6 [50.0-67.7] 
respectively. These values were significantly different (Kruskal-Wallis test, p<0.001). 
Similarly, the three groups based on functional activity at discharge differed in the Clavien-








Figure 16.The CCI values in relation to functional activity on discharge from the hospital. Boxplots 












4.3. Evaluation and validation of POSSUM and P-POSSUM score for 
prediction of in-hospital morbidity and mortality 
4.3.1. Physiological and Operative Score distribution 
The median Physiological score was 18 [15-22], with minimal score of 12 and maximal value 
of 54. It was significantly different between patients with and without complications (19 [16-
23] vs 16 [14-20], p = 0.001) and also between patients who died and who survived (22 
[16.7-34.5] vs 18 [15-22], p=0.034). The range of Physiological scores is presented in Figure 
18. 
The median Operative severity score was 16 [14-21]. The minimum value of the score was 7 
and the maximum was 29. Similarly to Physiological score, patients with and without 
complications differed significantly with regards to the Operative score (15 [13-18] vs 18 
[15-21], p< 0.001). The score was higher in deceased patients than in survivors (22 [15-25.2] 









Figure 18. Distribution of patients regarding the Physiological score; Each bar represents the number 











Figure 19. Distribution of patients regarding the Operative severity score; Each bar represents the 
number of patients with that score 
 
4.3.2. POSSUM vs morbidity 
The overall O:E ratio for morbidity was 1.07, meaning that the POSSUM score slightly 
underpredicted the occurrence of complication. It was particularly pronounced in the lowest 
risk group where the O:E ratio was 3.0. The calibration of the POSSUM score for morbidity 
was poor as assessed with the Hosmer Lemeshow test (p<0.015) (Table 24) 
Table 24. The summary table of the three risk groups with predicted complications using 









Expected no. of 
patients with 
complications 





   0 to ≤ 15 13.99 6 1 3 3.0 
> 15 to ≤ 50 33.36 75 25 29 1.16 
> 50 to ≤ 100 72.61 125 91 93 1.02 
> 0 to ≤ 100 56.61 206 117 125 1.07 
O:E – observed complications:expected complications; χ2 5.85, DF 1, p=0.015 
 
Discriminatory power of the POSSUM score in predicting morbidity was analyzed with the 
receiver operating characteristic (ROC) curve. The area under the curve (AUC) was 0.708 
(95% confidence interval, 0.634-0.781) indicating fair performance. (Figure 20) 
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                  Figure 20. Receiver operating characteristic curve (ROC) for POSSUM morbidity 
The best threshold to differentiate between patients with and without complications was 
determined by the Youden index. The selected threshold, corresponding sensitivity, 
specificity, positive predictive value (PPV) and Youden index are shown in table 25. 
Table 25. Prognostic value of POSSUM for morbidity 
Best threshold Sensitivity Specificity PPV Youden index 
0.54 0.72 0.68 0.76 0.28 
PPV –positive predictive value 
4.3.3. POSSUM vs Mortality 
The POSSUM score overestimated mortality since the overall O:E ratio was 0.38. The 
overprediction was present in all risk groups, except the group of the lowest risk where only 1 
death was expected and occurred. The observed and expected proportions were significantly 
different across all POSSUM risk groups (p< 0.001), suggesting poor calibration. (Table 26) 
Table 26. The summary table of the four risk groups of predicted mortality using POSSUM 



















    0 to ≤ 5 3.54 29 1 1 1.0 
> 5 to ≤ 15 9.41         84 8 2 0.25 
> 15 to ≤ 50 25.81  86 22 8 0.36 
> 50 to ≤ 100 77.70  7 5 3 0.60 
>  0 to ≤ 100 17.75 206 37 14 0.38 
O:E – observed deaths: expected deaths; χ2=19.75, DF 2, p< 0.001 
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4.3.4. P-POSSUM vs Mortality 
The P-POSSUM score has shown an underprediction in the lowest risk group (O:E ratio 1.67) 
and the overestimation of mortality in the middle-risk group (>15 to < 50%; O:E=0). 
However, the overall O:E ratio was 0.93. Since the p value calculated with the Hosmer 
Lemeshow test was 0.072, we could not reject the null hypothesis that the observed and 
expected proportions are the same across all P-POSSUM risk groups. (Table 27) 
Table 27. The summary table of the four risk groups of predicted mortality using P-POSSUM 






















    0 to ≤ 5 2.23 124 3 5 1.67 
> 5 to ≤ 15 8.74              66 6 6 1.00 
> 15 to ≤ 50 25.69 13           3 0 0 
> 50 to ≤ 100 98.97 3 3 3 1.00 
>  0 to ≤ 100 7.21 206 15 14 0.93 
O:E – observed deaths:expected deaths; χ2=5.27, DF 2, p=0.071 
 
Discrimination of the POSSUM score and the P-POSSUM score in predicting mortality, 









Figure 21. Receiver operating characteristic (ROC) curve for performance in mortality prediction of 
the POSSUM and the P-POSSUM score; There were no significant difference between the areas 
under the curve (AUC) of the two scores (z-statistic 0.0498, p=0.960) 
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 The AUCs (95% CIs) of the POSSUM and P-POSSUM  were not significantly different  
(0.744 vs 0.739, z-statistic 0.049, p= 0.960) (Table 28)  
Table 28. Prognostic characteristics of the POSSUM and the P-POSSUM score for mortality 
Score AUC 95% CI S.E. p value 
POSSUM 0.744 0.607-0.880 0.070 0.002 
P-POSSUM 0.739 0.598-0.880 0.072 0.003 
         AUC- area under curve, CI-confidence interval, S.E. – standard error 
 
4.4.    Clinical relevance of the markers of tissue perfusion for the 
prediction of severely complicated postoperative course 
According to our findings presented in chapter 4.2.1. a cut-off CCI of 50 was chosen  to 
classify patients according to the overall burden of complications.  This threshold was chosen 
because it corresponds to the CD grade IIIb (at least one complication requiring reoperation) 
or multiple complications of lesser severity. Out of 206 patients, 167 (81.1%) had the CCI ≤ 









                                   Figure 22. Distribution of patients regarding the CCI 
 
Hemodynamic and data regarding peripheral perfusion of patients with CCI ≤ 50 and above 
50 measured at two time points (on admission to the ICU and 12 hours later) are shown in 
table 29. Univariate analysis identified nine variables recorded on ICU admission associated 
with a more complicated postoperative course (CCI>50): peripheral temperature (p<0.001), 
central temperature (p=0.010), capillary refill time (p< 0.001), delta T (p<0.001), heart rate 
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(p<0.001), systolic pressure (p=0.008), base excess (p<0.001), CO2 gap (p=0.027), and 
PaCO2 (p=0.04). There were no significant differences on admission between these two 
groups of patients with regards to mean arterial pressure (p=0.386), ScvO2 (p=0.676), PvCO2 
(p=0.695), lactate concentration (p=0.106), and oxygen saturation (p=0.604). The analysis of 
data obtained 12 hours after the ICU admission has shown that seven variables were 
significantly different between patients with the CCI ≤ 50, and patients with the CCI > 50: 
systolic pressure (p=0.008), pH (p=0.001), base excess (p< 0.001), ScvO2 (p=0.004), pvCO2 
(p=0.005), PvCO2 (p=0.005), PaCO2 (p<0.001), and lactate (p<0.001).  
 




CCI ≤ 50 CCI > 50 CCI ≤ 50 CCI > 50 
Peripheral temperature 
(˚C) 
26.74 ± 2.56 25.16 ± 1.36a 29.96 ± 3.91b 28.75 ± 3.86b 
Central temperature (˚C) 35.70 ± 0.77 35.38 ± 0.88a 36.39 ± 0.51b 36.33 ± 0.75b 
Delta T (˚C) 8.07 ± 2.41 10.22 ± 1.67a 6.43 ± 3.81b 7.58 ± 3.75b 
Heart rate (bpm) 77.4 ±15.4 92.3 ± 20.9a 80.6 ± 16.0b 82.0 ± 19.8 
Systolic pressure (mmHg) 138.2 ± 24.3 125.9 ± 31.8a 126.5 ± 19.3b 116.2 ± 29.0a,b 
MAP (mmHg) 94.1 ± 16.1 91.3 ± 26.6 88.2 ± 15.2b 82.3 ± 24.2b 
ScvO2 (%) 72.2 ± 9.4 72.9 ± 11.0 73.5 ± 6.4 69.7 ± 9.6
a 
Arterial pH 7.33 ± 0.07 7.30 ± 0.07a 7.39 ± 0.55b 7.34 ± 0.14a,b 
BE (mmol/l) -5.65 ± 3.82 -8.45 ± 4.88a -2.12 ± 3.63b -7.30 ± 9.07a,b 
PaCO2 (kPa) 5.11 ± 0.67 4.84 ± 0.71
a 5.03 ± 0.65 4.55 ± 0.86a 
PvCO2 (kPa) 6.21 ± 0.63 6.16 ± 0.68 6.02 ± 0.62
b 5.67 ± 0.86a,b 
CO2 gap (mmHg) 7.83 ± 3.83 9.28 ± 2.73
a 7.21 ± 3.26b 7.99 ± 2.70 
ΔpCO2/Ca-vO2 1.84[1.42-2.20] 2.51[1.82-3.06]
a 1.92[1.36-2.28] 1.93[1.75-2.33]b 
SpO2 (%) 99 [96-100] 99 [97-99.7] 98 [97-100]  99 [98 -99] 
Capillary refill time (s) 3.10 ± 1.25 3.83 ± 1.12a 2.63 ± 0.97b 2.62 ± 1.07b 
Lactate (mmol/l) 1.8 [1.1-2.5] 2.0 [1.6-2.5] 1.1 [0.7-1.7]b 2.8 [1.7-3.4]b,c 
H0 – admission to the ICU; H12-12hours after ICU admission; Delta T – temperature gradient between central and 
peripheral temperature; bpm-beats per minute; MAP – mean arterial pressure; ScvO2 – central venous oxygen saturation; 
BE- base excess; PaCO2 - central venous carbon dioxide tension; PvCO2 – central venous carbon dioxide tension, CO2 gap – 
central venous-to arterial carbon dioxide gradient; SpO2 – pulse oxymetry oxygen saturation; Data are presented as mean ± 
standard deviation or median [interquartile range]; a p value < 0.05 indicates significant difference between patients with 
CCI≤50 and CCI>50 (Student’s t-test); b p value < 0.05 indicates significant difference between values at specific time points 
(H12 versus H0; Wilcoxon signed-rank test); c p <0.05 indicates significant difference between patients with CCI≤50 and 
CCI>50 (Mann-Whitney-U test)   
 
These two groups didn’t differ regarding the capillary refill time (p=0.926), central 
temperature (p=0.501), peripheral temperature (p=0.084), delta T (p=0.095), heart rate 
(p=0.627), mean arterial pressure (p=0.057), and oxygen saturation (p=0.641). 
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Changes in hemodynamic and perfusion parameters over time were compared using the 
paired samples Wilcoxon test (Wilcoxon signed-rank test). The analysis of the entire cohort 
showed that there was a significant difference (p<0.001) in all analyzed parameters from H0 
to H12, except the heart rate (p=0.127), ScvO2 (p=0.921), SpO2 (p=0.383), and PaCO2 
(0.307). In patients whose CCI was below 50, only three variables didn’t change significantly 
over time: SpO2 (p=0.279), ScvO2 (p=0.45), and PaCO2 (p=0.683). On the other hand, 
patients with a more complicated postoperative course (CCI>50) had nonsignificant change 
of 5 parameters: heart rate (p=0.102), SpO2 (p=0.972), ScvO2 (p=0.115), PaCO2 (p= 0.133), 
and delta T (p=0.064).(Table 29) 
Trends in capillary refill time, lactate concentration, delta T, and CO2 gap during the first 12 
hours in the ICU are shown in  figure 24.  
 
Figure 24.  Trends in delta T , lactate, capillary refill time, and CO2 gap regarding to the severity of 
postoperative complications (CCI>50 vs CCI≤ ≤50) 
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Central-to-toe temperature gradient (Delta T) was significantly different between patients 
with CCI>50 and CCI≤50 on admission to the ICU (p< 0.001). It changed significantly 
(p<0.001) over time in both groups, and the difference bacame insignificant after 12 hours 
(p=0.093).  
Lactate concentration which didn’t differ between the two groups of patients on admission to 
the ICU (p=0.106), changed significantly over time in both groups, resulting in a significant 
difference , with higher values in patients with CCI > 50 (2.8mmol/l [1.7-3.4] vs 1.1mmol/l 
[0.7-1.7], p<0.001). 
On the other hand, significantly different capillary refill time between groups on admission 
(p<0.001), has shown a significant decrease in CCI>50 group, and an increase in CCI≤50 
group with a consequential non-significant values after 12 hours in the two groups (p=0.857). 
Finally, although  CO2 gap showed trend towards a decrease in both groups over time, it 
remained significantly different and higher in the CCI>50 group (8.9±2.7 mmHg vs 7.2±3.3 
mmHg, p<0.031). 
Figure 25. Trend in ΔPCO2/Ca-vO2 with regard to the CCI (≤50 and >50); ΔPCO2-CO2 gap; Ca-vO2 
– central arteriovenous oxygen content difference 
 
On admission to ICU, patients with CCI >50 had significantly higher ΔPCO2/Ca-vO2 ratio 
(2.51[1.82-3.06]mmHg/ml vs 1.84 [1.42-2.20] mmHg/ml, p<0.001). The change over time in 
both groups resulted in nonsignificantly different values after 12 hours (1.93 [1.75-
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2.33]mmHg/ml vs 1.92 [1.75-2.33]mmHg/ml, p=0.331).(Figure 25) 
To test the ability of perfusion parameters on admission (H0) to the ICU and after 12 hours 
(H12) to discriminate between patients with more and less complicated postoperative course 
(CCI > 50 and CCI ≤ 50) we generated receiver operating characteristic (ROC) curves. 
(Figures 26 and 27) The area under the curve (AUC) for the occurrence of severe 
complications resulting in the CCI > 50 based on admission values of capillary refill time, 
lactate concentration, deltaT and CO2 gap was 0.666, 0.580,0.764, and 0.653, respectively. In 
other words, only deltaT could make a fair discrimination between the two outcomes. The 











Figure 26. Receiver operating characteristic curve (ROC) comparing the ability of capillary refill 
time, delta T, lactate concentration and CO2 gap to discriminate between patients with CCI ≤ 50 
(n=167) and patients with CCI > 50 (n=39) on admission at the ICU. Area under the curve (AUC) was 
0.666, 0.764, 0.580, and 0.653, respectively. 
 
The area under the ROC curve for the CCI > 50 based on measurements 12 hours after 
admission (H0) for capillary refill time, lactate concentration, delta T, and CO2 gap were as 




Figure 27.Receiver operating characteristic (ROC) curve comparing the ability of capillary refill 
time, delta T, lactate concentration, and CO2 gap to discriminate between patients with CCI ≤ 50 and 
patients with CCI > 50 12 hours after the admission to the ICU. Area under the curve was 0.497, 
0.612, 0.852, and 0.618, respectively. 
 
The best threshold lactate value after 12 hours for discriminating between patients who will 
and who will not develop a seriously complicated postoperative course (CCI>50) was 1.65 
mmol/l (sensitivity 84.2%, specificity 72.7%, PPV 64.0%). Of the 39 patients who developed 
the CCI>50, 33 had lactate concentration after 12 hours ≥ 1.65mmol/l. 
Multivariate analysis included significant predictors from the univariate analysis. After 
checking for correlations, we decided to exclude pH since it was highly correlated to BE 
(r=0.741), mean arterial pressure since it correlated with systolic pressure (r=0.683), and 
peripheral temperature because of the strong negative correlation with delta T (r=-0.950). We 
adjusted for vasopressor use and transfusion because of their possible effect on perfusion 
parameters and the outcome. The results of the multivariable analysis are shown in table 30. 
Multivariate analysis showed that Capillary refill time at H0 (OR 2.124; 95% CI 1.168-4.219, 
p=0.020), lactate concentration at H12 (OR 2.593; 95%CI 1.603-4.579, p<0.001), base excess 
at H12 (OR 0.824; 95% CI 0.678-0.968, p=0.024), and vassopressor use (OR 22.596; 95% CI 






Table 30. Multivariate analysis of parameters associated with a severely complicated 
postoperative course (CCI >50) 
 B (SE) Odds ratio 95% confidence interval p value 
Constant -8.421 (7.642)    
Capillary refill 0.753 (0.323) 2.124 1.128-3.998 0.020 
Delta T  0.458 (0.020) 1.581 1.101-2.270 0.013 
Heart rate 0.009 (0.018) 1.009 0.974-1.044 0.629 
CO2 gap 0.102 (0.115) 1.107 0.884-1.387 0.377 
ΔpCO2/Ca-vO2 0.993 (0.423) 2.708 1.177-6.184 0.019 
Systolic pressure 0.020 (0.014) 1.020 0.992-1.048 0.168 
SpO2 -0.040 (0.027) 0.961  0.911-1.014 0.143 
BE 0.165 (0.102) 1.179 0.966-1.439 0.106 
PaCO2 -0.696 (0.576) 0.499 0.161-1.542 0.227 
Lactate 12 0.953 (0.261) 2.593 1.555-4.325 <0.001 
Systolic pressure 12 0.012 (0.020) 1.012  0.974-1.052 0.531 
BE 12 -0.194 (0.085) 0.824 0.697-0.974 0.024 
ScvO2  12 -0.069 (0.047) 0.933 0.850-1.024 0.144 
PvCO2 12 0.206 (0.846) 1.229 0.234-6.446 0.808 
PaCO2 12 0.744 (0.985) 2.104 0.305-14.513 0.450 
Vassopresor use 3.118 (1.121) 22.596 2.513-203.146 0.005 
Transfusion 0.571 (0.609) 1.771 0.537-5.843 0.348 
Lactate 12, Systolic pressure 12, BE 12, ScvO2 12, PvCO2 12, PaCO2 12 represent the measurements 
12 hours after ICU admission; significant p values are indicated in bold text 
 
4.5. Development of model for prediction of complications after major 
abdominal surgery 
The first step in model development was to select variables to predict complications as 
explained in the methodology chapter. We selected variables from the following groups: 
Preoperative, Intraoperative, Postoperative on ICU admission, Postoperative 12 hours after 
the ICU admission, and Postoperative Day 1. The procedure was the same for all groups of 
variables and consisted of three steps:  
Step 1: Two group comparison to select covariates that are significantly different across groups 
(with and without complications) 
Step 2: Checking the correlations of the covariates from step 1 and selecting among the highly 
correlated ones (r ≥ 0.6) based on domain knowledge 
Step 3: Among the covariates from step 2, further selection based on statistical algorithms (median 





Selected variables in step 1 (two-group comparison) among continuous variables were: 
Serum albumin, CRP, Haemoglobin, and Preoperative length of hospital stay. 
Table 31. Two group comparison for continuous preoperative variables 
Variable Complication = Yes Complication = No p. 
wilcox 
p.t 
count mean SD median IQR count mean SD median IQR 
Age 125 64.62 11.16 65 15 81 62.78 12.81 65 18 0.2823 0.2921 
Albumin 1 113 35.15 6.4 36 9 74 39.45 4.32 40 6 0.0000 0.0000 
ALT1 102 36.6 57.67 19 19 65 30.83 44.25 16 14 0.4198 0.4676 
AST1 102 38.77 50.44 20 11 65 31.28 35.34 20 17 0.5268 0.2608 
Bilirubin1 115 41.82 96.98 12.6 11.25 79 32.68 73.19 13.1 8.65 0.5211 0.4557 
BMI 122 25.35 5.08 24.55 5.48 78 24.13 3.87 24.29 5.12 0.1790 0.0551 
Creatinin1 116 92.59 84.57 74 32.75 79 75.35 18.83 78 24 0.8931 0.0359 
CRP1 68 41.22 76.2 11.2 36.13 42 12.09 18.51 5.95 10.13 0.0251 0.0035 
Hgb1 116 119.17 21.51 119.5 37 79 130.2 17.83 132 18.5 0.0003 0.0001 
Preoperative 
LOS (days) 
125 13.62 11.94 9 10 81 9.32 8.49 5 10 0.0018 0.0028 
WBC 1 116 6.67 3.23 6.11 2.13 79 6.58 2.01 6.17 2.6 0.3595 0.8044 
Number of 
drugs 
125 2.26 2.21 2 4 81 2.25 2.23 2 3 0.9844 0.9772 
Platelets 1 116 259.47 152.86 222 128 75 243.32 75.44 244 99.5 0.3757 0.3336 
Urea 1 116 6.64 5.91 5.35 2.33 79 5.89 2.2 5.7 3.25 0.6260 0.2132 
ALT-alanin aminostransferase; AST- aspartate aminotransferase; BMI – Body Mass Index; CRP1- 
preoperative C-reactive protein: Hgb 1- preoperative haemoglobin, LOS-length of stay, WBC-white 
blood cells; p.wilcox – p value by Mann-Whitney-Wilcoxon test; p.t – p value by Student’s t-test 
 
 
The categorical covariates that were significantly associated with complications (p<0.05) 
were ASA, Diabetes, and Corticosteroids. However, we found that the variable 
„Corticosteroids“ had zero 1’s among patients without complications, and the Fisher’s test 
might be inaccurate for case like this. It may also cause larger variance and instability in 
predictive model. Therefore, we excluded “corticosteroids“, even though it had p value 0.044. 





Table 32. Two-group comparison for categorical preoperative variables 
Variable Complication = Yes Complication = No p value 
value n.obs percent CI.lower CI.upper n.obs percent CI.lower CI.upper 
Gender 0 42 33.60% 25.32% 41.88% 31 38.27% 27.69% 48.86% 0.552 
1 83 66.40% 58.12% 74.68% 50 61.73% 51.14% 72.31% 
Functional status 0 105 84% 77.57% 90.43% 70 86.42% 78.96% 93.88% 0.694 
1 20 16% 9.57% 22.43% 11 13.58% 6.12% 21.04% 
Comorbidity 0 31 24.80% 17.23% 32.37% 21 25.93% 16.38% 35.47% 0.871 
1 94 75.20% 67.63% 82.77% 60 74.07% 64.53% 83.62% 
ASA>2 0 55 44% 35.30% 52.70% 48 59.26% 48.56% 69.96% 0.045 
1 70 56% 47.30% 64.70% 33 40.74% 30.04% 51.44% 
 
Respiratory 
0 106 84.80% 78.51% 91.09% 70 86.42% 78.96% 93.88% 0.841 
1 19 15.20% 8.91% 21.49% 11 13.58% 6.12% 21.04% 
Diabetes 0 97 77.60% 70.29% 84.91% 76 93.83% 88.59% 99.07% 0.002 
1 28 22.40% 15.09% 29.71% 5 6.17% 0.93% 11.41% 
Renal 0 110 88% 82.30% 93.70% 74 91.36% 85.24% 97.48% 0.497 
1 15 12% 6.30% 17.70% 7 8.64% 2.52% 14.76% 
Hepatic 0 102 81.60% 74.81% 88.39% 68 83.95% 75.96% 91.94% 0.711 
1 23 18.40% 11.61% 25.19% 13 16.05% 8.06% 24.04% 
Neurologic 0 118 94.40% 90.37% 98.43% 77 95.06% 90.34% 99.78% 1 
1 7 5.60% 1.57% 9.63% 4 4.94% 0.22% 9.66% 
Psychiatric 0 124 99.20% 97.64% 100.76% 80 98.77% 96.36% 101.17% 1 
1 1 0.80% -0.76% 2.36% 1 1.23% -1.17% 3.64% 
Endocrine 0 112 89.60% 84.25% 94.95% 71 87.65% 80.49% 94.82% 0.658 
1 13 10.40% 5.05% 15.75% 10 12.35% 5.18% 19.51% 
Obesity 0 110 88% 82.30% 93.70% 77 95.06% 90.34% 99.78% 0.137 
1 15 12% 6.30% 17.70% 4 4.94% 0.22% 9.66% 
Malnutrition 0 115 92% 87.24% 96.76% 70 86.42% 78.96% 93.88% 0.240 
1 10 8% 3.24% 12.76% 11 13.58% 6.12% 21.04% 
Chronictherapy 0 45 36% 27.59% 44.41% 23 28.40% 18.58% 38.21% 0.290 
1 80 64% 55.59% 72.41% 58 71.60% 61.79% 81.42% 
Corticosteroids 0 118 94.40% 90.37% 98.43% 81 100% 100% 100% 0.044 
1 7 5.60% 1.57% 9.63% 0        0 0 0 
Chemotherapy 0 111 88.80% 83.27% 94.33% 77 95.06% 90.34% 99.78% 0.137 
1 14 11.20% 5.67% 16.73% 4 4.94% 0.22% 9.66% 
Antibiotic 0 106 84.80% 78.51% 91.09% 62 76.54% 67.32% 85.77% 0.145 
1 19 15.20% 8.91% 21.49% 19 23.46% 14.23% 32.68% 
Smoker 0 88 71.54% 63.57% 79.52% 59 72.84% 63.15% 82.53% 0.874 




Table 32. Two-group comparison for categorical preoperative variables (Continued) 
 
Variable                       Complication=Yes                                             Complication=No                            p value 
 
value         n.obs percent     CI.lower       CI.upper       n.obs  percent      CI.upper     CI.lower 
 
Alcohol 0 73 59.35% 50.67% 68.03% 52 64.20% 53.76% 74.64% 0.557 
1 50 40.65% 31.97% 49.33% 29 35.80% 25.36% 46.24% 
Weight loss 0 79 64.23% 55.76% 72.70% 56 69.14% 59.08% 79.20%  
0.546 
1 44 35.77% 27.30% 44.24% 25 30.86% 20.80% 40.92% 
Cardiovascular.no 0 83 66.40% 58.12% 74.68% 54 66.67% 56.40% 76.93% 1 
1 42 33.60% 25.32% 41.88% 27 33.33% 23.07% 43.60% 
Cardiovascular.HTA 0 84 67.20% 58.97% 75.43% 58 71.60% 61.79% 81.42% 0.540 
1 41 32.80% 24.57% 41.03% 23 28.40% 18.58% 38.21% 
Cardiovascular. 
Other 
0 83 66.40% 58.12% 74.68% 50 61.73% 51.14% 72.31% 0.552 
1 42 33.60% 25.32% 41.88% 31 38.27% 27.69% 48.86% 
HTA-Hypertension;value 0-absent; value 1-present; n.obs-number of patients; CI-confidence interval; 
p values are obtained with Fisher’s test if the variables were binary, and Chi-square test if they had 
three levels or more 
Step 2 
Covariates albumin, CRP, and haemoglobin had 2, 9, and 1 missing data respectively. We 
used the median imputation to fill in the missing data, and then calculated correlations. (Table 
33) All of the covariates were not highly correlated, therefore, they were passed to step 3. 
 
                    Table 33. Correlation table of preoperative variables selected at step 1 
 
Albumin1 CRP1 Hgb1 Preoperative LOS ASA Diabetes 
Albumin1 1 -0.37 0.59 -0.14 -0.32 0.03 
CRP1 -0.37 1 -0.22 0.13 0.22 -0.01 
Hgb1 0.59 -0.22 1 -0.13 -0.09 -0.09 
Preoperative LOS -0.14 0.13 -0.13 1 0.17 0.04 
ASA -0.32 0.22 -0.09 0.17 1 0.25 
Diabetes 0.03 -0.01 -0.09 0.04 0.25 1 
LOS-length of stay; albumin1-preoperative concentration of albumin; CRP1-preoperative   
concentration of C-reactive protein; Data represent Pearson’s r 
Step 3 
Selected variables in step 3 were (Lasso and stepwise regression): 
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Lasso : Albumin, CRP, Haemoglobin, Preoperative LOS, and Diabetes 
Note: Cross validation has been used to determine the parameter „lambda“ in Lasso model 
that yields the maximal area under curve (AUC). 
Stepwise logistic regression: Albumin, Preoperative LOS, and Diabetes. 
 
4.5.2.Intraoperative variables 
Step 1  
Selected variables after two–group comparison between patients with and without 
complications among continuous variables were: Duration of surgery and Intraoperative 
fluids.(Table 34) 
Table 34. Two group comparison of continuous intraoperative variables 
Variable Complication = Yes Complication = No p.wilcox p.t 
count mean SD median IQR count mean SD median IQR 
Duration 
(min) 
125 290.9 142.5 260 170 81 228.6 93.7 210 160 0.002 <0.001 
Intraoperative 
fluids (ml) 
124 4246.1 2056.6 4000 3151.7 81 2901.5 1178.6 3000 1731 <0.001 <0.001 
 
The significant categorical variables (p<0.05) were: Intraoperative warming, Multiorgan 
resection, and Minimally invasive or hybrid surgical approach. Two group comparison of 
categorical intraoperative variables are shown in table 35. The p values are obtained by 
Fisher’s test for binary variables and chi-square test for variables with 3 or more levels.  
Step 2 
Among the variables selected in step 1 (Duration of surgery, Intraoperative fluids, 
Intraoperative warming, Multiorgan resection, and Minimally invasive or hybrid approach), 
covariate Intraoperative fluids has one missing value. After filling in the missing with column 







Table 35. Two group comparison of categorical intraoperative variables 
Variable value Complication = Yes Complication = No p.value 
n.obs percent CI.lower CI.upper n.obs percent CI.lower CI.upper 
 0 13 10.40% 5.05% 15.75% 5 6.17% 0.93% 11.41%  
Disease 1 112 89.60% 84.25% 94.95% 76 93.83% 88.59% 99.07% 0.326 
 0 118 95.16% 91.38% 98.94% 71 87.65% 80.49% 94.82%  
Anesthesia 1 6 4.84% 1.06% 8.62% 10 12.35% 5.18% 19.51% 0.063 
 0 70 56% 47.30% 64.70% 32 39.51% 28.86% 50.15%  
Warming 1 55 44% 35.30% 52.70% 49 60.49% 49.85% 71.14% 0.023 
 0 9 7.20% 2.67% 11.73% 4 4.94% 0.22% 9.66%  
Monitoring 1 116 92.80% 88.27% 97.33% 77 95.06% 90.34% 99.78% 0.573 
 0 55 44% 35.30% 52.70% 46 56.79% 46% 67.58%  
Adverseevents 1 70 56% 47.30% 64.70% 35 43.21% 32.42% 54% 0.087 
 0 98 78.40% 71.19% 85.61% 61 75.31% 65.92% 84.70%  
Colorectal surgery 1 27 21.60% 14.39% 28.81% 20 24.69% 15.30% 34.08% 0.614 
 0 106 84.80% 78.51% 91.09% 70 86.42% 78.96% 93.88%  
Hepatic surgery 1 19 15.20% 8.91% 21.49% 11 13.58% 6.12% 21.04% 0.841 
 0 121 96.80% 93.71% 99.89% 73 90.12% 83.63% 96.62%  
Other surgery 1 4 3.20% 0.11% 6.29% 8 9.88% 3.38% 16.37% 0.066 
 0 98 78.40% 71.19% 85.61% 69 85.19% 77.45% 92.92%  
Pancreatico-biliary 
surgery 
1 27 21.60% 14.39% 28.81% 12 14.81% 7.08% 22.55% 0.276 
 0 94 75.20% 67.63% 82.77% 52 64.20% 53.76% 74.64%  
Oesophagogastric 
surgery 
1 31 24.80% 17.23% 32.37% 29 35.80% 25.36% 46.24% 0.116 
 0 108 86.40% 80.39% 92.41% 80 98.77% 96.36% 101.17%  
Multiorgan 
resection 
1 17 13.60% 7.59% 19.61% 1 1.23% -1.17% 3.64% 0.002 
 0 13 10.40% 5.05% 15.75% 16 19.75% 11.08% 28.42%  
Midline, subcostal 
approach 
1 112 89.60% 84.25% 94.95% 65 80.25% 71.58% 88.92% 0.067 
 0 116 92.80% 88.27% 97.33% 74 91.36% 85.24% 97.48%  
Thoracoabdominal 
approach 
1 9 7.20% 2.67% 11.73% 7 8.64% 2.52% 14.76% 0.792 
 0 121 96.80% 93.71% 99.89% 72 88.89% 82.04% 95.73%  
Minimally invasive 
or hybrid approach 
1 4 3.20% 0.11% 6.29% 9 11.11% 4.27% 17.96% 0.037 
Value 0 – variable absent; 1- variable present 
 
Variables „Duration of surgery“ and „Intraoperative fluids“ were strongly correlated (r=0.62). 
It is logical and expected that patients receive more fluids during the long operation. Even 
though the correlation was strong, we thought it was important to include both in the analysis. 
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Therefore, we combined them and calculated a new covariate to represent the amount of 
intraoperative fluids adjusted for the duration of surgery and body weight (ml/kg/h). Since 
there was no significant difference between patients with and without complications 
regarding the new variable (p=0.512, TABLE 14), we chose the Duration of surgery to be 
selected in step 1. 
 
                           Table 36. Correlation table of intraoperative variables in step 1 








Duration 1 0.62 0.48 0.15 0.1 
Intraoperative 
fluids 
0.62 1 0.11 0.18 -0.02 
Warming 0.48 0.11 1 0.1 0.02 
Multiorgan 
resection 





0.1 -0.02 0.02 -0.08 1 
Numbers in the table represent correlation coefficients (Pearson’s r) 
 
Step 3 
Selected variables in step 3 (Lasso and stepwise regression) were: 
Lasso: Duration of surgery, Intraoperative warming, Multiorgan resection, and Minimally 
invasive or hybrid approach 
Stepwise logistic regression: Duration of surgery, Multiorgan regression, and Minimally 
invasive or hybrid approach 
 
4.5.3. Postoperative variables on admission to the ICU 
Step 1 
The comparison of patients who did and did not develop complications is shown in table 15, 
page 59. The selected variables were: Peripheral temperature, Delta T, Heart rate, pH, Base 





Among the variables selected in step 1, PvCO2 had 4 missing values and PaCO2 had 2 
missing values. After median imputation, we performed the correlations. (Table 37) 
Table 37. Correlation table of postoperative variables on ICU admission selected in step 1 
BE 1           
DeltaT -0.22 1 
HR -0.35 0.15 1 
Lactate -0.54 0.23 0.40 1 
Peripheral 
temperature 
0.24 -0.95 -0.08 -0.21 1 
pH 0.74 -0.18 -0.24 -0.35 0.19 1 
PvCO2 0.12 0.10 -0.10 -0.02 -0.10 -0.26 1 
Systolic 
pressure 
0.35 -0.15 -0.24 -0.38 0.19 0.21 0.05 1 
MAP 0.38 -0.02 -0.12 -0.41 0.08 0.21 0.20 0.68 1 
PaCO2 0.30 -0.09 -0.06 -0.12 0.11 -0.13 0.70 0.21 0.25 1 
Airway 0.25 -0.12 -0.17 -0.17 0.16 0.30 -0.08 0.03 0.04 0.02 1 
 BE Delta 
T 
HR Lactate Peripheral 
temperature 
pH PvCO2 Systolic 
pressure 
MAP PaCO2 Airway 
BE-base excess; Numbers are correlation coefficients (Pearson’s r) 
Peripheral temperature and Delta T have shown a strong negative correlation (r= -0.95), 
which is expected as Delta T is the gradient between Epitympanic and Peripheral 
temperature. Base excess and pH were also strongly correlated (r=0.74), as well as Systolic 
pressure and MAP (r=0.68). Therefore, we decided to choose Delta T, Base excess, and 
Systolic pressure for further analysis. 
Step 3 
Selected variables from this group using Lasso and stepwise regression are: 
Lasso: Delta T, Heart rate, Base excess, and PvCO2 
Stepwise logistic regression: Delta T, Heart rate, Base excess, PvCO2, and PaCO2 
 
4.5.4.Postoperative variables 12 hours after ICU admission 
Step 1 
Variables significantly different between patients with and without complications are shown 
in table 16, page 60. Selected variables according to the difference were: Heart rate, pH, Base 
excess, Anion gap, Capillary refill, Glycemia, Lactate, PaCO2, PvCO2, ScvO2, CO2 gap, 




The numbers of missing data for the variables from step 1 were: 
Anion gap Base excess Capillary refill Glycemia Heart rate Lactate PaCO2 
3 3 2 2 3 4 5 
pH PvCO2 ScvO2 CO2 gap Intubation Ventilation  
2 4 7 4 0 0  
 
Missing data were filled by column mean, and correlations were calculated subsequently. 
(Table 38) 
Table 38. Correlation of postoperative variables 12 hours after admission selected in step 1 
AG12 1 
BE12 -0.70 1 
CRT12 0.27 -0.25 1 
Glycemia12 -0.06 -0.16 0.01 1 
HR12 -0.17 0.06 -0.10 0.18 1 
Lactate12 0.82 -0.73 0.26 0 -0.19 1 
PaCO212 -0.38 0.57 -0.10 -0.12 -0.11 -0.39 1 
PH12 -0.72 0.74 -0.29 -0.02 0.22 -0.73 0.09 1 
PvCO212 -0.32 0.47 -0.08 -0.05 -0.14 -0.34 0.79 0.04 1 
ScvO212 -0.31 0.24 -0.13 -0.08 0.02 -0.36 0.31 0.22 0.12 1 
CO2gap12 0.08 -0.15 0.09 0.09 -0.08 0.10 -0.38 -0.07 0.24 -0.32 1 
Intubation 12 -0.29 0.28 -0.20 -0.02 -0.10 -0.37 0.38 0.13 0.35 0.21 -0.06 1 
Ventilation12 0.32 -0.26 0.19 0.02 0.04 0.43 -0.26 -0.19 -0.24 -0.15 0.04 -0.83 1 
 AG12 BE12 CRT12 Glycemia 
12 














AG 12-anjon gap 12 hours after ICU admission;BE 12-base excess; CRT12-capillary refill time;HR 12-heart 
rate; PaCO2-arterial partial pressure of carbon dioxide; PvCO2 12-central venous partial pressure of carbon 
dioxide; ScvO2 12-central venous oxygen saturation; numbers represent correlation coefficients  
We found that Lactate 12, pH 12, Base excess 12, and Anion gap 12 are highly correlated 
with each other. Although representing a difference between PvCO2 and PaCO2, CO2 gap 
was not highly correlated to these variables. As expected, intubation was highly correlated  to 
mechanical ventilation. We chose Lactate 12, CO2 gap 12, and Ventilation 12, and drop other 
highly correlated variables.  
Step 3 
Selected variables in step 3 after applying Lasso and stepwise regression were: 
Lasso: Capillary refill 12, Lactate 12, ScvO2 12, CO2 gap 12, Glycemia 12, Ventilation 12, 
and Heart rate 12 
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Stepwise logistic regression: Capillary refill 12, Lactate 12, and Heart rate 12 
4.5.5.Postoperative variables on the first postoperative day 
 
Step 1 
After two group comparison, based on significant differences between patients with and 
without complications, the following variables were selected: Albumin 2, Creatinine 2, 
Drainage output, Fluid balance, Haemoglobin 2, Intravenous fluids, Urea 2, Bilirubin 2, 
SAPS II score, and Transfusion. (Table 17, page 61). The covariate Vasopressor was present 
only in patients with complications, therefore it was removed from further selection as it 
might cause instability in the prediction model. 
Step 2 
Some variables selected in step 1 had missing values, so we used median imputation to fill in 
the missing data. These are the numbers of missing data for the variables from step 1: 
Albumin 2 Creatinine 2 Drainage output Fluid balance IV fluids 
4 4 1 0 0 
Urea 2 Bilirubun 2 Transfusion Hemoglobin 2 SAPS II 
3 4 0 4 0 
 
The correlations of the selected variables are shown in table 39.  SAPS II score, Creatinine 2, 
and Urea 2 were highly correlated with each other, as was Fluid balance with Intravenous 
fluids. Therefore, we chose SAPS II and Fluid balance and dropped other highly correlated 
ones. 
Step 3 
Selected variables in step 3 were: 
Lasso: Albumin 2 and Transfusion 





Table 39. Correlations of postoperative variables on day 1 selected in step 1 
Albumin2 1 
Creatinine2 -0.22 1 
Drainage -0.41 0.24 1 
Fluidbalance -0.40 0.34 0.35 1 
Hgb2 0.24 -0.27 -0.17 -0.29 1 
IVfluids -0.33 0.24 0.45 0.86 -0.32 1 
SAPSII -0.30 0.67 0.32 0.32 -0.28 0.27 1 
Urea2 -0.21 0.92 0.26 0.34 -0.26 0.23 0.71 1 
Bilirubin2 -0.06 0.14 0.05 0.13 -0.10 0.12 0.24 0.21 1 
Transfusion -0.32 0.20 0.33 0.38 -0.41 0.41 0.28 0.21 0.05 1 
 Albumin2 Creatinine2 Drainage Fluidbalance Hgb2 IVfluids SAPSII Urea2 Bilirubin2 Transfusion 
The highly significant correlations are highlighted and bolded 
 
4.5.6.Building a model to predict the complications 
Table 40 shows the variables selected following the above procedures. There is total of 22 
predictors from all three groups. 
Table 40. The variables selected by lasso regression from preoperative, intraoperative and 
postoperative group 
 Preoperative Intraoperative Postoperative 
On admission 
to ICU 
12 hours after the 
admission 























„Capillary refill 12“ 
„Lactate 12“ 




„Heart rate 12“ 
„Albumin 2“ 
„Transfusion“ 
λ 0.016 0.001 0.037 0.003 0.071 
 
We conducted a univariate analysis to fit the logistic regression model on each of the selected 
variables. A multivariable logistic regression was applied to build a model using all of the 
above 22 variables from the within-group selection. The results of the univariate and 















 OR 95% CI B (SE) OR 95% CI P 
value 
 Intercept   18.66(8.05)    
 Albumin 1 0.86 0.81-0.92 0.01 (0.08) 1.01 0.86 - 1.19 0.899 
A CRP 1 1.02 1.01-1.05 -0.02 (0.01) 0.97 0.95-1.01 0.065 
 Hgb 1 0.97 0.96-0.99 -0.03 (0.02) 0.97 0.93-1.01 0.144 
 Preoperative LOS 1.04 1.01-1.08 0.06 (0.03) 1.06 0.99-1.13 0.076 
 Diabetes 4.39 1.75-13.40 2.64 (1.08) 14.08 1.94-141.13 0.014 
 Duration of surgery 1.00 1.00-1.01 0.00 (0.00) 1.000 0.998-1.002 0.956 
 Warming 0.51 0.29-0.90 -2.09 (0.89) 0.12 0.02-0.63 0.019 
B Multiorgan resection 12.59 2.51-229.24 5.34 (1.67) 208.73 10.98-9394.84 0.001 
 Minimally invasive or 
hybrid approach 
0.26 0.07-0.84 0.29 (1.21) 1.34 0.11-14.34 0.809 
 Base excess 0.80 0.73-0.87 -0.02 (0.11) 0.98 0.79-1.20 0.828 
C Delta T 1.25 1.11-1.42 0.04 (0.12) 1.04 0.82-1.32 0.724 
 Heart rate 1.06 1.04-1.08 0.08 (0.03) 1.08 1.02-1.16 0.016 
 PvCO2 0.64 0.40-1.01 -1.18 (0.66) 0.31 0.08-1.11 0.075 
 Capillary refill 12 1.56 1.15-2.14 0.69 (0.37) 2.00 1.00-4.28 0.058 
 Lactate 12 3.34 2.16-5.55 0.85 (0.50) 2.35 0.94-6.80 0.087 
 ScvO2 12 0.95 0.91-0.99 0.08 (0.05) 1.08 0.97-1.21 0.158 
D CO2 gap 12 1.09 0.99-1.21 0.24 (0.12) 1.28 1.02-1.63 0.037 
 Glycemia 12 1.17 1.06-1.31 -0.26 (0.14) 0.77 0.58-1.01 0.064 
 Ventilation 12 5.85 1.60-37.69 0.45 (2.34) 1.57 0.02-153.76 0.847 
 Heart rate 12 1.03 1.01-1.05 0.03 (0.03) 1.03 0.98-1.09 0.263 
E Albumin 2 0.59 0.50-0.68 -0.75 (0.16) 0.47 0.33-0.62 <0.001 
 Transfusion 9.51 4.13-25.92 0.64 (0.93) 1.91 0.29-11.87 0.489 
A-preoperative variables; B-Intraoperative variables; C-Postoperative on admission; D- Postoperative 
variables 12 hours after the admission; E-Postoperative variables on day 1; LOS –length of stay; Hgb-
haemoglobin 
 
When we applied the above model (with all variables selected from step 3 as predictors) on 
the training data, the predictive error statistics are shown below. (Table 42 ) 
Table 42. Predictive error statistics of the model with all selected predictors 
Error rate Sensitivity Specificity PPV AUC 
0.097 0.92 0.88 0.92 0.96 
PPV-positive predictive value; AUC-area under curve 
The model performs well on the training data. However, we found it overfitting when testing 
it via cross validation (CV). We split the data into 5 equal folds, each time treating one fold 
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as the testing data. We built the model on the rest and then applied on the testing data to 
calculate the error statistics on one fold. The results of 5-fold CV are shown in table 43. Each 
row in the table represents the error statistics on one fold. The model does not perform 
consistently well on all folds, especially the third row, indicating that the model with whole 
22 predictors has the overfitting problem. In other words it corresponds too closely to a given 
data set and may therefore fail to predict future observations reliably. Possible reason is 
because the variables entered in the model may somehow be correlated to each other. The 
other reason may be the limited number of data points. 
                         Table 43. Predictive error statistics of the model with 22 predictors 
Fold Error rate Sensitivity Specificity PPV AUC 
1 0.190 0.92 0.65 0.79 0.833 
2 0.146 0.83 0.92 0.96 0.820 
3 0.317 0.81 0.55 0.65 0.824 
4 0.195 0.79 0.83 0.92 0.922 
5 0.049 1.00 0.90 0.91 0.981 
                                 PPV – positive predictive value; AUC-area under curve 
To solve the overfitting issue, and to create a model that is not cumbersome for clinical use, 
we decided to conduct further variable selection and fit the risk model using penalised lasso 
regression. We combined the selected covariates from each group in table 40, and repeated 
lasso procedures to select the final predictors. The extent of shrinkage of regression 
coefficients was controlled with the parameter lambda (λ). Different λ values select different 
set of predictors, and the corresponding results are shown in table 44. 
Table 44. The final predictors selected by lasso regression from each group 
 Preoperative Intraoperative Postoperative 
On admission 
to ICU 
12 hours after the 
admission 




0.1 NA NA BE 
Heart rate 








Heart rate 12 Albumin 2 
Transfusion 






Capillary refill 12 
Heart rate 12 
Albumin 2 
Transfusion 
ICU-intensive care unit; BE-base excess 
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The figures 28 and 29 show how the area under curve (AUC) changes as the lambda 
parameter changes. There is a sudden drop in AUC when lambda is beyond 0.3. However, the 
AUCs are similar (>0.8) when λ are less than 0.3. Figure 29 demonstrates what happens with 
AUC when the range of λ is narrowed down to 0-0.25. Although the AUC is still decreasing, 
the drop is very small. The final model is selected to have large AUC value but at the 
















Figure 29. Change in area under curve (AUC) with change of lambda in the range of 0-0.25 
 
Three different logistic models have been built on the three sets of predictors corresponding 
to different lambda values in Lasso. The models are summarized in table 45. The overall 
performances are very similar regarding to error rate, sensitivity, specificity, and AUC. The 
model corresponding to lambda 0.1 has fewer predictors. However, it only includes the 
postoperative covariates, while model corresponding to lambda 0.06 considered at least one 
covariate from each group. It may be unusual that some of predictors are insignificant since 
they are selected by Lasso algorithm. In fact, it could totally happen, since the significance of 
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each predictor in the model depends on other predictors. The removal of a predictor only 
because its coefficient is insignificant would cause the model to change totally with that 
predictor removed. The interaction between predictors is usually complicated, specially when 
the number of predictors is large and they are somehow correlated to each other. Lasso 
algorithm helps to select a subgroup of predictors that have good performance in predicting 
outcome, but it does not necessarily mean all the selected predictors have significant 
coefficients. 
Since the model with lambda being 0.06 has a reasonable number of predictors (7 predictors), 
with at least one predictor from each group, and the model has satisfactory performance, we 
have decided the final lasso model to predict complications must include these predictors: 
Diabetes, Multiorgan resection, Base excess (ICU admission), Heart rate (ICU admission), 
Heart rate (12 hours after ICU admission), Albumin (on the first postoperative day), and 
Transfusion (within the last 24h hours). 
Table 45. Logistic regression model fitted on the lasso selected variables to predict  complications 
         
λ 
 














BE, -0.14, 0.87 [0.77-0.97] 
HR, 0.05, 1.05 [1.08-1.02] 
Albumin 2, -0.51, 0.60 [0.51-0.71] 
Transfusion, 1.76, 5.81 [1.82-18.54] 
0.16 0.87 0.78 0.894 
0.06 Intercept 11.11 
BE, -0.103, 0.902 [0.788-1.023] 
HR,0.044, 1.045 [1.006-1.087] 
HR12, 0.032, 1.032 [0.997-1.071] 
Albumin 2, -0.542, 0.582 [0.470-0.693] 
Diabetes, 2.039, 7.686 [1.939-36.598] 
Multiorgan resection, 2.611, 13.615 [1.497-
338.413] 
Transfusion, 1.647, 5.190 [1.64-19.061] 
0.17 0.89 0.78 0.903 
0.05 Intercept 11.83 
Hgb 1, -0.02, 0.98 [0.95-1.00] 
BE, -0.11, 0.90 [0.78-1.03] 
HR, 0.06, 1.06 [1.01-1.10] 
Capillary refill 12, 0.33, 1.39 [0.84-2.30] 
HR 12, 0.03, 1.03 [0.99-1.07] 
Albumin 2, -0.53, 0.59 [0.48-0.71] 
Diabetes, 1.80, 6.02 [1.44-25.27] 
Multiorgan resection, 3.01, 20.27 [1.66-248.03] 
Transfusion, 1.06, 2.89 [0.71-11.88] 
0.16 0.88 0.77 0.901 
BE-base excess on ICU admission; HR-heart rate on ICU admission; Albumin 2-albumin concentration on the 
first postoperative day; HR 12-heart rate 12 hours after ICU admission; Hgb 1-preoperative hemoglobin; 
Capillary refill 12 – capillary refill 12hours after ICU admission;AUC-area under curve; Predictors with 




When we applied stepwise variable selection on the above logistic regression model (λ=0.06), 
the whole model was selected, which means predictors BE and HR 12 cannot be removed, 
even though with insignificant coefficients. The within sample error statistics is summarized 
below (Table 46, Figure 30): 
 
Table 46. Error statistics of the logistic regression model fitted on the lasso selected predictors 
Error rate Sensitivity Specificity PPV  AUC 
0.146 0.896 0.79 0.868 0.930 













Figure 30. The within sample receiver operating characteristic (ROC) curve of the logistic 
regression model fitted on the lasso selected predictors  (λ=0.06)   
 
We performed 5-fold cross validation to compare the final model with the model with 22 
predictors.(Table 47) Clearly, the final model performs consistently well on each fold, or at 




             Table 47. Predictive error statistics for the model with 7 predictors 
Fold Error rate Sensitivity Specificity PPV AUC 
1 0.143 0.92 0.76 0.85 0.946 
2 0.195 0.76 0.92 0.96 0.882 
3 0.219 0.95 0.60 0.71 0.876 
4 0.146 0.86 0.83 0.92 0.917 
5 0.097 0.95 0.85 0.87 0.967 
                                PPV-positive predictive value; AUC-area under curve 
 
4.5.7.Correlation of the predicted probability by lasso selected model with the CCI 
There was a strong positive correlation of the probability of complications predicted by the 
model with the Comprehensive Complication Index (CCI) (r=0.73, p<0.001). Greater 
probability for complications (as predicted by the model) is associated with greater CCI. 
(Figure 31) 
 
Figure 31. Scatter plot of lasso predicted probability of complications against CCI; Blue smooth line 
is generated by local regression (LOESS) 
 
4.5.8.Rounding the coefficients 
To simplify the model, we further rounded the coefficients to integers or some nicer numbers 




Table 48. Original and new (rounded) regression coefficients of the model with 7 predictors 
Variable Coefficient New coefficient 
(Intercept) 10.603 11.00 
BE -0.103 -0.10 
HR 0.044 0.04 
HR 12 0.032 0.03 
Albumin 2 -0.542 -0.55 
Diabetes 2.039 2.00 
Multiorgan resection 2.611 3.00 
Transfusion 1.647 2.00 
 
The error statistics based on the new coefficients are summarized in table 49. Compared with 
the original model, the overall error rate is similar (old vs new 0.146 vs 0.141), sensitivity is 
sacrificed a little (0.896 vs 0.848). However, specificity is increased from 0.790 to 0.877 and 
PPV is increased from 0.868 to 0.914. The AUC keeps the same. 
Table 49. Error statistics of the model with 7 predictors and rounded coefficients 
Error rate Sensitivity Specificity PPV AUC 
0.141 0.848 0.877 0.914 0.934 
 
This new model with rounded coefficients needs further testing on validation data set. 
 
4.6. Model validation 
 
Model validation was performed in a new set of patients operated at the Clinic for Digestive 
surgery from September 2018 to December 2018. The eligibility criteria, predictors, 
measurements and outcome definitions were identical to those in the development set. The 
validation cohort included 60 patients, and 37 of them developed complications in the 
postoperative period. The median CCI in the validation set was 20.9 [0.0-42.5]. 
Characteristics of patients in the development and validation set are shown in table 49. They 
didn’t differ significantly regarding the parameters from the model except for the multiorgan 














Diabetes 33 (16.0) 15 (25.0) 0.111 
Multiorgan resection 18 (8.7) 11 (18.3) 0.036 
Heart rate 80.2 ± 17.5 83.0 ± 17.9 0.262 
BE -6.2 ± 4.2 -6.05 ± 4.85 0.814 
HR 12 80.8 ± 16.7 82.7 ± 17.8 0.445 
Albumin 2 31.1 ± 4.0 30.2 ± 4.1 0.129 
Transfusion 60 (29.1) 19 (31.7) 0.737 
Complications 125 (60.7) 37 (61.6) 0.890 
CCI 20.9 [0 – 44.9] 20.9 [0 – 42.5] 1.000 
    
BE-base excess; HR 12 – heart rate 12hours after ICU admission; Albumin 2 – albumin concentration 
on the first postoperative day; CCI-The Comprehensive Complication Index 
 
We calculated the probability of developing complications for each patient according to the 





Where p is the probability for developing complications and y is a linear combination of 
weighted predictors including the model’s constant. 
 
For the original model: 
 y = 10.60 – 0.103xBE + 0.044xHR + 0.032xHR 12 – 0.542x Albumin 2 + 2.039x Diabetes + 2.611x 
Multiorgan resection + 1.647xTransfusion 
For the model with rounded coefficients: 
y= 11.00 – 0.10xBE + 0.04xHR + 0.03xHR 12 – 0.55xAlbumin 2 + 2.0xDiabetes +3.0xMultiorgan 
resection + 2.0xTransfusion 
(Diabetes, Multiorgan resection, and Transfusion = 0 if absent, and 1 if present) 
The predictive performance of the original model and the model with rounded coefficients is 
shown in table 50 and figure 32. 




  Table 50. Predictive performance of the original model and model with rounded coefficients 
on validation data set 
Model Error rate Sensitivity Specificity PPV AUC 
Original 0.167 0.919 0.696 0.829 0.913 
Rounded coefficients 0.133 0.919 0.783 0.872 0.909 











Figure 32. Receiver operating characteristic (ROC) curve for risk of occurrence of postoperative 
complications predicted with the original model and the model with rounded coefficients; The area 
under curve (AUC), (95% confidence interval) for the original model is 0.913 (0.841-0.985), p<0.001. 
AUC for model with rounded coefficients is 0.909 (0.835-0.984), p<0.001 
 
The comparison of areas under curve of the original model and model with rounded 
coefficients showed no significant difference between them (z statistic 0.075, p=0.940).  Both 
models predict complications pretty well on validation data, particularly the simplified model 









Surgery can be considered safe nowadays since the majority of surgical procedures are 
associated with a mortality rate of less than 1%. Taking into account the huge global volume 
of surgery, it is still accompanied by more than 1.5 million of potentially preventable deaths, 
which almost equals the mortality attributed to road trauma. Postoperative complications are 
the leading cause of surgery-related mortality. Not only for that reason, postoperative 
morbidity represents a significant global health problem. Along with prolonged 
hospitalization and increased costs, it can be associated with some far-reaching consequences 
such as disability, diminished quality of life, and reduced long-term survival. Therefore, the 
identification of patients at high risk for developing postoperative complications is a 
challenging task for perioperative caregivers. Development of strategies aimed at reducing 
postoperative morbidity with outcome measures reported in a standardized fashion is equally 
important. 
This prospective, observational study attempted to provide a multilayer overview of 
postoperative morbidity in high-risk patients undergoing major abdominal surgery. We 
addressed several questions: How frequent are complications in this population of patients? 
What is their impact on resource utilization? Which method for the assessment of 
postoperative morbidity is the most appropriate for this category of patients? Is the POSSUM 
scoring system an adequate tool for prediction of postoperative morbidity and mortality? We 
also explored whether monitoring of early postoperative perfusion indicators adds any value 
in the identification of patients with more complicated clinical course. Finally, we developed 
a statistical model to predict the occurrence of postoperative complications after a major 
abdominal surgery that included preoperative, intraoperative, and early postoperative risk 
factors 
Incidence and type of postoperative complications; The association with length of stay and 
functional activity 
Our study provided data for a cohort of 206 consecutive high-risk surgical patients admitted 
to the ICU following major or major + abdominal surgery. They made 4.6% (206/4458) of 
the total number of patients operated at our hospital during the study period. The proportion 
of ICU beds to hospital beds is 5.7% (14/245). However, these patients accounted for less 
than quarter (206/856; 24.1%) of all ICU admissions directly after surgery. In-hospital death 
104 
 
occurred in 14 (6.8%) patients. It is the expected mortality rate for procedures considered as 
high-risk.8 The analysis of two large data sets in the United Kingdom revealed that the overall 
mortality after elective general surgery was 0.44%.8 However, the mortality rate for complex 
procedures involving stomach or duodenum was 8.4% and 6.7% for esophagectomy. The 
European Surgical Outcomes Study (EUSOS) that assessed outcomes after non-cardiac 
surgery in Europe reported the overall mortality of 4%, which was higher than expected.3 The 
mortality rate after upper gastrointestinal, lower gastrointestinal, and hepato-biliary surgery 
was 6.9%, 5.7%, and 5.0%, respectively. The findings of this study suggested that besides the 
country where surgery was done, surgery-specific and patient-specific risk factors act 
together to increase the mortality risk.3 Three patient-related factors: ASA score, metastatic 
cancer, and liver cirrhosis acted independently in that direction. A recent study that obtained 
data from the NSQIP database and included only patients with an American Society of 
Anesthesiologists physical status (ASA-PS) class of 1 or 2 reported an overall 30-day 
mortality rate of 0.07% after elective non-cardiac surgery.202 In this population of relatively 
healthy patients, male gender, duration of surgery, age, smoking, and hypertension were 
independently associated with mortality, while general surgery had the highest mortality 
rate.202 Patients in our study were older (63.9 ± 11.8 years vs 49.7 ± 15.8), predominantly 
male (64.6% vs 39.1%), more frequently smokers (27.7% vs 17.8%), with a history of 
diabetes (16% vs 4.7%), and half of them had the ASA-PS class of 3 or 4. Moreover, they all 
underwent complex surgery, mainly for cancer (91.3%) or metastatic cancer (16.0%). It is 
therefore not surprising that patients in our cohort had a considerably higher mortality rate. 
On the other hand, our data originate from a high volume, university-affiliated center, 
specialized in digestive surgery which may explain the lower mortality than reported by some 
authors.203 
The overall postoperative in-hospital morbidity in our cohort was high, as 125 (60.7%) 
patients developed at least one complication. It is usually reported that the incidence of 
complications following major gastrointestinal surgery is around 30%.203–205 There are also 
reports that the occurrence of complications in unselected patients can even be higher than 
70%.31,206 The apparent heterogeneity may be in part explained by variation in criteria used to 
define a complication, and also by dissimilarities of studied populations and clinical 
setting.41,207 In accordance with findings of previous investigations, the infectious 
complications (16.9%) were the most frequently encountered.204,208 Infectious complications 
are found to be the main source of postoperative morbidity after abdominal surgery.209 In a 
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multicenter study, Pessaux et al showed that the age, malnutrition or obesity, cirrhosis, a 
vertical abdominal incision, prolonged operative time, and anastomosis of the bowel 
represent the independent risk factors for infectious complications after abdominal 
operations.210 Even the country’s income according to the UN’s Human Development Index 
(HDI) influence the burden of surgical site infections (SSI) after gastrointestinal surgery.211 
Our cohort consisted mainly of oncological patients whose immunological disturbances and 
susceptibility to infections are well known, particularly in the advanced disease or following 
adjuvant therapy. 
Pulmonary complications were also common in our study, making 15.2% of all 
complications. The analysis of NSQIP database with more than 160000 patients who 
underwent major abdominal surgery demonstrated that among all patient-related and surgery-
related variables, esophagectomy was the strongest predictor of postoperative pulmonary 
complications.94 They were also more likely to occur after upper abdominal approach, being 
more common following open compared to laparoscopic surgery.94,98 
Patients with complications were more likely to have preoperative anemia, hypoalbuminemia, 
and higher CRP levels. They were diabetics more frequently, had a higher ASA score and 
were more likely to receive chronic corticosteroid therapy. In contrast to many other studies, 
no particular comorbidity, except diabetes, was associated with the occurrence of 
complications in our study.212,213 We believe that clinicians, aware of the risks inherent to 
complex cardiovascular or pulmonary comorbidities, undertook measures for optimization of 
patients’ condition, thereby reducing the baseline risk. It is a common practice at our hospital 
to enable a prolonged preoperative hospitalization in order to complete necessary consultant 
investigations and to provide treatments prior to surgery so that chronic disorders can be 
stabilized. Patient preoperative management is individually tailored. Strategies for 
preoperative optimizations vary, and the choice is usually made on the discretion of the 
attending surgeon or anesthesiologist. These strategies were beyond the scope of our study, 
and preoperatively we recorded only the patient’s medical history and the variables contained 
in the Physiological POSSUM score. 
Length of hospital stay (LOS), commonly used as a measure of clinical outcome, is an 
indicator of perioperative resource consumption. It is easy to define and quantify and may 
serve as a suitable marker of resource utilization when detailed data on hospital costs are not 
available. When used to estimate hospitalization costs, level of care should be taken into 
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account, since the expenditures of the ICU stay are much higher than those of the ward 
hospitalization. 
All indices of hospitalization, i.e. ICU LOS, postoperative LOS, and total LOS were 
significantly greater in patients with complications in our study. A considerably greater 
proportion of these patients had a prolonged hospital LOS. It is in agreement with previous 
studies that clearly demonstrated the association of postoperative complications with 
LOS.214,215 The study that analyzed data on 11 elective major operations from the NSQIP 
database demonstrated that intraoperative factors along with the postoperative adverse events 
contributed more to the risk for prolonged LOS than preoperative characteristics, such as 
comorbidities or functional activity.216  
However, there are some limitations that should be considered when using hospital LOS as 
the outcome. First, the level of fitness on discharge from the hospital may differ greatly 
between wards and institutions. It can be an important source of bias when comparing inter-
institutional perioperative outcomes. All patients in our study were discharged without 
complications, and if the complication requiring readmission occurred within 30 days after 
discharge, it was recorded and the new LOS was added up to the previous. Still, not all of the 
patients were in the same state of well-being on discharge from hospital, since the over-all 
functional activity was significantly lower in patients with complications. Second, even in 
patients with the same level of fitness on discharge, the hospital LOS can vary markedly due 
to non-clinical, mainly socially influenced factors. The hospital LOS cannot be taken as a 
pure surrogate for postoperative morbidity, particularly in older patients in whom the 
accessibility of social service packages or rehabilitation facilities may influence the duration 
of postoperative hospitalization.217 Similar can be applied to the ICU LOS, since the 
admission and discharge criteria differ between hospitals and the length of ICU stay can be 
influenced by the availability of critical care beds. 
The evaluation of postoperative morbidity with the Clavien-Dindo Classification and the 
Comprehensive Complication Index 
To the best of our knowledge, this study is the first to evaluate the CCI as a system for 
complication reporting and to compare it with the Clavien-Dindo classification in a relatively 
homogenous population of high-risk surgical patients undergoing major abdominal surgery. 
This is the population of patients in whom multiple postoperative complications are expected, 
not only as a result of complex surgery but also because of the patient-inherent risks. The rate 
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of multiple complications was high in the present study, as 98 patients (47.6%) developed 
more than one complication. The median CCI for the entire cohort was 20.9 [0-44.9], which 
is similar to other studies reporting results of specific types of major abdominal surgery.31,32 
The majority of patients with complications had the highest CD grade II (62/125 patients; 
49.6%). However, their median CCI was 29.6, ranging from 20.9 to 47.4.  The range of CCI 
values between the extremes further increased with the rising CD grade, with overlapping of 
lower CCI values of the higher CD grade with higher values of the lower CD grade. It is 
totally expected when multiple complications are being assessed. For example, a patient with 
one grade I complication (superficial wound infection) and one grade II complication 
(arrhythmia) would be reported as CD II with a CCI of 22.6. The other patient with one grade 
I complication (transient confusion) and four grade II complications (urinary tract infection, 
deep venous thrombosis, pneumonia, and Cl.difficile infection) would also be reported as a 
CD II, with a CCI value of 42.7. Conversely, according to the Clavien-Dindo classification, a 
patient with a single IVa grade complication (pulmonary embolism resulting in an acute 
respiratory failure) would be categorized as a more severely complicated than a patient who 
had reoperation due to an anastomotic breakdown (grade IIIb), complicated with pleural 
effusions (grade IIIa), anemia (grade II), tachyarrhythmia (grade II), and deep venous 
thrombosis (grade II). The CCI value of the first patient would be 42.4, while that of the latter 
would be 56.0. It has been demonstrated by Slankamenac and coworkers that a postoperative 
course with multiple complications is perceived by patients as a more severe.28 Although the 
perceptions of patients, nurses, and physicians mainly matched with the assigned Clavien-
Dindo grade, we believe that in the setting of high-risk surgical patients the therapy applied to 
treat the most severe complication cannot be used as the only method to describe reliably the 
entire postoperative course.  
The number of postoperative complications in our study increased with the rising CD grade, 
as well as the proportion of patients with more than three complications. Clavien et al 
demonstrated similar findings in their study aiming to prospectively assess the value of the 
CCI compared with a standard classification of complications.35 However, we found a 
significantly stronger correlation of the CCI with the number of complications than the 
association of the CDC with this parameter. It has been shown that the number of 
complications impacts not only the patients’ safety and satisfaction, but is also strongly 




The CCI values corresponded well with the CD grade in our study, reflected by the 
significant difference among each two grades, except the grades IVa and IVb. We assume 
that this can be attributed to the small number of patients in the IVb grade. Nevertheless, the 
two scales demonstrated a strong positive correlation. 
Both systems for complication reporting showed strong correlations with hospitalization 
indices. The CCI was uniformly better correlated with all analyzed parameters, particularly 
with the ICU LOS and a prolonged ICU stay. Several authors were also able to show the 
stronger relation of the CCI with a hospital LOS.28,31,92,218–220 However, there are some issues 
that need to be addressed regarding hospital LOS as an outcome measure. First, since the CCI 
and the CDC exhibit a strong correlation, with a correlation coefficient close to 1, it is 
possible to get inflation of t-statistics and clinically insignificant differences in correlations 
with LOS may be found statistically significant. Second, as previously said, there are many 
limitations of the length of stay as a clinical outcome, since discharge criteria may vary 
significantly between surgeons and institutions influenced by various nonclinical issues. 
Third, a longer postoperative course doesn’t necessarily reflect the severity of the 
complication. There are severe complications that can resolve completely after a promptly 
indicated reoperation. On the other hand, some less severe complications might require long-
term conservative treatment. Anyhow, length of hospital stay continues to be extensively 
used as an outcome measure, since it is commonly applied for cost assessments, and is easily 
accessible in medical records. 
Our study demonstrated the association of the CCI as well as of the CD grade with functional 
activity on discharge. In a paper by Legner et al, it has been shown that postoperative 
complications significantly influenced a discharge location (home, home with assistance, or 
institutional care) after abdominopelvic surgery, but their severity has not been reported.221 
Although it is not easy, from a statistical point of view, to compare the effects of these two 
scales, we think that the impact of both of them on this patient-centered outcome is even 
more important finding than the effect on resource utilization.  
The limitations of this study are common with those that originate from a single center. Local 
patterns of perioperative care may have influenced the treatment of complications. Personal 
practice of the attending surgeons and the available resources on wards most probably 
affected the length of preoperative and postoperative hospital stay. The fact that the study 
was conducted in the biggest tertiary care university hospital may in part explain the high 
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number of complications. 
The strength of the study is that it was performed in a well-defined cohort of high-risk 
patients with a planned admission to the ICU, which reduced a bias coming from an early 
postoperative process of care. The prospective nature of the study allowed a meticulous 
recording of all postoperative complications, enabling a reliable CCI calculation. 
 
The evaluation of the POSSUM and the P-POSSUM scoring system for complications and 
mortality after high-risk major abdominal surgery 
A stone inscription of Hammurabi’s law written almost 4000 years ago stated: „ If a doctor 
has treated a free man but caused a serious injury from which the man dies...the man is to cut 
off his hands“.222 It has been well recognized in the meantime that the outcomes of surgery 
measured by the mortality rate or long-term disability cannot be attributed exclusively to the 
surgeon’s performance, but also to the patients’ physical status and characteristics of the 
operation. Taking the mortality rate as the sole indicator would lead to the flawed conclusion 
that the units admitting only the low-risk patients perform better than the tertiary centers with 
high turn-over of more demanding cases. This observation was the basis for the development 
of methods for the surgical audit that rely on patient and operation risk-adjusted outcomes. 
The POSSUM (Physiological and Operative Severity Score for the Enumeration of Mortality 
and Morbidity) scoring system was designed in 1991 for surgical audit across the wide 
surgical spectrum.116 This system, as well as its related models (P-POSSUM, O-POSSUM, 
CR-POSSUM, E-POSSUM) modified in order to enchance predictive performance of the 
original score, have been also employed to determine an individual patient’s risk for a 
specific planned or urgent operation. 
Our study evaluated the predictive performance of the POSSUM and P-POSSUM score for 
postoperative morbidity and mortality. As far as we know, it was the first validation of the 
POSSUM scoring system in patients undergoing abdominal surgery in Serbia.  
In the present study, the accuracy of POSSUM to predict postoperative morbidity was beyond 
optimal, since the underprediction of complications was found in all risk groups. It was 
particularly pronounced in the lowest risk band. Poor calibration of the score that we 
encountered confines its application for risk prediction in individual patients. In a systematic 
review of POSSUM and its related models as predictors of morbidity after surgery for 
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colorectal cancer, Richards et al showed considerable variations in the observed to expected 
morbidity (O:E) ratios between four analyzed studies.223 It is also noteworthy that only 4 out 
of 10 studies evaluated POSSUM performance for prediction of complications, while all of 
them assessed the accuracy in prediction of mortality. The differences in O:E ratios for 
morbidity can be found across all studies regarding POSSUM (Table 5.1). It may be in part 
explained by arbitrary and non-uniform definitions of complications that differ from the 
original POSSUM descriptions. Our study defined complications according to the European 
Perioperative Clinical outcome (EPCO) definitions of perioperative outcome measures, 
issued by the European Society of Anaesthesiology – European Society of Intensive Care 
Medicine (ESA-ESICM) joint taskforce in 2015.199 The list of suggested and defined 
complications is more comprehensive than the original Copeland’s list.116 It is therefore 
possible that that the underprediction of morbidity by the POSSUM score encountered in our 
study can be attributed to the more precise definitions of complications and a more detailed 
follow-up.  
In terms of postoperative mortality, both POSSUM and P-POSSUM showed reasonable 
discrimination with similar area under ROC curves of 0.744 and 0.739, respectively. In other 
words, both scores had a good power to discriminate between patients by assigning the higher 
value to the patients who died. The results of our study suggest that POSSUM largely 
overpredicts mortality in our population (O:E ratio 0.38) and shows a lack of fit in all risk 
groups. Similar results can be found in many studies related to abdominal surgery. (Table 
5.1) Wang et al. in a systematic review of 1734 pancreatic resections found a significant 
overprediction of mortality by POSSUM (O:E ratio, 0.35) and the underprediction by P-
POSSUM (O:E ratio, 1.39) for this type of surgery.126 Because the original POSSUM score 
was shown to overestimate mortality, particularly in low risk groups due to the nature of the 
logistic regression derived equation, the P-POSSUM was developed with the same predictors 
by adjusting the equation to overcome this shortcoming.127 Poor calibration of POSSUM and 
P-POSSUM that doesn’t allow a reliable individual risk prediction may be in part explained 
by the fact that these scores were developed in a population of general surgical patients. 
Therefore, the predictors proven to be of importance for the outcome of the specific type of 
surgery were not included in the model. In order to enhance the reliability of the prediction of 
postoperative mortality, several specialty-specific derivatives of POSSUM have been 
proposed, including CR-POSSUM for colorectal surgery, V-POSSUM for vascular surgery, 






For example, CR-POSSUM takes into account 6 physiological (age, cardiac failure, systolic 
blood pressure, heart rate, hemoglobin, urea) and 4 operative variables (complexity of the 
surgery, peritoneal soiling, Duke cancer stage, and urgency of surgery) in a logistic 
regression-derived formula.129 These variables were shown to be specific for patients 
undergoing colorectal surgery. However, subsequent analyses of the CR-POSSUM didn’t 
demonstrate superior performance in predicting mortality when compared to POSSUM and 
P-POSSUM. In a study of patients undergoing resection for colorectal cancer, the 
discriminatory power of CR-POSSUM was far below optimum (AUC=0.59) and inferior to 
that of the P-POSSUM score (AUC=0.70).224 The systematic review that assessed the 
predictive value of POSSUM models for outcomes after colorectal surgery included ten 
studies on POSSUM, 17 studies on P-POSSUM, and 14 studies on CR-POSSUM, with more 
than 10000 patients.223 The review clearly demonstrated that all models overestimate 
mortality after colorectal surgery, with O:E ratio for POSSUM, P-POSSUM, and CR-
POSSUM of 0.31, 0.90, and 0.64, respectively.223 The similar was shown in the analysis of 
POSSUM and O-POSSUM for mortality prediction after oesophageal and gastric surgery.225 
It appeared that surgery-specific O-POSSUM added no value since it overestimated mortality 
to a higher extent than POSSUM and P-POSSUM score.225 We believe that the fact that 
POSSUM was developed more than 25 years ago may have influenced its low accuracy for 
mortality prediction in recent studies. The advent of minimally invasive surgery, fast track 
protocols, and improvement of perioperative care, contributed to the substantial drop in 
mortality in the past decades. The operative component of the POSSUM doesn’t take into 
consideration any of these important parameters, therefore neglecting factors that positively 
influence the outcome. 
In our study, the overall O:E ratio of the P-POSSUM score was 0.93, suggesting slight 
overestimation of mortality. However, the calibration (goodness-of-fit) was satisfactory. This 
finding is in accordance with other studies that showed P-POSSUM was able to accurately 
predict mortality, particularly in populations comprised of high-risk patients.225,226  
The drawback of our study is a relatively small number of patients included in the analysis. It 
didn’t allow for testing the calibration of the scores in deciles of risk. The study probably 
wasn’t powered enough to assess the predictive performance of POSSUM and P-POSSUM 
given the low mortality rate after elective surgery. Usually, very large populations are needed 
to draw conclusions regarding the predictive accuracy of any model. Nevertheless, due to 
considerable overestimation of mortality that was encountered in our study, we think that the 
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POSSUM score cannot be used in our population of high-risk patients for individual risk 
prediction, particularly not when making decisions about potentially curative surgery. On the 
other hand, based on the results of previous studies, we don’t believe that the accuracy for 
individual risk prediction can be improved by creating additional surgery-specific POSSUM 
derivatives, or by readjustments of POSSUM equation.227,228 Furthermore, clinical utility and 
practical value of many different POSSUM predictive models is questionable. 
Despite the limited usefulness for the assessment of individual risk, we believe that P-
POSSUM score, due to non-significant O:E ratio for mortality found in our study, can be 
used for surgical inventory to compare the mortality of the populations after major abdominal 
surgery.  
 
The association of disturbances of peripheral perfusion with postoperative complications  
The principal finding of our study regarding the peripheral perfusion is that postoperative 
perfusion disturbances encountered early after major abdominal surgery were more 
pronounced in those patients whose postoperative course was burdened with more severe 
complications. Almost all indicators of peripheral perfusion were more markedly altered in 
patients who developed the more complicated postoperative course, as assessed with the CCI. 
This difference was already present on admission to the ICU and even more predictive than 
12 hours later. 
Perioperative hemodynamic optimization through goal-directed protocols has demonstrated 
efficacy in reducing complications and shortening the postoperative length of stay.229,230 
Goal-directed protocols suggest the use of manifold strategies such as fluid challenges, 
transfusion, and inotropes in a strictly protocolized manner aimed at achieving predefined 
hemodynamic targets. The idea around these protocols is to optimize oxygen delivery and 
keep the balance between oxygen delivery and consumption by maintaining global 
hemodynamic parameters such as stroke volume, mean arterial pressure, and central venous 
oxygen saturation (ScvO2).
230 However, there is growing evidence that the normal range of  
ScvO2 achieved during the implementation of goal-directed strategy in surgical patients may 
not reflect the optimal perfusion during the postoperative period.197,198 Therefore, relying on 
ScvO2 and other global hemodynamic parameters can produce a situation in which the true 
optimization of perfusion may be missed. Patients in our study were admitted to the ICU with 
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normal values of mean arterial pressure (MAP) and ScvO2 and it was the same for patients 
with severe and non-severe complications. Different strategies and monitoring techniques 
(Esophageal Doppler, LidCo Rapid) were used intraoperatively to accomplish these values, 
on the discretion of the attending anesthesiologist. On the other hand, patients with severe 
complications presented on admission to the ICU, with the higher central-to-toe temperature 
gradient (Δ T), the higher CO2 gap and ΔpCO2/Ca-vO2 value, and the increased capillary refill 
time (CRT). None of these parameters were routinely monitored intraoperatively.  
The events in the peripheral circulation during the immediate postoperative period resemble 
those of septic or hypovolaemic shock. The increased vascular tone as a consequence of 
increased sympathetic output and activated baroreceptor reflex is a compensatory mechanism 
with the aim to preserve the perfusion of vital organs.231 It is usually achieved at the expense 
of reduced perfusion in splanchnic organs, skin, and kidneys. The physiological stress 
response that accompanies major surgery is characterized by inflammation mediated by 
cytokines released from the surgical site.232 Inflammatory cascade along with the neural and 
endocrine mechanisms for volume conservation, such as the release of aldosterone and 
vasopressin, as well as catecholamine-induced vasoconstriction cause fluid shifts between 
compartments and affect the microcirculation.231,232 Furthermore, stress-induced catabolism 
leads to increased oxygen demands. The extent of this stress response is largely dependent on 
the type of operation, but it has been demonstrated that it is associated with the development 
of postoperative organ dysfunction and impaired healing, thus strongly influencing the 
outcome.233  Postoperative alterations of peripheral perfusion can occur even in the 
circumstances of maintained systemic hemodynamics.143,173 
In our cohort, increased ΔT, enlarged CO2 gap and ΔpCO2/Ca-vO2 , and delayed CRT that 
were encountered on admission to the ICU in patients who suffered a more complicated 
postoperative course may reflect the extent of these inflammatory changes and disturbances 
of peripheral perfusion.  
Central-to-toe temperature gradient has been shown to correlate well with the extent of skin 
vasoconstriction, and that even its subjective evaluation may discriminate patients with 
abnormal perfusion and more severe organ dysfunction.146 It was shown that mean ΔT was 
associated with ICU and hospital mortality in patients with septic shock while the mean 
ScvO2 was not.
141 Our patient population had decreased both central and peripheral 
temperature on admission to the ICU, and we believe that it can partly be attributed to 
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inadvertent intraoperative hypothermia. However, Δ T was significantly greater in patients in 
whom more severe complications occurred postoperatively. Because of the observational 
nature of our study, we can’t determine whether subsequent use of warming or the 
resuscitation measures that were undertaken influenced the decrease of ΔT after 12 hours in 
the ICU, making it insignificantly different between two groups of patients. Our results show 
that ΔT on admission to the ICU after the operation was the single most important perfusion 
parameter that could make good discrimination between patients with less and more severe 
complications. The fact that its prognostic value has not been found later during ICU stay 
points to the intraoperative period and the need for close monitoring of intraoperative 
temperature and prevention of hypothermia. The study of Kaplan et al demonstrated that 
surgical patients with cool extremities had lower cardiac output, cardiac index, pH, and SvO2 
compared to patients with warm extremities.234 Despite no differences with regards to heart 
rate, systolic and diastolic blood pressure, arterial partial pressures of oxygen and carbon 
dioxide, patients with cold extremities had significantly higher lactate values.234 A recent 
meta-analysis showed that perioperative hypothermia was not associated with surgical site 
infections.235 The large cross-sectional study with 30-day follow up conducted in surgical 
patients in China revealed the same.236 However, it was also able to demonstrate that 
hypothermia was associated with more postoperative shivering, longer PACU stay, more 
complications requiring ICU readmission, and longer hospitalization.236  
Patients with more severe complications in our study had a delayed capillary refill time on 
admission from the operating room. Although the delayed CRT may have been influenced by 
the low peripheral temperature, this parameter remained a significant predictor of the CCI>50 
in the multivariate analysis. Questions have been raised regarding the clinical reliability of 
CRT in the assessment of peripheral perfusion, due to its inherent subjectivity. In our study, 
CRT was measured by one investigator. However, good interobserver reliability between 
assessors was demonstrated.142 Furthermore, it was shown that CRT correlates well with the 
sonographic pulsatility index, a validated measure of visceral blood flow.237 The correlation 
of CRT with the intestinal flow was particularly strong.237  
Patients in our study had normal values of central venous oxygen saturation (ScvO2) on 
admission to the ICU. No differences were observed between patients with the less and more 
severe postoperative course. However, the difference became evident after 12 hours, since the 
ScvO2 decreased in patients with CCI>50. Optimization of ScvO2 (reaching target values 
>70%) is a standard component of goal-directed protocol that was proven beneficial in 
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improving outcomes of major abdominal surgery.230 Since goal-directed therapy is aimed at 
optimizing tissue perfusion and oxygen delivery by the administration of fluids and 
vasoactive drugs, it should be underlined that none of the hemodynamic parameters stands 
out as its best endpoint during the perioperative period. The fact that systemic hemodynamic 
parameters cannot reveal alterations of tissue perfusion represents the rationale for the use of 
other indicators of tissue well-being, such as lactate and ScvO2. The value of ScvO2 is 
determined by global oxygen delivery (DO2) and consumption (VO2). Both DO2 and VO2 are 
subject to extensive changes during the perioperative period.184 Pearse et al showed that 
ScvO2 sharply decreases immediately after the end of surgery, despite unchanged DO2 and 
cardiac index, suggesting the increased oxygen consumption after emergence from 
anesthesia.184 On the other hand, the common practice of administering high FiO2 during 
anesthesia may mask the detrimental intra-operative effects on tissues, if the monitoring was 
based on ScvO2. The value of ScvO2, as well as of other O2-derived parameters should be 
interpreted cautiously when identifying tissue hypoxia during the perioperative period. 
Normal or even high ScvO2 can be found despite severe tissue hypoxia if the tissue oxygen 
extraction has been impaired. The similar was shown for oxygen extraction ratio (O2ER).
195 
A randomized controlled trial by Jammer et al, conducted in patients undergoing colorectal 
surgery failed to prove the benefits of ScvO2-guided goal-directed therapy in terms of 
reducing postoperative morbidity.238 In the study of Robin et al, ScvO2 couldn’t discriminate 
between high-risk patients with and without postoperative complications.197 Moreover, many 
of these patients, similarly to patients in our study were already “optimized” intraoperatively 
using ScvO2 as the therapeutic endpoint. The main finding of that study was that an enlarged 
CO2 gap was highly predictive for postoperative morbidity.
197 
These results match with those of previous studies demonstrating that the increased CO2 gap 
was associated with worse outcomes in patients with septic shock or isovolemic anemia.239,240 
According to the Fick equation, CO2 gap is directly related to CO2 production (VCO2) and 
inversely related to cardiac output (CO).189 Therefore, an increase in CO2 gap can be found 
during the low-flow state, even though no additional CO2 has been generated. The stagnation 
phenomenon that lies behind the widening of CO2 gap during the low-flow states may explain 
the situation in which a normal ScvO2 is associated with the increased CO2 gap. Futier et al in 
the study that included high-risk surgical patients undergoing major abdominal surgery 
demonstrated that postoperative complications occurred more frequently in patients with the 
increased CO2 gap, despite the normal values of ScvO2 and CI.
241 They proposed the use of 
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CO2 gap as a complementary tool to ScvO2 to detect the relative flow insufficiency when 
hemodynamics has been apparently optimized.180  Patients in our study who developed more 
severe complications (CCI>50) had a significantly greater CO2 gap on admission to the ICU 
compared to the patients with CCI<50. The value of CO2 gap in both groups decreased 
thereafter,though significantly only in patients with less severe complications. We assume 
that the drop in this value occurred as a result of the therapy received during the first hours of 
ICU stay. Previous studies suggested that the physiological value of CO2 gap is < 
6mmHg.179,197 Silva et al found even lower value (< 5mmHg) measured preoperatively in 
high-risk patients to be predictive for mortality.242 Patients in our cohort exhibited higher 
median values of CO2 gap than reported by previous studies.
195,197,241 It should be pointed out 
that CO2 gap is determined by several factors besides cardiac output (CO): venoarterial CO2 
content difference, CO2 dissociation curve, and minute ventilation.
243 It is noticeable that 
patients in our study who demonstrated wider CO2 gap had lower arterial CO2 partial pressure 
(PaCO2). It can be ascribed to hyperventilation which may have happened at the start of 
postoperative mechanical ventilation, on admission to ICU. Besides, hypothermia which was 
common in our patients may have influenced the relationship between CO2 content and CO2 
partial pressure. 
It should be emphasized that CO2 gap can be a marker of tissue hypoxia only when hypoxia 
ensues from the low flow.189 Normal values of CO2 gap can be found in the severely hypoxic 
conditions, i.e. in septic shock, if the hyperdynamic circulation is sufficient to wash out the 
excess carbon dioxide. It was shown in the animal model that an increase in CO2 gap 
occurred only when hypoxic conditions were induced by a decrease in flow (ischemic 
hypoxia), and not when hypoxia was elicited by a decrease in FiO2 with maintained blood 
flow (hypoxic hypoxia).244  Therefore, a combination of venoarterial CO2 difference and 
arteriovenous O2 content difference (ΔpCO2/Ca-vO2) was proposed as a better indicator of 
anaerobic CO2 production and tissue hypoxia, regardless of the blood flow.
177,195 Patients 
with the more complicated postoperative course in our study were found to have significantly 
higher ΔpCO2/Ca-vO2 ratio on admission to the ICU. The occult tissue hypoxia despite normal 
hemodynamic and oxygenation parameters may have been responsible for the later 
development of complications. Furthermore, in the multivariate analysis, ΔpCO2/Ca-vO2 was 
identified as the independent predictor of severe postoperative complications, while CO2 gap 
was not independently associated with CCI>50. 
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Serum lactate levels were similar on admission to the ICU in patients with and without severe 
complications. However, a significant difference in lactate levels between the two groups of 
patients was shown 12 hours after the admission. We demonstrated that the lactate levels 
assessed at 12 hours following the operation had the highest discriminative power to detect 
patients with a more complicated postoperative course. This is not surprising, knowing that 
hyperlactatemia is a relatively late phenomenon after the onset of hypoxia since the liver can 
increase the clearance of lactate produced during anaerobic metabolism.245 The cut-off lactate 
value at 12 hours for CCI>50 was 1.65 mmol/l, which is the value commonly considered to 
be within the normal range in critically ill patients. However, a relative hyperlactatemia has 
already been identified as a bad prognostic factor in septic patients, suggesting that the serum 
lactate within the reference range should be interpreted cautiously.246,247 A number of studies 
showed that hyperlactatemia (lactate levels between 2 and 4 mmol/l) is associated with a 
worse clinical outcome in patients with septic shock. The lower threshold has been proposed  
according to the new evidence.248 Since the patients undergoing the elective abdominal 
surgery are considerably different compared to septic patients, in our opinion, the upper limit 
of lactate levels associated with worse outcomes in this population should be different as 
well. The results from this and other studies indicate the need for re-defining the cut-off 
values of serum lactate to predict outcomes in the perioperative setting.171 Nevertheless, 
additional studies are required to elucidate which of lactate-guided therapies can improve 
perioperative outcomes. Overall clinical context should be considered when treating 
postoperative hyperlactatemia. For example, the attempts to normalize lactate levels through 
resuscitation with fluids or inotropes, in the absence of other signs of tissue hypoperfusion, 
may expose patients to overhydration and high doses of inotropes without any obvious 
benefit.174 Thus, it is important to take into account other potential aerobic mechanisms of 
hyperlactatemia and to treat the underlying causes accordingly. With this regard, recognition 
of signs of hepatic dysfunction is essential as it is related to lactate clearance.249 Moreover, 
reduction of increased muscle work arising from shivering, or increased work of breathing 
can decrease serum lactate levels. The study by Berg et al. demonstrated that the 
administration of thiamine may increase the aerobic metabolism in critically ill patients with 
stable hemodynamics, by enabling pyruvate to enter the Krebs cycle.250 However, the role of 
thiamine in decreasing serum lactate and thus affecting the postoperative course remains 
unclear and requires additional studies. 
The multivariate analysis of perfusion parameters adjusted for vasopressor use and 
transfusion showed that the independent predictors of the more complicated postoperative 
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course (CCI>50) were capillary refill, central-to-toe temperature gradient, and ΔpCO2/Ca-vO2 
on admission to the ICU and lactate level and base excess 12 hours after the admission. These 
results suggest that the key indicators of tissue hypoperfusion and hypoxia could be detected 
early after the operation. We believe that the increased lactate and base excess that were 
recorded later denote the expected after-effects of the deranged perfusion present 
immediately after the operation. In our study, indicators of peripheral perfusion were not 
monitored systematically during the operation. Therefore, the association of alterations of 
tissue perfusion that were present on admission to the ICU after surgery with severe 
postoperative complications should perhaps shift our focus to the intraoperative period. We 
hypothesize that the timely recognition of these derangements and the appropriate treatment 
could diminish postoperative morbidity to some extent. 
To the best of our knowledge, no study to date has evaluated the specific perioperative goal-
directed algorithm aimed to optimize the peripheral perfusion. The experimental animal study 
demonstrated favorable effects of restrictive fluid administration and permissive hypotension 
on microcirculation in a model of hemorrhagic shock.251 Den Uil and colleagues showed 
dose-dependent beneficial effects of nitroglycerin on microcirculation, as measured with the 
decrease of central-to-peripheral temperature gradient and Side-stream Dark Field imaging, 
in patients with cardiogenic shock.252 These effects were measurable before changes in 
systemic hemodynamics and were independent of cardiac index.252 Clinical research during 
the past decade yielded many studies that suggested perioperative goal-directed protocols 
targeting macrohemodynamic parameters. These studies had conflicting results.253 Further 
studies are needed to determine the effect of perioperative interventions based on the 
indicators of peripheral perfusion. Given the results we reported, we believe these indicators 
might be an important complementary tool for the assessment of hemodynamic status and 
patient management.  
Our study has several limitations. First, the observational nature of the study didn’t allow us 
to draw conclusions about the causality of the observed association between alterations of 
peripheral perfusion and the severity of complications. Second, we took the arbitrary cut-off 
value of the CCI of 50 to discriminate between more and less severe complications. This 
threshold was chosen because the results of our previous study showed that the CCI of 
around 50 corresponds to the Clavien-Dindo grade 3b (reoperation under general anesthesia) 
or multiple complications of lesser severity. Maybe the results of this study would have been 
different if the other cut-off was chosen. Third, we didn’t collect data on preoperative and 
intraoperative parameters of tissue perfusion. It is possible that the duration of tissue 
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hypoperfusion and hypoxia had a significant effect on the occurrence of complications. 
However, many of the indicators of the tissue perfusion normalized during the first 12 hours 
in the ICU. The admission value was the one that independently predicted severe 
complications. Fourth, some of the possible confounding factors, such as the postoperative 
pain control or liver function that may have influenced the lactate values were not recorded. 
Finally, the drawback of our study is that we didn’t collect the data on interventions and 
therapies that could have altered values of perfusion indicators. Nevertheless, all patients 
were treated according to the standards of local care and none of the variables that we 
analyzed were directly used to guide patient management in the ICU.   
 
Development and validation of the new model for prediction of complications  
 
George Box (1919-2013), one of the greatest statisticians of the 20th century stated: “All 
models are wrong, but some are useful”.254 Indeed, any model represents just a simplification 
or estimate of reality, and hence will never reflect the reality in its entirety. Models for risk 
prediction are widely used in medicine to predict the probability of the outcome of interest 
from a given set of risk factors selected on the basis of clinical experience and literature 
review.255 According to the calculated probability of the event, patients can give informed 
consent for the planned treatment while physicians can be guided in decision making or 
planning of the process of care. A good model should be parsimonious, following the 
philosophy of William of Ockham, 14th-century Franciscan monk and philosopher, whose 
view at parsimony was also known as Occam’s razors.254 In other words, a model should be 
simple, with minimum assumptions and predictors but with the greatest explanatory power. 
In practice, regression methods are commonly used to develop prediction models from a 
specific dataset. If the model is not parsimonious, the problem of the model overfitting is 
frequently encountered. This happens with the use of standard regression methods since they 
capture in the model not only the association between the predictors and outcomes but also 
the noise coming from random variations in the dataset.255 The overfitted model usually 
predicts well in the original dataset but fails to perform accurately in the new sets of data 
from other patient populations. Regularization is one of the common mechanisms to avoid 
overfitting and can be achieved by employing methods of penalized regression that apply 
constraints to the value of regression coefficients. Lasso (Least Absolute Shrinkage and 
Selection Operator) regression is a popular statistical method and the machine learning 
algorithm, introduced in 1996 by Tibshirani, which reduces overfitting and automatically 
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performs variable selection.256 By shrinking regression coefficients to zero following the 
predefined rule, Lasso effectively removes these predictors from the final model. Thereby, 
the final model gains higher prediction accuracy (by allowing a little bit bias to reduce the 
variance) and enhanced interpretability, since it includes the smaller number of predictors.256 
Most of the commonly used scores for prediction of postoperative complications rely only on 
preoperative risk factors. Findings from our study demonstrate the significance of early 
postoperative predictors for the outcome of surgery. Besides, sometimes surgery represents 
the only acceptable treatment no matter how great is the predicted risk. Therefore, we thought 
that it was important to include all perioperative phases during the risk assessment. We 
needed a model able to early identify patients at risk for postoperative complications based on 
preoperative, intraoperative, and early postoperative risk factors. Early prediction of 
complications would allow for correction of modifiable conditions in order to decrease the 
risk. It would also help to plan postoperative monitoring and level of care, precluding 
unnecessary “preventive” ICU stay.  
In this study, we used two different statistical methods to develop the model. We applied 
stepwise forward-backward algorithm and lasso algorithm to first select variables within each 
group (preoperative, intraoperative, postoperative). After within-group selection, we 
combined the selected covariates from each group and repeated the above-mentioned 
procedures to select the final predictors. Finally, we used these predictors to fit the logistic 
regression model. The final stepwise regression model was built with 11 predictors (1 
preoperative, 3 intraoperative, and 7 postoperative) and it demonstrated a good within sample 
discrimination (AUC 0.95). However, the model with so many predictors can be cumbersome 
for the clinical application and it predominantly selected predictors from the postoperative 
period. It was shown that the inherent problem with the stepwise regression is that variables 
selected in later steps may represent noise, thereby causing the overfitted model, unable to 
perform well during external validation.257 On the other hand, the final lasso model was built 
with 7 predictors: 1 from the preoperative period (history of diabetes), 1 from the 
intraoperative period (multiorgan resection), 2 from admission to the ICU (heart rate and base 
excess), 1 obtained 12 hours after ICU admission (heart rate), and 2 recorded on the first 
postoperative day (albumin concentration and transfusion within 24 hours). The model 
showed good performance, both within sample (AUC 0.93, PPV 0.87) and after 10-fold 
cross-validation (AUC 0.90, PPV 0.84). 
It is estimated that around 20% of patients list diabetes as comorbidity when admitted for an 
operation.258 The association of diabetes, short-term and long-term glycemic control with 
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adverse postoperative outcomes such as major adverse cardiac events, surgical site infections, 
pneumonia, and sepsis have been proven by many studies.259,260 It has been shown that 
patients who develop diabetes-related complications have 13 times greater odds for 30-day 
mortality following colorectal surgery.261 Diabetic patients also have a longer length of 
hospital stay irrespective of the type of surgical procedure and higher odds for late 
cardiovascular events.262 In our study, history of diabetes was the single most important 
preoperative predictor of complications, as diabetic patients were 7.5 times more likely to 
develop at least one postoperative complication. To date, no studies have analyzed the impact 
of diabetes severity, associated comorbidity and short-term preoperative glycemic control 
taken together on the occurrence of complications after abdominal surgery. According to the 
American Diabetes Association perioperative hyperglycemia influences postoperative 
outcome more than the HbA1c.
263 Further studies are needed to determine which of the 
optimization strategies can be safely implemented in diabetic patients and whether the 
postponement of the elective surgery to achieve better glycemic control or to optimize 
chronic diabetes-related conditions would yield any benefit. 
The multiorgan resection was ascribed the highest regression coefficient in the model we 
developed, suggesting the greatest contribution to the overall risk for complications. It is not 
surprising given that only one patient with multiorgan resection in our study experienced no 
complications. The association of multiorgan resection with complications was addressed in 
previous studies, many of them asking whether it is worth the risk that it engenders. Martin et 
al in the large retrospective study of more than 1200 patients who underwent gastrectomy 
found that the resection of two or more organs was the single independent predictor of 
postoperative morbidity.264 Similar conclusions were made by Ozer and associates.265 
Patients with multiorgan resection due to the advanced colorectal cancer were shown to have 
a good overall survival and long-term outcomes, despite a more complicated postoperative 
course.266 Multivisceral resections in complex hepatic and pancreatic surgery were 
particularly burdened with postoperative morbidity.267 All patients with multiorgan resection 
in our study were operated for cancer. We believe that the chronic inflammation already 
present in the locally advanced cancer was additionally amplified by the inflammation of 
surgical stress, which may explain the high rate of complications seen in this category of 
patients. Furthermore, many of them received blood transfusion which can also be the 
contributing factor for worsening prognosis, probably via immunosuppressive mechanisms 
and higher susceptibility to infections.268 
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Excessive sympathetic activity during systemic inflammatory response syndrome (SIRS) 
causing tachycardia was shown to be associated with worse prognosis in patients with sepsis 
or congestive heart failure.269,270 The deleterious effect of catecholamines may be also 
attributed to immunosuppression and metabolic changes they produce. Postoperative 
tachycardia is generally considered to be a foreseeable consequence of the released 
catecholamines in response to surgical stress, usually of benign nature and transient. In non-
cardiac surgery, it is commonly attributed to large volume shifts, mechanical stimulation 
during the operation, or postoperative pain and hence not taken seriously. However, it was 
shown that postoperative tachycardia within 4 days following non-cardiac surgery was the 
independent predictor of adverse outcomes, such as pulmonary embolism or elevated 
troponin.271 Haskins et al reported that sustained tachycardia was associated with serious 
adverse events after ventral hernia repair.272 Heart rate both on admission to ICU and 12h 
later was selected in the final model for prediction of complications in our study. Even 
though heart rate 12 hours following admission had non-significant regression coefficient, it 
couldn’t be removed from the model, since the model’s performance decreased consequently. 
Recent evidence suggest that beta-blockade could afford beneficial effects to patients in 
sepsis through suppression of inflammation, modification of metabolic status, improvement 
of glucose homeostasis, and control of tachycardia.273 Similarly, the protective short-term 
effect of beta-blockers was demonstrated in patients after non-cardiac surgery.274 
Base excess (BE) has been traditionally used to assess the metabolic status and is considered 
to be the most reliable indicator of the non-respiratory component of the acid-base balance.275 
It is a better indicator of clearance of metabolic acidosis than pH and is superior in the 
prediction of complications and mortality after trauma.276 A recent systematic review 
concluded that a BE less than -6 mmol/l is predictive of mortality in trauma patients.277 Base 
excess was found to correlate with fluid requirement and hypovolemic shock and this 
association was attributed to tissue hypoperfusion and hypoxia.275 Abdominal surgery is 
accompanied with significant fluid losses, infusions of large volumes of saline, hypotension, 
hypothermia, and hypoxemia, and it is not surprising that the metabolic acidosis with 
decreased BE was found to be the most frequent acid-base disorder upon admission to ICU 
following surgery.278 Our results confirm the findings of previous studies. Although with 
non-significant regression coefficient, BE on admission to ICU was selected by lasso 
regression and included in the final model as this improved the model’s predictive 
characteristics. Prognostic value of BE for complications and mortality was previously 
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confirmed in populations of critically ill patients, after cytoreductive surgery with 
hyperthermic intraperitoneal chemotherapy, and cardiac surgery.279–281 Davis et al in a study 
that included patients with ongoing resuscitation due to bleeding trauma, classified them into 
three groups according to the value of deranged BE : mild, 2 to -5 mmol/l; moderate, -6 to -
14 mmol/l; and severe, < -15 mmol/l. These authors concluded that the increasing base deficit 
was associated with the increasing volume of fluid needed for resuscitation and that further 
decline of BE despite the resuscitation was suggestive of ongoing bleeding.282 Several studies 
have shown that BE and lactate concentration can be used complementary to predict the 
outcome and to identify patients that would benefit from the admission to the ICU.279,281 The 
improvement in BE upon resuscitation in the ICU was associated with improved prognosis.281  
Stress response during critical illness and following surgery has been comprehensively 
studied in an attempt to find a suitable marker of its extent and severity. Some of the 
indicators are not easily measurable, like insulin resistance for instance, and some of them, 
like interleukin-6 have never become a part of routine clinical practice. The slow kinetics of 
CRP impacts the rise of its value only 2-3 days following surgical trauma. Albumin is the 
serum protein that normally makes near 60% of proteins in human plasma. It is also a 
negative acute phase protein since it is downregulated by inflammatory mechanisms during 
major stress.283 In contrast to CRP, albumin concentration declines sharply immediately after 
trauma, making it a sensitive measure of surgical stress.283 Mechanisms behind the sudden 
albumin drop after surgery are not completely understood. They involve the exaggerated 
catabolism, impaired hepatic synthesis, and displacement into the third space.284 One of the 
most interesting recent explanations is the hypothesis of occult protein-losing enteropathy 
that arises from the stress-induced derangement of splanchnic circulation.285 Serum albumin 
concentration on postoperative day 1 (POD 1) was shown to be strongly predictive of 
complications in our study. As shown by our data, a decrease in albumin concentration by 
1g/l increases the probability of complications by around 40%. This finding is in accordance 
with previous studies in the field of major abdominal surgery. Labgaa et al found that the 
postoperative drop in albumin concentration on POD 1  by > 10g/l was associated with a 
threefold increase in the rate of complications.286 Albumin decline after gastrectomy was 
shown to be more predictive for the outcome than the CRP value, while in the patients 
undergoing laparoscopic colorectal surgery for treatment of carcinoma it was the only 
independent factor associated with severe complications.287,288 However, the common 
practice of endless infusions of human albumin to treat postoperative hypoalbuminemia seem 
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to be without evidence-based justification. Previous randomized controlled trials 
demonstrated that the postoperative albumin supplementation was not beneficial in correcting 
hypoalbuminemia, nor led to the improvement of postoperative outcome after gastrointestinal 
surgery.289,290  
Allogenic blood transfusion still represents the cornerstone in the treatment of perioperative 
anemia. Anemia is a common condition in patients undergoing abdominal surgery, both 
preoperatively due to the nature of the underlying disease, and postoperatively as the 
consequence of perioperative bleeding. It was shown that anemia increases postoperative 
mortality and is associated with the increased needs for transfusion.291 However, the 
associated adverse effects may overcome the benefits of allogenic blood transfusions, many 
of which are not easy to explain.292 There are some possible pathways by which allogenic 
blood transfusion may worsen the outcome, and the most prominent is the transfusion-related 
immunomodulation and immunosuppression making patients more susceptible to infections 
or the development of distant metastases and cancer recurrence.293 Storage of packed red 
blood cells contributes to changes that diminish the principal function of transfusion, which is 
the oxygen delivery to tissues.294 Besides, storage lesions impair deformability of 
erythrocytes resulting in a reduced microvascular flow.294 There are many studies that clearly 
demonstrate the detrimental effect of transfusion on short-term and long-term outcomes of 
patients undergoing major abdominal surgery.203,295,296 The recent work by Veličković et al, 
conducted in a large cohort of patients operated for esophageal cancer showed that allogenic 
blood transfusion was not associated with long-term survival.297 One of the determinants of 
survival in this study were major complications, and they were significantly more common 
among transfused patients. It is difficult, however, to undisputably claim that the association 
of blood transfusion and outcomes is a causal one. The aforementioned results come from the 
observational studies and the effect of potential confounders can’t be ruled out. For example, 
it may be that the indication for transfusion, such as surgeon’s inexperience or the locally 
advanced tumor that caused intraoperative bleeding were the real source of complications and 
not the transfusion itself.298 
Transfusion within the day of surgery was selected in the final model for the prediction of 
complications in our study. We performed several selection procedures during our data 
analysis, and this predictor has always been selected regardless of the applied algorithm. It 
was shown that the problem of correlations in the design matrix doesn’t affect lasso 
prediction if the appropriate selection of the tuning parameter lambda was performed.299 
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Lasso is known for its tendency to pick one while ignoring the rest among the very correlated 
predictors. It is interesting that blood transfusion in our study was not highly correlated with 
preoperative hemoglobin nor with the intraoperative bleeding, which features the liberal 
transfusion policy at our institution. Therefore, we believe that transfusion itself was the real 
predictor of complications. 
The calculation of the probability for complications requires values of the seven selected 
predictors. For instance, 60-year old patient, without a history of diabetes, who underwent 
left hemicolectomy, whose heart rate on admission to ICU was 62/min and BE on admission -
0.2 mmol/l, whereas heart rate 12 hours after admission to ICU was 63/min, who hadn’t been 
transfused and whose albumin concentration on the first postoperative day was 36g/l, would 
have 4% chance of developing postoperative complication. On the other hand, 42-year old 
patient, without history of diabetes, who underwent multiorgan resection for locally advanced 
gastric cancer, whose heart rate and BE on ICU admission were 103/min and -3.1 mmol/l and 
heart rate after 12 hours was 105/min, who received transfusion and whose albumin level on 
the first day was 18g/l, would be predicted to have 100% chance for postoperative 
complications. 
Our model has several limitations. First, we used dichotomized variables for some of the 
categorical predictors with more than 2 levels. It certainly made the analysis easier, but we 
maybe missed the chance to get more sophisticated information. Second, we didn’t include in 
the analysis some of the variables that were previously described as predictors of 
postoperative morbidity, such as malnutrition or frailty. Instead, we used other surrogate 
indices such as body mass index, weight loss, functional activity, or the number of drugs as  
chronic therapy. Third, we tried to collect and analyze as much information as possible  
which resulted in more than a hundred variables that were finally analyzed. However, we 
didn’t include data regarding the performance of the attending surgeon and the 
anesthesiologist, which are difficult to measure objectively. The literature suggests the use of 
some surrogate measures, such as the experience, the volume expressed in the number of 
specific procedures per year, or the position. We don’t think that these substitutes accurately 
describe the performance in each situation. On the other hand, we intuitively feel that the 
occurrence of complications is not dependent solely on objective measures.  
The strength of the model is that it includes information from the early postoperative period. 
To the best of our knowledge, there are no suggested risk scores for prediction of 
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complications to date that take into account the risk factors from the immediate postoperative 
period along with preoperative and intraoperative information. Lasso penalty was shown to 
correctly select the subset of important predictors. We demonstrated that the predicted 
probability for complications strongly correlates with the CCI. Therefore, the clinicians are 
given an opportunity to make decisions regarding the postoperative strategies and the process 
of care with more data than before the operation. This model was validated in an independent 









1. The postoperative complication rate in high-risk patients after major abdominal surgery is 
high as the complications occur in more than half (60.7%) of the patients. Complications 
significantly increase ICU stay and postoperative length of hospital stay and are associated 
with lower functional activity on discharge from the hospital. 
 
2. The Comprehensive Complication Index and the Clavien-Dindo classification are the 
effective methods for reporting of complications after major abdominal surgery. With equal 
or better correlation with hospital length of stay and the possibility to take into account the 
overall burden of complications, the CCI may be the more accurate scale in high-risk patients 
with a likelihood for multiple complications. 
 
3. POSSUM score is inaccurate for morbidity prediction in high-risk surgical patients as it 
significantly under-predicts in low-risk groups. The use of the POSSUM score to predict 
mortality is inappropriate in our patient population because of the poor calibration and the 
huge over-prediction. P-POSSUM score is the accurate tool and its use can be suggested in 
high-risk patients undergoing major abdominal surgery for mortality prediction and for the 
comparative surgical audit.  
 
4. Peripheral perfusion early after major abdominal operations was more markedly altered in 
patients who developed a more complicated postoperative course (CCI>50). Central-to-toe 
temperature gradient after surgery could best discriminate patients with the CCI > 50 on 
admission to ICU following surgery. Lactate concentration demonstrated the best 
discrimination of the CCI > 50 12 hours after the admission. Capillary refill time, central-to-
toe temperature gradient, and venoarterial pCO2 to arteriovenous oxygen content ratio on 
admission to ICU, as well as lactate concentration and base excess 12 hours after the 
admission were the independent predictors of the more complicated postoperative course. 
 
5. We developed a risk score based on seven predictors (diabetes, multiorgan resection, heart 
rate and base excess on admission to ICU, heart rate 12 hours after admission to ICU, 
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albumin on the first postoperative day, and transfusion on the day of surgery) selected by 
lasso methodology to predict complications in high-risk patients after elective major 
abdominal surgery. The model was validated in the separate cohort of patients and it 
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Figure 2. Study workflow; BMI-body mass index; SBP-systolic blood pressure; MAP-mean arterial pressure; CVP-central venous 
pressure, SpO2 –oxygen saturation; ScvO2-central venous oxygen saturation; BE-base excess: AG-anion gap; CRT-capillary refill 
time; delta T-central-to-toe temperature difference; SAPS II-Simplified Acute Physiological Score; LOS-length of stay; CD- 
Clavien-Dindo Classification; CCI – The Comprehensive Complication Index 
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